UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2018
or
o
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                     to                
 
Commission file number: 001-37515
 
Aqua Metals, Inc.
(Exact name of registrant as specified in its charter)
Delaware
 
 
 
47-1169572
(State or Other Jurisdiction of
Incorporation or Organization)
 
 
 
(I.R.S. Employer Identification
Number)
2500 Peru Dr.
McCarran, Nevada 89437
(Address of principal executive offices)
 
(775) 525-1936
(Registrant’s telephone number, including area code) 
Securities registered pursuant to Section 12(b) of the Act:
Name of Each Exchange on Which Registered:
 
 
Common Stock
The Nasdaq Capital Market
 
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes o No x
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x  No o
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x  No o
 
Indicate by check mark if disclosure of delinquent filers in response to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company (as defined in Rule 12b-2 of the Act):
Large accelerated filer o
 
Accelerated filer  x
 
 
 
Non-accelerated filer o
 
Smaller reporting company  x
 
 
Emerging Growth Company x
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)
Yes o No x

State the aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $100,626,250.
 
The number of shares of the registrant’s common stock outstanding as of February 26, 2019 was 44,354,852.
 
DOCUMENTS INCORPORATED BY REFERENCE
 
Portions of the registrant’s definitive proxy statement for the registrant’s 2019 Annual Meeting of Stockholders to be filed pursuant to Regulation 14A within 120 days of the registrant’s year ended December 31, 2018 are incorporated herein by reference into Part III of this Annual Report on Form 10-K.



TABLE OF CONTENTS

 
 
 
Page
 
 
 
 
 
 
20
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




CAUTIONARY NOTICE
 
This annual report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Those forward-looking statements include our expectations, beliefs, intentions and strategies regarding the future. Such forward-looking statements relate to, among other things,
our future financial and operating results;
our intentions, expectations and beliefs regarding anticipated growth, market penetration and trends in our business;
the timing and success of the roll-out of our first 16 Aqua refining modules; 
the ability to maximize selling value from the broken lead-acid batteries, or LABs;
the timing and success of our plan of commercialization;
our ability to operate our AquaRefining process on a commercial scale;
our ability to realize the expected benefits of our strategic partnership with Johnson Controls;
our ability to procure LABs in sufficient quantities at competitive prices;
the success of our first LAB recycling facility near Reno, Nevada;
the availability of working capital to pursue the development of additional recycling centers;
the effects of the putative class action and shareholder derivative lawsuits filed against us;
the timing and success of our development of additional recycling facilities;
the effects of market conditions on our stock price and operating results;
our ability to maintain our competitive technological advantages against competitors in our industry;
our ability to have our technology solutions gain market acceptance;
our ability to maintain, protect and enhance our intellectual property;
the effects of increased competition in our market and our ability to compete effectively;
costs associated with defending intellectual property infringement and other claims;
our expectations concerning our relationships with suppliers, partners and other third parties; and
our ability to comply with evolving legal standards and regulations, particularly concerning requirements for being a public company and environmental regulations.


1



These and other factors that may affect our financial results are discussed more fully in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in this report. Market data used throughout this report is based on published third party reports or the good faith estimates of management, which estimates are presumably based upon their review of internal surveys, independent industry publications and other publicly available information. Although we believe that such sources are reliable, we do not guarantee the accuracy or completeness of this information, and we have not independently verified such information. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur, and we urge readers to review and consider disclosures we make in this and other reports that discuss factors germane to our business. See in particular our reports on Forms 10-K, 10-Q, and 8-K subsequently filed from time to time with the Securities and Exchange Commission.


2



PART I
 
Item 1.
Business
 
Background
 
We were formed as a Delaware corporation on June 20, 2014 for the purpose of engaging in the business of recycling lead through a novel, proprietary and patent-pending process that we developed and named “AquaRefining”. Since our formation, we have focused our efforts on the development and testing of our AquaRefining process, the development of our business plan, the raise of our present working capital and the development of our initial lead acid battery, or LAB, recycling facility in the Tahoe Regional Industrial Center, McCarran, Nevada (“TRIC”).
 
We completed the development of our first LAB recycling facility at TRIC and commenced production of battery breaking and limited operations during the first quarter of 2017. The TRIC facility now produces varying products for commercial sales primarily consisting of ingoted AquaRefined lead, lead compounds, ingoted hard lead and as well as plastic. In April 2017, we commenced the shipment of products for sale, consisting of lead compounds as well as plastics. In April 2018, we commenced the limited production of lead bullion, including AquaRefined lead. In July 2018, we commenced the sale of pure AquaRefined lead in the form of two tonne blocks, and in October 2018, we commenced the sale of AquaRefined lead in the form of battery manufacturing ready ingots. In November 2018, we received official vendor certification from Johnson Controls for our AquaRefined lead and in December 2018, we commenced shipments directly to Johnson Controls owned and partner battery manufacturing facilities.
After several months of engaging in extensive diligence and engineering evaluations, on February 28, 2019, we has entered into an Operations, Management and Maintenance Agreement with Veolia North America Regeneration Services LLC (Veolia) to provide operations, maintenance and management services at our Aqua Metals' AquaRefining facility in McCarran, Nevada.
Veolia is expected to contribute operational and technological expertise and organizational capabilities in aqueous based process chemistries and electrolysis along with taking on responsibility for operations, supply chain, offtake and management of the plant. Veolia employees will begin working onsite starting March 4, 2019 at the McCarran facility. In addition to receiving expertise and support from Veolia North America resources overall, this Agreement provides for Veolia to relocate up to six (6) full time employees with strong operations, process engineering, management expertise to join the Aqua Metals team at our AquaRefinery in McCarran, Nevada. Veolia North America will take over the primary responsibility for scaling the facility through the remainder of 2019 to CP1-16 (Commercial Plant 1, 16 AquaRefining modules) of capacity. The Agreement also provides for Veolia and Aqua Metals to work together to plan in 2019 and complete the expansion of the TRIC facility to 32 AquaRefining modules.

We believe the Agreement will allow us to leverage off Veolia’s supply chain and offtake and waste stream buying power and expertise. The intention of the parties is to grow the relationship where Veolia will serve as Aqua Metals’ go to market execution partner to staff and manage AquaRefining facilities with mutually agreed performance metrics for Aqua Metals and our partners. We expect this will begin with the first facility we deploy with Johnson Controls Power Systems Division (being transitioned to Brookfield Asset Management, which has over $350B of assets under management) as a part of our efforts to complete the Joint Development Agreement with them by June 2019, with the blueprint for deploying AquaRefining upgrades to existing battery recycling facilities. A more complete summary of the terms of the Agreement is set forth in Part II, Item 9.B. "Other Information."

Veolia North America Regeneration Services, LLC is the wholly-owned subsidiary of Veolia Environnement S. A. (Paris Euronext: VIE). Veolia​ Environnement is the global leader in optimized resource management. With nearly 169,000 employees worldwide, Veolia Environnement designs and provides water, waste and energy management solutions that contribute to the sustainable development of communities and industries. Through its three complementary business activities, Veolia Environnement helps to develop access to resources, preserve available resources, and to replenish them. In 2017, Veolia Environnement supplied 96 million people with drinking water and 62 million people with wastewater service, produced nearly 55 million megawatt hours of energy and converted 47 million metric tons of waste into new materials and energy. Veolia Environnement recorded consolidated revenue of USD 30.1 billion in 2017. www.veolia.com.

Unless otherwise indicated, the terms “Aqua Metals”, “Company”, “we,” “us,” and “our” refer to Aqua Metals, Inc. and its wholly-owned subsidiaries.
 
All references in this report to “ton” or “tonne” refer to a metric ton, which is equal to approximately 2,204.6 pounds.
 
Since our organization in 2014, we have engaged in several capital raising transactions, the most recent of which are summarized below in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - General.”
 

3



Overview
 
Aqua Metals is seeking to reinvent lead recycling with its patented and patent-pending AquaRefining technology. Unlike smelting, AquaRefining is a room temperature, water-based process. It is deployed as a factory built modular system which allows the lead-acid battery industry to simultaneously improve environmental impact and scale production to meet demand. Aqua Metals has built its first recycling facility in Nevada’s Tahoe Reno Industrial Complex. Lead is a globally traded commodity with a worldwide market value in excess of $20 billion. Lead acid batteries (LABs) are the primary consumer use of all lead produced in the world. Because the chemical and metallurgical properties of lead allow it to be recycled and reused indefinitely, LABs are also the dominant feed source for lead production across the world. As such, LABs are almost 100% recycled for purposes of capturing the lead contained therein for re-use. We believe that our proprietary and patented AquaRefining process will provide for the existing LAB recycling facility to leverage our capabilities for expanded production of a much higher purity lead with fewer environmental and regulatory issues than is possible with the current conventional methods of lead production.
 
In recent years, recycled lead has become increasingly important to LAB production. Recycled lead surpassed mined lead in the 1990s and now represents more than 60% of the lead content in new LABs. Whether it is produced from lead ore or recycled LABs, lead has historically been produced by smelting. Smelting is a high-temperature, metallurgical/chemical reduction, energy intensive and often a highly polluting process. As a consequence of the environmental and health issues, lead smelting has become increasingly regulated in many countries. In the U.S., regulatory non-compliance has forced the closure of large lead smelters in Vernon, California, Frisco, Texas and Herculaneum, Missouri over the last several years. In response to increasing environmental regulation over the past three decades, there has been an expansion of LAB smelting capacity in Mexico and other less regulated countries. The resulting transportation of used LABs from where they originate in the U.S. to smelters in Mexico, South Korea, the Philippines and elsewhere is an increasingly significant logistical and global environmental cost.
 
AquaRefining uses a bio-degradable aqueous solvent and a novel ambient temperature electro-chemical process to produce lead suitable for use in LAB production. Our AquaRefining process produces lead with a purity that is equivalent to primary lead (i.e., higher than 99.99% purity). We believe that AquaRefining can provide a more efficient production process as compared with alternative methods of producing equivalent grades of lead. We also have the potential to locate AquaRefining facilities closer to the source of used LABs, thereby reducing transport costs and supply chain bottlenecks. On this basis, we believe that AquaRefining reduces environmental plant emissions, health concerns and permitting needs compared with lead smelting. We believe that the combined advantages offered by AquaRefining represent a potential step change in lead recycling technology that includes improved product quality, advantages in footprint and logistics as well as reduced environmental impact.
The modular nature of AquaRefining makes it possible both to start LAB recycling at a smaller scale than is possible with a typical smelter setup, and to add AquaRefining to existing battery recycling operations to expand production capacity or to reduce smelting processes. Our plan is to pursue two complementary business streams. The first is to supply AquaRefining and supporting equipment to third parties to supplement or replace smelting in their battery recycling operations. We intend to pursue this at least initially through our relationship with Johnson Controls Inc., with which we have entered exploratory discussions centered on the addition of AquaRefining to one of its existing battery recycling operations. We also intend to pursue similar arrangements with other companies operating recycling operations. The second is to expand our own lead recycling operations at our plant in McCarran, Nevada, subject to our receipt of additional capital.
 
Our Markets
 
The Lead Market
 
Lead is a globally traded metal commodity and is the essential component of over 80% of the world’s rechargeable batteries. Lead is globally traded primarily on the London Metals Exchange, or LME, although the smaller Shanghai Metals Exchange (SHME) in China also trades the element. Conventionally in the industry, there are two separate groupings of lead: i) primary lead which refers to lead produced at primary smelters that use mined lead concentrates (generally lead sulfide) as their major feedstock, and ii) secondary lead which refers to lead smelters utilizing LABs as their main feed source.
 
Originally, the majority of the lead used in batteries was sourced from primary smelters but in recent decades, secondary lead has grown to become the dominate product used. Industry data shows that six million metric tons of lead was produced in 1995 of which approximately 45% was primary and 55% was from secondary sources. Twenty years later, by 2015, global lead production had increased to approximately 11 million metric tons, of which more than 65% was secondary. Importantly, primary lead production had increased only marginally during this period. This marginal increase is partially due to lead-zinc mine deposits are being depleted across the globe in existing mines. As such, an increasing quantity of primary lead is now the predominate byproduct of zinc mining.
 
In 2005, secondary lead traded on the LME in a range of $1,000 to $1,200 per metric ton. During 2018, secondary lead traded in a range of approximately $1,900 to $2,700 per metric ton.

4



 
As noted above, although lead is traded as a commodity on the LME/SHME, the major sales are the sales directly between producers/ traders and users (whom are typically battery manufacturers). The LME daily price is used as the benchmark in forming the basis of physical trades, forward contracts and hedge strategies for both primary and secondary lead. Based on market and product knowledge with buyers of lead in the U.S. and Global lead markets, different grades (termed alloys) of lead are traded at a premium to the base LME price. Lead alloys, which are generally specifically designed for the customer, are also sold at a premium above the base LME, whereas by-products (generally lead compounds or scrap) are traded at a discount to the LME as they are based on the lead content and its form. 
 
Lead Smelting
 
Currently, smelters produce virtually all the world’s mined and recycled lead. Smelting is an energy intensive and, in some poorly managed plants, a highly polluting process. At its core, smelting is a relatively high temperature (excess of 900°C) metallurgical reduction process in which lead compounds are heated and reacted with various reducing agents to remove the oxygen, sulfur, and other impurities. The process leaves behind bullion lead and waste slag. In smelting, depending upon the operation, 0.5% to 5% of the lead can be lost to the “slag”, with the resultant lead bullion containing both wanted and unwanted impurities.
 
In developed countries, there is both increased environmental regulation and enforcement of such, including monitoring of permissible blood lead levels in employees and local populations. These regulations and the increasing enforcement have made it more expensive to operate smelters. According to a report titled “Hazardous Trade?” produced by the Secretariat of the Commission for Environmental Cooperation in 2013, this has led to a decline of lead smelters in the U.S., an expansion of smelting operations in Mexico and a resultant increase in the export of used LABs from the U.S. followed by the re-import of recycled lead. This trade is believed to be largely driven by the lower costs related to the less stringent environmental standards and enforcement in Mexico. For the foregoing reasons, we believe that lead smelting facilities are increasingly located in less regulated areas remote from both the source of used LABs and the demand for lead. We believe that the remote location of smelting increases the transport costs to the production of recycled lead.
 
Lead Acid Batteries
 
Although the LAB is one of the earliest battery technologies, in terms of energy capacity deployed and installed manufacturing capacity, it still dominates the battery industry today. Historically, the largest market for LABs has been as starter batteries for vehicles. However, with the increasing electrical load on modern vehicles and the adoption of “Stop-Start” conventional 12V “starter batteries”, LABs are evolving into more capable and higher value products. At the same time, large new markets such as Cell Tower, Data Center and Industrial back-up are adding to demand. Consequently, existing LAB production facilities are being expanded and new facilities are being built.

According to CHR Metals, total lead output in 2017 was expected to be 20% higher than it was in 2012. Similar prospects for healthy growth in the lead industry continue to be published and support continued growth in demand for lead for at least the next 20 years. We believe that grid storage and other energy storage applications linked to renewable energy (solar and wind) will also generate increased demand for LABs, where low cost, safety and reliability will make them attractive options.
 
The increase in LAB manufacturing in general and particularly in China, India and Southeast Asia, has increased demand for lead, putting pressure on global recycling networks to meet this demand. At present, we believe that much of the LAB recycling performed outside of the U.S., Canada, the EU, Japan, and Australia is carried out in outdated facilities with poor environmental standards and insufficient enforcement. China, India, Pakistan and South America appear to be moving toward tougher regulation and enforcement. We believe that this will drive a demand in foreign markets for more less polluting LAB recycling processes.
 
AquaRefining Process
 
We developed AquaRefining to be a less expensive, cleaner and modular alternative to smelting. Our process has two key elements, both of which are integral to our issued patents and pending-patent applications. The first is our use of a proprietary, non-toxic solvent that dissolves lead compounds. The second is a proprietary electro-chemical process and electrolyzer that converts the dissolved lead compounds into high purity lead suitable for use in LAB production.
 
Similar to conventional LAB smelter recycling, our AquaRefining process begins with the crushing of used LABs and the separation of the metallic lead, active material (lead compounds), sulfuric acid and plastic for recycling. The active material (lead compounds) are first processed to remove sulfur and then dissolved in our solvent. Lead is then plated from the solvent using our patented and patent-pending process allowing the solvent to be reused.
 
Our AquaRefining process can generate the following outputs:
 

5



Lead and lead-based products, including high purity lead, lead alloys and lead compounds which are primarily intended for the LAB industry. We are also exploring higher value lead-based products which may offer performance and life-cycle benefits to the LAB industry; and
Recovered plastic chips, intended for re-use in the manufacture of battery casings and other recycled plastic products.

We expect to derive revenue primarily from the sale of lead-based products, with additional revenue derived from the sale of plastic chips.
 
A significant benefit of our AquaRefining process is that it is capable of producing higher purity product than that derived from primary smelters with product from secondary sources. As indicated above, primary grade lead is generally sold directly to battery companies.
 
Another significant benefit of our process is that we designed our AquaRefining equipment to be manufactured on a purpose-built production line in standard sized modules. This is not possible with the smelting process, as smelters need to be constructed on site. This gives us the ability to provide AquaRefining systems with capacities ranging from four metric tons per day to more than 400 metric tons per day all based on our standard module.
 
Lead recycling is subject to a variety of domestic and international regulations related to hazardous materials, emissions, employee safety and other matters. While our operations will be subject to these regulations, we believe that one of our potential advantages will be our ability to conduct lead recycling operations with less regulatory cost and burden than smelting operators due to the nature of our process. One of our key objectives will be to educate regulators and the public as to the environmental benefits of AquaRefining. We believe that we have the potential to develop a business model that offers the opportunity to conduct, in an environmentally friendly manner, an important recycling activity that historically has been conducted in an often highly polluting manner.
 
Our Business Model

Overall, our objective is to progress the lead recycling industry from one which is based primarily on smelting to one which is based on AquaRefining. Our expectation is that this will be a moderately paced process of evolution in which multiple business models will be evaluated. The two business models that we are currently most focused on are:

1)
the supply of AquaRefining and supporting equipment and services to third parties to use in their recycling operations on a licensing model. We are currently focused on exploring this business stream through our relationship with Johnson Controls;
2)
the expansion of our own AquaRefining capacity and facilities, subject to our receipt of additional capital.

The market for lead is global in scale but local in nature and execution, with large differences in local regulation, custom and practice. In some regions, it is highly regulated, and in others it is not. Consequently, we are evolving our business model to commercialize our technology optimally across multiple locations.
 
Lead recycling is subject to a variety of domestic and international regulations related to hazardous materials, emissions, employee safety and other matters. While our operations will be subject to these regulations, we believe that one of our potential advantages will be our ability to conduct lead recycling operations with less regulatory cost and burden than smelting operators. One of our key objectives will be to educate regulators and the public as to the environmental benefits of AquaRefining. We believe we have the potential to develop a business model that offers less regulatory cost and burden and the opportunity to conduct business in a socially responsible manner.
 
In the U.S. and similarly regulated countries, our plan is to build and operate LAB recycling facilities, both directly and in association with third parties through joint ventures, licensing and direct sales. As an example, on February 7, 2017, we entered into a series of agreements with Johnson Controls Inc., (Johnson Controls), pursuant to which, among other things, we agreed to work with Johnson Controls on the development of a program for upgrades of Johnson Controls’ and certain strategic partners’ of Johnson Controls existing lead smelters throughout North and South America, China and Europe to a lead recycling process utilizing our proprietary and patented AquaRefining technology and equipment, know-how and services.
 
Competition
 
At the present time, our primary competition in the production of lead comes from operators of existing smelters and other parties heavily invested in the existing supply chain for smelting. Our approach to this competition is to make AquaRefining available for the conversion of existing smelter-based facilities. However, it is prudent to assume that outside of our strategic relationships, a conversion to AquaRefining may be resisted by some of the incumbent lead producers. Competition in the supply of lead from such incumbents may come in the form of price competition for lead produced. However, to the extent we are successful in being a producer of high quality

6



lead without the regulatory costs or burden associated with smelting, we should be able to compete effectively with smelting as the preferred method of recycling lead, at least in the more regulated jurisdictions.
 
Another area where incumbents may seek to compete is in controlling access to used LABs. The market for used LABs is made up of the members of the LAB reverse supply chains, including auto repair shops, auto parts stores and auto dealers, LAB manufacturers who operate their own smelting operations and third parties who engage in the purchase and sale of used LABs. We believe that some LAB manufacturers who maintain their own smelting operations may feel threatened by our AquaRefining process. Such parties may attempt to restrict our access to used LABs. We have assumed at least some level of interference by incumbents, however, based on our operations to date, including our discussions and arrangements with certain suppliers of used LABs, we do not view access to used LABs be a significant risk to our LAB recycling operations.
 
Our business plan is not dependent on the acceptance of our process by lead smelters. We still intend to initially focus on operating our own AquaRefining facilities directly and working with Johnson Controls to implement Aqua Refining in a nominated lead smelting facility followed by deployments with additional 3rd parties to propagate AquaRefining as the technology of choice for recycling LABs.
 
We do not expect to experience significant competition in connection with our sale of lead. We believe that the market for lead is established, fluid and effective; and like the markets for other natural resources, such as oil, gas, gold, silver, etc., we do not expect to encounter any issues, conditions or qualifications for the sale of our lead production at prevailing market prices set by the LME. The vertically integrated LAB manufacturers who conduct smelting operations also are buyers of lead from third parties. We believe that they will still purchase lead from us if we are able to offer it at the market price.
 
Our First Recycling Facility: McCarran, Nevada
 
In May 2015, we purchased 11.73 acres of undeveloped land in the Tahoe Reno Industrial Center (TRIC), at McCarran, Nevada where we subsequently built a 136,750 square foot LAB recycling facility.
 
The building phase was completed by August 2016, at which time we started installing and commissioning equipment. We installed and commissioned the first production AquaRefining module in October 2016 and produced our first lead ingot using electrolyte we produced on-site using materials supplied by a third party, which were recovered from recycled batteries. We verified that the lead we produced by this method was over 99.99 percent pure.
We commenced initial battery breaking during December 2016 and progressed to regular single shift operation of the battery breaker in January 2017. From late 2016 through the date of this report, we implemented a number of upgrades to the facility, the battery breaking and separation processes and other more conventional aspects of our process.
 
As of December 2017, we had installed 16 AquaRefining modules at TRIC.  To date, we have operated the first four of the 16 modules and have made continuous improvements which have led to individual modules running in a steady state producing 100Kg/hour for several days at a time. As we bring the modules into commercial operation, we expect to continue to adjust the modules to further enhance operation. Although we staffed the facility and ran one or two AquaRefining Modules on a 24x7 basis from October to December 2018, we are currently running one or two modules 24-hours a day, four days a week to allow safe times for some of the key work to be completed for our contribution margin improvement projects. Subject to key work being completed in the first quarter of 2019, we intend to re-instate 24‑hour, seven days a week, continuous operations shortly thereafter and scale to running all four of the initial four modules before bringing the next four modules on line. We believe this operational strategy will allow us to maximize lead production, while enabling the remaining components of the plant to be synchronized in support of increased AquaRefining. Once we are satisfied with the operation of the first four modules, additional modules will be brought into production. This process will be repeated until full production is reached with all 16 modules. Our goal is to operate all 16 modules on a 24/7 continuous basis by the end of 2019. However, due to the delays and unforeseen issues in the completion of the AquaRefining production line we have experienced to date, there can be no assurance that we will not encounter additional delays and issues. 
Supply, Off-Take and Other Strategic Agreements
 
In support of our first facility, we have entered into a series of agreements and relationships providing for our supply of LABs and the off-take of the recycled lead we produce. As described in more detail below, Interstate Battery has agreed to supply us with LABs pursuant to a written agreement entered into in May 2016. In addition, we have established an important relationship with Battery Systems. Inc., an independent LAB distributor with a distribution facility located next to our TRIC facility, for Battery Systems’ supply of used LABS to us. We have also entered into an agreement with Johnson Controls pursuant to which Johnson Controls has agreed to purchase from us, recycled lead on both a tolling (fee to convert used LABs to recycled materials) and merchanting (sale of recycled materials) basis. We have made progress in diversifying our feedstock supply through various sources at more favorable pricing. Consequently, we believe that we have secured an ample supply of used LABs and demand for our lead-based products for the foreseeable future.
 

7



Johnson Controls Agreements
 
Equipment Supply Agreement. We entered into an equipment supply agreement dated February 7, 2017 with Johnson Controls pursuant to which we agreed to collaborate on the development of a program for the installation of new greenfield builds and conversion of existing Johnson Controls and certain strategic partners of Johnson Controls’ existing lead smelters to a lead recycling process utilizing our proprietary and patent-pending AquaRefining technology and equipment, know-how and services. We have agreed with Johnson Controls to develop an appropriate program blueprint, and enter into a definitive development program agreement reflecting that blueprint, pursuant to which we will provide to Johnson Controls and certain strategic partners of Johnson Controls, by way of licensing or sale, the following products and services in the regions of North and South America, Europe and China:

AquaRefining technology and the related equipment, engineering and systems integration support sufficient to convert or retrofit existing smelter-based operations and/or the construction of new Johnson Controls and Johnson Controls’ strategic partners’ battery recycling facilities based on our AquaRefining technology;
Training, evaluation and certification of Johnson Controls’ operations personnel sufficient for such personnel to competently operate our AquaRefining technology and equipment; and
Ongoing technical support, maintenance services and warranties.

We plan to provide the above services and equipment to Johnson Controls in conjunction with our partner, Veolia North America Regeneration Services, LLC, on a serviced license basis, including Johnson Controls’ ongoing licensing fees payable to us based on the operational capacity of the AquaRefining equipment supplied by us. We have agreed not to license our AquaRefining technology and equipment to third parties in the aforementioned regions until such time as we and Johnson Controls have agreed on certain matters relating to the initial conversion of a Johnson Controls facility. Johnson Controls and we have agreed to use good faith, commercial best-efforts to conclude the discussion and negotiation of the development program agreement no later than April 30, 2019, and to enter into a definitive development program agreement no later than June 30, 2019. The equipment supply agreement may be terminated by either party upon 60 days’ prior written notice if the parties have not entered into the development program agreement by June 30, 2019, of which there can be no assurance. The equipment supply agreement allows each party the right to seek early termination based on a material breach by the other party that goes uncorrected for 30 days following notice of breach. The equipment supply agreement contains representations, warranties and indemnities that are customary to commercial agreements of this nature.
Tolling/Lead Purchase Agreement. We have entered into a tolling/lead purchase agreement dated February 7, 2017 with Johnson Controls pursuant to which we have agreed to sell to Johnson Controls, and Johnson Controls has agreed to purchase from us, recycled lead on both a tolling (fee to convert used LABs to recycled materials) and merchanting (sale of recycled materials) basis.
 
Pursuant to the agreement, Johnson Controls has agreed to purchase from us, and we have agreed to sell to Johnson Controls, up to 100% of the recycled lead we produce for automotive applications, other than by way of tolling arrangements, on a monthly basis, unless we receive notice from Johnson Controls six months advance of its intention to purchase less than 100% of our output in any given month. Our agreement with Johnson Controls excludes, and we are free to manufacture and sell to third parties, recycled lead for non-automotive uses, such as stationery batteries for back-up power systems for Internet/Cloud applications or grid scale storage applications. During fiscal year 2018 and 2017, approximately 88% and 96% of our revenues, respectively, were derived from sales to Johnson Controls.
 
We have also agreed to provide tolling services to Johnson Controls whereby Johnson Controls will deliver to us used lead acid batteries, or LABs, and we will recycle the used LABs and return the recycled lead to Johnson Controls for a fee. Johnson Controls has agreed to send to us for tolling, and we have agreed to toll for Johnson Controls, used LABs representing a significant allocation of the production capacity of our initial recycling facility in McCarran, Nevada. To date, none of our sales to Johnson Controls have been from tolling.
 
The tolling/lead purchase agreement has a minimum term of five years and upon the expiration of the initial term the agreement, either party can terminate the agreement upon three years prior written notice. Either party may elect to terminate the agreement for any reason after the second anniversary of the agreement, which termination shall be effective on the third anniversary of the notice of termination. Either party may terminate the agreement on ten days’ prior written notice of breach that goes uncorrected during the notice period. The tolling/lead purchase agreement contains representations, warranties and indemnities that are customary to commercial agreements of this nature.

In the fourth quarter of 2018, Johnson Controls International announced that it would sell its power solutions business, which makes, distributes and recycles automotive batteries, to the investment firm Brookfield Business Partners L.P., in a cash deal valued at $13.2 billion. The deal is expected to close in mid-2019. We have received no indication from Johnson Controls or Brookfield that their current strategies relating to Aqua Metals may change.

 

8



Interstate Battery Partnership
 
On May 18, 2016, we entered into a supply agreement with Interstate Battery pursuant to which Interstate Battery agreed to sell to us, and we agreed to buy from Interstate Battery, used LABs. Interstate Battery will sell us used LABs on a cost-plus basis and the agreement subjects us and Interstate Battery to certain minimum purchase and sale requirements. We have granted Interstate Battery limited rights of first refusal to supply our future AquaRefineries. Our agreement with Interstate Battery is for an initial term of 18 months from the date of first delivery of used LABs to us and will be subject to automatic renewals thereafter unless either party elects to terminate the agreement. The agreement allows each party the right to seek early termination based on certain commercial contingencies. The supply agreement contains representations, warranties and indemnities that are customary to commercial agreements of this nature. In June 2018, we reinvigorated our partnership and established an Omnibus Agreement with Interstate Battery in consideration of adjusting the terms of a warrant to purchase 702,247 shares of our common stock from $7.12 per share to $3.33 per share and extending the expiration date of the warrant from May 2018 to June 2020. Interstate Battery materially improved our feedstock supply pricing and agreed to waive alleged violations of a negative covenant related to our purchase of Ebonex as well as the Clark Key Man event. Interstate Battery also reworked the Mould Key Man event to allow us to pay $500,000 for the transfer of the Key Man event to a Cotton Key Man event rather than paying $2,000,000 for a Mould Key Man event as previously specified in the Investor Rights Agreement. We opted for this transfer and subsequently paid Interstate Battery the $500,000 transfer fee in February 2019. In January 2019, we also repaid Interstate Battery the outstanding principal and interest on the convertible debt in the amount of $6.7 million.


 
Intellectual Property Rights
 
We regard the protection of our technologies and intellectual property rights as an important element of our business operations and crucial to our success. We endeavor to generate and protect our intellectual property assets through a series of patents, trademarks, internal and external policy and procedures and contractual provisions.
 
Patent Portfolio
 
Currently, we have secured one US patent, 13 international patents, and two allowances (one US and one international). In addition to the US patent, we have international patents/allowances in the European Union, Korea, Japan, China, Australia, Canada, African Intellectual Property Organization, Mexico, South Africa and the Ukraine. We also have 90 patent applications pending in the United States and numerous corresponding patent applications pending in 20 additional jurisdictions across seven distinct patent applications relating to certain elements of the technology underlying our AquaRefining process and related apparatus and chemical formulations. The claims of the granted patents substantially address the same subject matter and are drawn to various aspects of processing lead materials using an aqua refining process. Differences in the claim number and scope are due to local rules and practice.
 
We intend to continue to prepare and file domestic and foreign patent applications covering expanding aspects and applications of our technology, as circumstances warrant.
 
There can be no assurance that any patents will issue from any of our current or any future applications. Also, any patents that may issue may not survive a legal challenge to their scope, validity or enforceability, or provide significant protection for us. Competitors may work around our patents so they are not infringing. Our patent portfolio and our existing policy and procedures safeguarding our trade secrets nonetheless may face challenges so that our competitors can copy our AquaRefining process.
Trademark Portfolio
 
We have filed for trademark registration in the US and foreign countries for the following trademarks:
AQUA METALS (US and 15 foreign countries)
AQUAREFINING (US and 11 foreign countries)
AQUAREFINE (US only)

Trade Secrets and Contract Protection
 
We have developed our internal policy and procedures in safeguarding our trade secrets and proprietary information. Our procedures generally require our employees, consultants and advisors to enter into confidentiality agreements. These agreements provide that all confidential information developed or made known to the individual during the course of the individual’s relationship with us is to be kept confidential and not disclosed to third parties except under specific circumstances. In the case of our employees, the agreements provide that all of the technology that is conceived by the individual during the course of employment is our exclusive property. The

9



development of our technology and many of our processes are dependent upon the knowledge, experience and skills of key scientific and technical personnel.
 
Government Regulation
 
Our operations in the United States will be subject to the Federal, state and local environmental, health and safety laws applicable to the reclamation of LABs. While the lead reclamation process itself is generally not subject to Federal permitting requirements, depending on how any particular operation is structured, our facilities may have to obtain environmental permits or approvals from Federal, state or local regulators to operate, including permits or regulatory approvals related to air emissions, water discharges, waste management, and the storage of LABs on-site should that become necessary. We may face opposition from local residents or public interest groups to the installation and operation of our facilities. Failure to secure (or significant delays in securing) the necessary approvals could prevent us from pursuing some of our planned operations and adversely affect our business, financial results and growth prospects.
 
In addition to permitting requirements, our operations are subject to environmental health, safety and transportation laws and regulations that govern the management of and exposure to hazardous materials such as the lead and acids involved in LAB reclamation. These include hazard communication and other occupational safety requirements for employees, which may mandate industrial hygiene monitoring of employees for potential exposure to lead. Failure to comply with these requirements could subject our business to significant penalties (civil or criminal) and other sanctions that could adversely affect our business. Changes to these regulatory requirements in the future could also increase our costs, require changes in or cessation of certain activities, and adversely affect the business.
 
The nature of our operations involves risks, including the potential for exposure to hazardous materials such as lead, that could result in personal injury and property damage claims from third parties, including employees and neighbors, which claims could result in significant costs or other environmental liability. Our operations also pose a risk of releases of hazardous substances, such as lead or acids, into the environment, which can result in liabilities for the removal or remediation of such hazardous substances from the properties at which they have been released, liabilities which can be imposed regardless of fault, and our business could be held liable for the entire cost of cleanup even if we were only partially responsible. Like any manufacturer, we are also subject to the possibility that we may receive notices of potential liability in connection with materials that were sent to third-party recycling, treatment, and/or disposal facilities under the Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended (“CERCLA”), and comparable state statutes, which impose liability for investigation and remediation of contamination without regard to fault or the legality of the conduct that contributed to the contamination, and for damages to natural resources. Liability under CERCLA is retroactive, and, under certain circumstances, liability for the entire cost of a cleanup can be imposed on any responsible party.
 
As our business expands outside of the United States, our operations will be subject to the environmental, health and safety laws of the countries where we do business, including permitting and compliance requirements that address the similar risks as do the laws in the United States, as well as international legal requirements such as those applicable to the transportation of hazardous materials. Depending on the country or region, these laws could be as stringent as those in the US, or they could be less stringent or not as strictly enforced. In some countries in which we are interested in expanding our business, such as Mexico and China, the relevant environmental regulatory and enforcement frameworks are in flux and subject to change. Therefore, while compliance with these requirements will cause our business to incur costs, and failure to comply with these requirements could adversely affect our business, it is difficult to evaluate such potential costs or adverse impacts until such time as we decide to initiate operations in particular countries outside the United States.
Employees
 
As of the date of this report, we employ 76 people on a full-time basis. None of our employees are represented by a labor union.
 
Financial and Segment Information
 
We operate our business as a single segment, as defined by generally accepted accounting principles. Our financial information is included in the consolidated financial statements and the related notes.
 
Available Information
 
Our website is located at www.aquametals.com and our investor relations website is located at https://ir.aquametals.com/. Copies of our Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Reports on Form 8-K, and amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, are available, free of charge, on our investor relations website as soon as reasonably practicable after we file such material electronically with or furnish it to the Securities and Exchange Commission, or the SEC. The SEC also maintains a website that contains our SEC filings. The address of the site is www.sec.gov. Further, a copy of this Annual Report on Form 10-K is located at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. Information on the operation of the Public Reference Room can be obtained by

10



calling the SEC at 1-800-SEC-0330. The contents of our website are not intended to be incorporated by reference into this Annual Report on Form 10-K or in any other report or document we file with the SEC, and any references to our websites are intended to be inactive textual references only.


11



Item 1A.
Risk Factors
 
There are numerous and varied risks, known and unknown, that may prevent us from achieving our goals. If any of these risks actually occur, our business, financial condition or results of operation may be materially adversely affected.  In such case, the trading price of our common stock could decline and investors could lose all or part of their investment.
 
Risks Relating to Our Business

Since we have a limited operating history and have only recently commenced revenue producing operations, it is difficult for potential investors to evaluate our business. We formed our corporation in June 2014 and only commenced revenue producing operations in the first quarter of 2017. From inception through December 31, 2018, we generated a total of $6.5 million of revenue, all of which was derived primarily from the sale of lead compounds and plastics and, to a lesser extent, the sale of lead bullion, including Aqua Refined lead. To date, our operations have primarily consisted of the development and testing of our AquaRefining process, the construction of our initial LAB recycling facility at TRIC, the continuing development of our LAB recycling operations at TRIC and limited revenue producing operations as we bring those LAB recycling operations online. Our limited operating history makes it difficult for potential investors to evaluate our technology or prospective operations. As an early stage company, we are subject to all the risks inherent in the initial organization, financing, expenditures, complications and delays in a new business, including, without limitation:
the timing and success of our plan of commercialization and the fact that we continue to experience delays in ramping up our LAB recycling operations at TRIC;
our ability to bring modules online and ramp up production on a commercial scale.
our ability to profitably operate our AquaRefining process on a commercial scale;
our ability to realize the expected benefits of our strategic partnership with Johnson Controls;
our ability to procure LABs in sufficient quantities at competitive prices; and
our ability to receive proper certification from and meet the requirements of our customers regarding the purity of our AquaRefined lead.
Investors should evaluate an investment in us in light of the uncertainties encountered by developing companies in a competitive environment. There can be no assurance that our efforts will be successful or that we will ultimately be able to attain profitability.
Our business is dependent upon our successful implementation of novel and unproven technologies and processes and there can be no assurance that we will be able to implement such technologies and processes in a manner that supports the successful commercial roll-out of our business model. While much of the technology and processes involved in our lead recycling operations are widely used and proven, the AquaRefining component of our lead recycling operations is largely novel and unproven. While we have shown that our proprietary technology can produce AquaRefined lead on a small scale, we have only recently completed, and put into limited operation, the processes that we believe will support the production of AquaRefined lead on a commercial scale. Further, as we complete our AquaRefining production line, we continue to encounter unforeseen complications that have delayed the ramping up of our AquaRefining modules and the integration of our AquaRefining process with the traditional lead recycling operations. There can be no assurance that we will be able to overcome these production and performance issues in a timely manner or that we will not encounter additional unforeseen complications that will cause further delays in our planned commercial roll-out of all 16 AquaRefining modules installed at TRIC and to ramp up the production of AquaRefined lead.
We will need additional financing to execute our business plan and fund operations, which additional financing may not be available on reasonable terms or at all. As of December 31, 2018, we had total cash of $20.9 million and working capital of $11.0 million, which gives no effect to a January 2019 public offering of our common shares from which we received approximately $9.1 million of net proceeds. As of the date of this report, we believe that we have working capital sufficient to fund our current plan of operations at TRIC over the next twelve months. However, we will require additional capital in order to increase production of AquaRefined lead at TRIC beyond that planned for 16 modules, to work with Johnson Controls on equipment integration and licensing to third parties, to fund working capital needs related to the ramp-up of our operations and to fund our continued losses from operations until such time as we are able to achieve positive cash flow from operations. There can be no assurance that we will be able to acquire the necessary funding on commercially reasonable terms or at all.  There can also be no assurance we will be able to conclude the proposed development agreement with Johnson Controls. We intend to seek additional funds through various financing sources, including the sale of our equity and debt securities, licensing fees for our technology, joint ventures with capital partners and/or project financing of our recycling facilities. However, there can be no assurance that such funds will be available on commercially reasonable terms, if at all. If such funding is not available on satisfactory terms, we may be unable to further pursue our business plan and we may be unable to continue operations, in which case you may lose your entire investment.
We have assigned the operation and management of our TRIC facility and any future facilities we may develop directly to Veolia, and there can be no assurance that we will realize the intended benefits of our relationship with Veolia or, if we do, that we will not develop a dependency on Veolia. In February 2018, we entered into an Operations, Management and Maintenance Agreement

12



with Veolia North America Regeneration Services, LLC, or Veolia. Pursuant to the Agreement, Veolia will provide operations, maintenance and management services at our AquaRefining facility at TRIC. We expect Veolia to contribute operational and technological expertise and organizational capabilities in aqueous based process chemistries and electrolysis along with taking on responsibility for operations, supply chain, offtake and management of the plant. While we believe the Agreement will allow us to leverage Veolia’s operations and process engineering expertise and supply chain, offtake and waste stream buying power and expertise, there can be no assurance that we will realize the expected benefits our agreement with Veolia. In addition, we have agreed to grant Veolia the right of first refusal to operate and manage any future facilities developed or licensed by us. It is our expectation that Veolia will serve as our go-to-market execution partner to staff and manage AquaRefining facilities with mutually agreed performance metrics for Aqua Metals and our partners. In the event, Veolia is successful in operating and managing the recycling facilities developed by us and our licensees, there is a risk that we will become dependent on Veolia for the operational and managerial expertise and labor. There can be no assurance that Veolia will be able successfully in managing our recycling facilities and those of our partners. There can also be no assurance that Veolia will continue to provide such services in the future, in which case the loss of Veolia as our service provider could cause a serious disruption in our operations.

There can be no assurance that we will be able to negotiate a long-term agreement with Veolia, in which case we may lose Veolia’s services at the end of the two-year term of our initial agreement. Our Operations, Management and Maintenance Agreement with Veolia is for a two-year term. Pursuant to the Agreement, we have agreed to enter into good faith negotiations for a longer-term version of the Agreement that will provide for Veolia’s management and operation of the TRIC facility for a ten-year term. We have agreed with Veolia to use our good faith commercial best-efforts to conclude negotiations for the long-term agreement by September 30, 2020. We have also agreed to enter into good faith negotiations with Veolia for a long-term agreement concerning Veolia’s participation in the commercial licensing and management of our future AquaRefining facilities developed by licensees of Aqua Metals. We have agreed with Veolia to use our good faith commercial best-efforts to conclude negotiations for the long-term licensing and future facilities agreement by June 30, 2020. There can be no assurance that we will be able to negotiate and conclude a definitive long-term agreement with Veolia on commercially reasonable terms, or at all. If we are unable to conclude long-term agreements with Veolia by the designated dates, it is likely that we will lose Veolia as the operator and manager of our TRIC facility.

We are subject to restrictive debt covenants that may limit our ability to run our business, finance our capital needs and pursue business opportunities and activities. As of the date of this report, we are indebted to Green Bank for approximately $9.5 million, which is secured by liens on substantially all of our assets. The credit agreement governing such indebtedness contains covenants that limit our ability to take certain actions. These covenants could limit our ability to finance our future operations and capital needs and our ability to pursue business opportunities and activities that may be in our interest. If we breach any of these covenants, the debt holder could declare a default under the credit agreement, in which case all of the indebtedness may then become immediately due and payable. If the debt under the credit agreement is accelerated, we may not have, or be able to obtain, sufficient funds to make these accelerated payments. In addition, since all of the indebtedness to Green Bank is secured by substantially all of our assets, a default under the credit facility could enable the debtholder to foreclose on its security interest and attempt to seize our assets. The affirmative and negative debt covenants could materially adversely impact our ability to operate and finance our business. In addition, our default under any of these covenants could subject us to accelerated debt payments or foreclosure proceedings that could threaten our ability to continue as a going concern.

In the event of the acceleration of the Green Bank loan, we will need additional financing to satisfy our obligations under the loan, which additional financing may not be available on reasonable terms or at all. As noted above, as of the date of this report, we are indebted to Green Bank for approximately $9.5 million. The credit agreement governing such indebtedness contain various affirmative and negative covenants and if we breach any of these covenants, the debt holder could declare a default under the credit agreement, in which case all of the indebtedness may then become immediately due and payable. If the debt under the credit agreement is accelerated, we may not have sufficient funds to make the accelerated payments, in which case we would be required to seek additional funds through various financing sources, most likely through the sale of our equity or debt securities. However, there can be no assurance that such funds will be available on commercially reasonable terms, if at all. Further, any sale of our equity or equity-linked securities will result in additional dilution to our stockholders.

Our outstanding debt may make it difficult for us obtain additional financing using our future operating cash flow. We currently owe approximately $9.5 million to Green Bank as of the date of this report. Such indebtedness could limit our ability to borrow additional funds to fund operations or expansion or increase the cost of any such borrowing, or both. Our inability to conduct additional debt financing could:
limit our flexibility in developing our business operations and planning for, or reacting to, changes in our business;
increase our vulnerability to, and reduce our flexibility to respond to, general adverse economic and industry conditions; and
place us at a competitive disadvantage as compared to our competitors that are not as highly leveraged.
Any of these or other consequences or events could have a material adverse effect on our ability to finance our business and our operations.

13



We may be required to pay up to $2.0 million of key-man payments as the result of the resignations of our chief executive officer and chief operating officer. On April 19, 2018, Stephen Clarke resigned as our president and chief executive officer and on December 3, 2018 Selwyn Mould resigned as our chief operating officer.  As a result of their resignations, we may be obligated to pay up to $2 million to Johnson Controls, payable, at our option, in cash or shares of our common stock, unless Johnson Controls approves the successor to Mr. Clarke and Mr. Mould.  Following the December 3, 2018 resignation of Mr. Mould, Johnson Controls delivered to us its claim for payment of the key-man penalties for Messrs. Clarke and Mould in the total amount of $2 million. We believe, however, that Johnson Controls’ demand was premature as it had not considered the adequacy of the replacements for Mr. Clarke or Mr. Mould and that any such claim can be asserted only after their replacements have been appointed and considered in good faith. We intend to dispute Johnson Controls’ claims for the key-man payments, however there can be no assurance we will be successful in doing so. If we are unsuccessful in doing so, we may be obligated to pay Johnson Controls up to $2 million payable in cash or, at our option, shares of our common stock having a market value of $2 million.
Our business model is new and has not been proven by us or anyone else. We are engaged in the business of producing recycled lead through a novel and unproven technology. While the production of recycled lead is an established business, to date all recycled lead has been produced by way of traditional smelting processes. To our knowledge, no one has successfully produced recycled lead in commercial quantities other than by way of smelting. In addition, our lead recycling production line at TRIC is the first-of-its-kind and neither we nor anyone else has ever successfully built a production line that commercially recycles LABs without smelting. While we have commenced limited lead recycling operations at our TRIC facility, through December 31, 2018 all of our revenues have been derived primarily from the sale of lead compounds and plastics and to a lesser extent, the sale of lead bullion, including Aqua Refined lead. We began shipments of lead bullion, which included AquaRefined lead in April 2018. In addition to the general risks associated with a novel and unproven technology, our business model is subject to a number of related risks, including:
our ability to acquire sufficient quantities of used LABs at competitive prices;
our ability to produce AquaRefined lead that is priced competitively with lead produced by traditional smelting;
our ability to produce AquaRefined lead on a commercial scale and at an adequate gross profit; and
our ability to sell our AquaRefined lead at prices and in quantities that provide an adequate net profit from operations.
Further, there can be no assurance that we will be able to produce AquaRefined lead in commercial quantities at a cost of production that will provide us with an adequate profit margin. The uniqueness of our AquaRefining process and our production line at TRIC presents potential risks associated with the development of a business model that is untried and unproven. As of the date of this report, we have begun to ramp up our existing AquaRefining modules into commercial operation, however we continue to experience performance and production issues. There can be no assurance that we will be able to overcome these production and performance issues in a timely manner or that we will not encounter additional unforeseen complications that will cause further delays in our planned commercial roll-out of our AquaRefining modules and the ramp up the production of AquaRefined lead.
Certain industry participants may have the ability to restrict our access to used LABs and otherwise focus significant competitive pressure on us. We believe that our primary competition will come from operators of existing smelters and other parties invested in the existing supply chain for smelting, both of which may resist the change presented by our AquaRefining process. Competition from such incumbents may come in the form of restricted access to used LABs. We believe that LAB manufacturers who also maintain their own smelting operations control a significant part of the market for used LABs. We will require access to used LABs at market prices in order to carry out our business plan. If those LAB manufacturers and others involved in the reverse supply chain for used LABs attempt to restrict our access to used LABs, that may adversely affect our prospects and future growth. There can be no assurance that we will be able to effectively withstand the pressures applied by our competition.
Even if we are successful in recycling lead using our processes, there can be no assurance that the AquaRefined lead will meet the certification and purity requirements of our potential customers. A key component of our business plan is to produce recycled lead through our AquaRefining process of the highest purity (at least 99.99% pure lead), which we refer to as AquaRefined lead. We believe that our AquaRefined lead will provide us with a revenue premium over the market price of lead on the London Metal Exchange, or LME, and, more importantly, our ability to produce AquaRefined lead will be vital to confirming the efficacy and relevancy of our proprietary technology. Our customers will require that our AquaRefined lead meet certain minimum purity standards and, in all likelihood, require independent assays to confirm the lead’s purity. As of the date of this report, we have produced limited quantities of AquaRefined lead and in November 2018 Johnson Controls confirmed its approval of the purity of our AquaRefined lead by providing to us official vendor approval to receive finished lead at its manufacturing facilities. However, we have not produced AquaRefined lead in commercial quantities and there can be no assurance that we will be able to do so or, if we are able to produce AquaRefined lead in commercial quantities, that such lead will continue to meet the required purity standards of our customers. If we are unable to commercially produce AquaRefined lead that meets the purity standards established by our customers, our entire business plan may be invalidated and you may suffer the loss of your entire investment.
While we have been successful in producing AquaRefined lead in small volumes, there can be no assurance that we will be able to replicate the process, along with all of the expected economic advantages, on a large commercial scale either for us or our

14



prospective licensees. As of the date of this report, our commercial operations have primarily involved the production of lead compounds and plastics from recycled LABs and, in April 2018, we commenced the limited production of lead bullion, including AquaRefined lead. While we believe that our development, testing and limited production to date has validated the concept of our AquaRefining process, the limited nature of our operations to date are not sufficient to confirm the economic returns on our production of recycled lead. There can be no assurance that the commencement of commercial production of AquaRefined lead at our TRIC facility will not incur unexpected costs or setbacks that might restrict the desired scale of our intended operations or that we will be to produce AquaRefined lead in commercial quantities at a cost of production that will provide us with an adequate profit margin.
We have completed the construction of our initial LAB recycling facility at TRIC, however we have been delayed in the ramping up of our lead recycling operations at TRIC and we may encounter further delays. We completed the construction of our initial LAB recycling facility at TRIC in August 2016 and commenced the limited production of recycled lead in the first quarter of 2017. However, as of the date of this report, our commercial operations have primarily involved the production of lead compounds and plastics from recycled LABs and we only recently commenced the limited commercial production of AquaRefined lead. However, we have encountered production and performance issues that have impaired and delayed our ability to ramp up the production of AquaRefined lead. There can be no assurance that we will be able to overcome these production and performance issues in a timely manner. In addition, since our lead recycling production line at TRIC is the first-of-its-kind, neither we nor anyone else has ever built a facility of this nature and there can be no assurance that we will not experience additional operational delays and issues, including significant downtime from time to time, as we progress into the commercial production of AquaRefined lead. There can be no assurance that the commencement of commercial AquaRefining operations at our TRIC facility will not incur unexpected costs or hurdles that might restrict the desired scale of our intended operations or negatively impact our projected gross profit margin.
Our business may be negatively affected by labor issues and higher labor costs. Our ability to maintain our workforce depends on our ability to attract and retain new and existing employees. As of the date of this report, none of our employees are covered by collective bargaining agreements and we consider our labor relations to be acceptable. However, we could experience workforce dissatisfaction which could trigger bargaining issues, employment discrimination liability issues as well as wage and benefit consequences, especially during critical operation periods. We could also experience a work stoppage or other disputes which could disrupt our operations and could harm our operating results. In addition, legislation or changes in regulations could result in labor shortages and higher labor costs. There can be no assurance that we may not experience labor issues that negatively impact our operations or results of operations.
Our intellectual property rights may not be adequate to protect our business. As of the date of this report, we have secured granted/allowed patents in the following countries/regions: U.S. (9837689, allowed 14/957026), Canada (2930945), China (105981212), Europe (3072180), Eurasia (allowed 201691047), South Africa (2016-04083), Korea (101739414, 101882932, 101926033), Japan (6173595), Mexico (357027), OAPI (17808), Ukraine (118037), and Australia (2014353227, 2015350562).
We also have further patent applications pending in the United States and numerous corresponding patent applications pending in 20 additional jurisdictions relating to certain elements of the technology underlying our AquaRefining process and related apparatus and chemical formulations. However, no assurances can be given that any patent issued, or any patents issued on our current and any future patent applications, will be sufficiently broad to adequately protect our technology. In addition, we cannot assure you that any patents issued now or in the future will not be challenged, invalidated, or circumvented.
Even patents issued to us may not stop a competitor from illegally using our patented processes and materials. In such event, we would incur substantial costs and expenses, including lost time of management in addressing and litigating, if necessary, such matters. Additionally, we rely upon a combination of trade secret laws and nondisclosure agreements with third parties and employees having access to confidential information or receiving unpatented proprietary know-how, trade secrets and technology to protect our proprietary rights and technology. These laws and agreements provide only limited protection. We can give no assurance that these measures will adequately protect us from misappropriation of proprietary information.

Our processes may infringe on the intellectual property rights of others, which could lead to costly disputes or disruptions. The applied science industry is characterized by frequent allegations of intellectual property infringement. Though we do not expect to be subject to any of these allegations, any allegation of infringement could be time consuming and expensive to defend or resolve, result in substantial diversion of management resources, cause suspension of operations or force us to enter into royalty, license, or other agreements rather than dispute the merits of such allegation. If patent holders or other holders of intellectual property initiate legal proceedings, we may be forced into protracted and costly litigation. We may not be successful in defending such litigation and may not be able to procure any required royalty or license agreements on acceptable terms or at all.
Our business strategy includes licensing arrangements and entering into joint ventures and strategic alliances, however as of the date of this report we have no such agreements in place and there can be no assurance we will be able to do so. Failure to successfully integrate such licensing arrangements, joint ventures, or strategic alliances into our operations could adversely affect our business. We propose to commercially exploit our AquaRefining process, in part, by licensing our technology to third parties and entering into joint ventures and strategic relationships with parties involved in the manufacture and recycling of LABs, including Johnson

15



Controls, among others. However, as of the date of this report, we have not entered into any such licensing, joint venture or strategic alliance agreements, apart from our equipment supply agreement with Johnson Controls, and there can be no assurance that we will be able to do so on terms that benefit us, if at all. In addition, licensing programs, joint ventures and strategic alliances may involve significant other risks and uncertainties, including distraction of management’s attention away from normal business operations, insufficient revenue generation to offset liabilities assumed and expenses associated with the transaction, and unidentified issues not discovered in our due diligence process, such as product quality, technology issues and legal contingencies. In addition, we may be unable to effectively integrate any such programs and ventures into our operations. Our operating results could be adversely affected by any problems arising during or from any licenses, joint ventures or strategic alliances.
There can be no assurance that we will be able to negotiate our key agreement with Johnson Controls on commercially reasonable terms, or at all. In February 2017, we entered into a series of agreements with Johnson Controls, including an equipment supply agreement pursuant to which, among other things, we agreed to work with Johnson Controls on the development of a program for the conversion of Johnson Controls and certain strategic partners of Johnson Controls’ existing lead smelters throughout North and South America, China and Europe to a lead recycling process utilizing our AquaRefining technology and equipment, know-how and services. The equipment supply agreement discusses the development of the conversion program in general terms and contemplates that the parties will enter into a definitive development program agreement that is based on the general terms set forth in the equipment supply agreement and provides more detailed terms and conditions, including the economic obligations and rights of each party. We have agreed not to license our AquaRefining technology and equipment to third parties in the aforementioned regions until such time as we and Johnson Controls have agreed on certain matters relating to the initial conversion of a Johnson Controls facility. Johnson Controls and we have agreed to use good faith, commercial best-efforts to conclude the discussion and negotiation of the development program agreement no later than April 30, 2019, and to enter into a definitive development program agreement no later than June 30, 2019. The equipment supply agreement may be terminated by either party upon 60 days’ prior written notice if the parties have not entered into the development program agreement by June 30, 2019. There can be no assurance that we will be able to negotiate and conclude a definitive development program agreement with Johnson Controls on commercially reasonable terms, or at all.
We are dependent on a limited number of suppliers of certain materials used in our AquaRefining process and our inability to obtain these materials as and when needed could cause a material disruption in our operations. Our AquaRefining process involves a significant number of elements, chemicals, solvents and other materials, in addition to used LABs. There are a limited number of suppliers of certain materials used in our AquaRefining process and we have no agreements in place for our supply of such materials. Our ability to conduct our AquaRefining process on a commercial scale will depend significantly on obtaining timely and adequate supply of these materials on competitive terms. Our inability to source these materials on a timely and cost-efficient manner could interrupt our operations, significantly limit our revenue sales and increase our costs. This factor could also impair our ability to meet our commitments to supply our customers. Our inability to obtain these materials as and when needed could cause a material disruption in our operations.
If we are unable to manage future expansion effectively, our business, operations and financial condition may suffer significantly, resulting in decreased productivity. If our AquaRefining process proves to be commercially viable, growth and expansion activities could place a significant strain on our managerial, administrative, technical, operational and financial resources. Our organization, procedures and management may not be adequate to fully support the expansion of our operations or the efficient execution of our business strategy. If we are unable to manage future expansion effectively, our business, operations and financial condition may suffer significantly, resulting in decreased productivity.
We may experience significant fluctuations in raw material prices and the price of our principal product, either of which could have a material adverse effect on our liquidity, growth prospects and results of operations. Used LABs are our primary raw material and we believe that in recent years the cost of used LABs has been volatile at times. In addition, we believe that the cost of used LABs can be seasonal, with prices trending lower in the winter months (as automobile owners increase their purchase of new LABs, thereby putting a greater number of used LABs on the market) and trend higher in the spring (as the purchase of new LABs, and supply of used LABs, decreases). Our principal product, recycled lead, has also experienced price volatility from time to time as well. For example, the market price of lead on the LME during 2018 ranged from approximately $1,900 to $2,700 per tonne. While we intend to pursue supply and tolling arrangements as appropriate to offset any price volatility, the volatile nature of prices for used LABs and recycled lead could have an adverse impact on our liquidity, growth prospects and results of operations.
Global economic conditions could negatively affect our prospects for growth and operating results. Our prospects for growth and operating results will be directly affected by the general global economic conditions of the industries in which our suppliers, partners and customer groups operate. We believe that the market price of our principal product, recycled lead, is relatively volatile and reacts to general global economic conditions. Lead prices decreased from $2,139 per tonne on May 5, 2015 to a low of $1,554 per tonne on November 23, 2015 because of fluctuations in the market. A month later, the price per tonne increased back up to $1,801 per tonne; the price per tonne was $2,008 on December 31, 2018. Our business will be highly dependent on the economic and market conditions in each of the geographic areas in which we operate. These conditions affect our business by reducing the demand for LABs and decreasing the price of lead in times of economic down turn and increasing the price of used LABs in times of increasing demand of LABs and

16



recycled lead. There can be no assurance that global economic conditions will not negatively impact our liquidity, growth prospects and results of operations.
We are subject to the risks of conducting business outside the United States. A part of our strategy involves our pursuit of growth opportunities in certain international market locations. We intend to pursue licensing or joint venture arrangements with local partners who will be primarily responsible for the day-to-day operations. Any expansion outside of the US will require significant management attention and financial resources to successfully develop and operate any such facilities, including the sales, supply and support channels, and we cannot assure you that we will be successful or that our expenditures in this effort will not exceed the amount of any resulting revenues. Our international operations expose us to risks and challenges that we would otherwise not face if we conducted our business only in the United States, such as:
increased cost of enforcing our intellectual property rights;
heightened price sensitivities from customers in emerging markets;
our ability to establish or contract for local manufacturing, support and service functions;
localization of our LABs and components, including translation into foreign languages and the associated expenses;
compliance with multiple, conflicting and changing governmental laws and regulations;
foreign currency fluctuations;
laws favoring local competitors;
weaker legal protections of contract terms, enforcement on collection of receivables and intellectual property rights and mechanisms for enforcing those rights;
market disruptions created by public health crises in regions outside the United States;
difficulties in staffing and managing foreign operations, including challenges presented by relationships with workers’ councils and labor unions;
issues related to differences in cultures and practices; and
changing regional economic, political and regulatory conditions.
U.S. Government regulation and environmental, health and safety concerns may adversely affect our business. Our operations in the United States will be subject to the Federal, State and local environmental, health and safety laws applicable to the reclamation of lead acid batteries. Our facilities will have to obtain environmental permits or approvals to operate, including those associated with air emissions, water discharges, and waste management and storage. We may face opposition from local residents or public interest groups to the installation and operation of our facilities. In addition to permitting requirements, our operations are subject to environmental health, safety and transportation laws and regulations that govern the management of and exposure to hazardous materials such as the lead and acids involved in battery reclamation. These include hazard communication and other occupational safety requirements for employees, which may mandate industrial hygiene monitoring of employees for potential exposure to lead. Failure to comply with these requirements could subject our business to significant penalties (civil or criminal) and other sanctions that could adversely affect our business.
In the event we are unable to present and operate our AquaRefining process and operations as safe and environmentally responsible, we may face opposition from local governments, residents or public interest groups to the installation and operation of our facilities.
The development of new AquaRefining facilities by us or our partners or licensees, and the expansion of our operations at TRIC, will depend on our ability to acquire necessary permits and approvals, of which there can be no assurance. As noted above, our AquaRefining facilities will have to obtain environmental permits or approvals to operate, including those associated with air emissions, water discharges, and waste management and storage. In addition, we expect that our planned expansion of AquaRefining operations at TRIC will require additional permitting and approvals. Failure to secure (or significant delays in securing) the necessary permits and approvals could prevent us and our partners and licensees from pursuing additional AquaRefining facilities or expanding operations at TRIC, and otherwise adversely affect our business, financial results and growth prospects. Further, the loss of any necessary permit or approval could result in the closure of an AquaRefining facility and the loss of our investment associated with such facility.
Our business involves the handling of hazardous materials and we may become subject to significant fines and other liabilities in the event we mishandle those materials. The nature of our operations involves risks, including the potential for exposure to hazardous materials such as lead, that could result in personal injury and property damage claims from third parties, including employees and neighbors, which claims could result in significant costs or other environmental liability. Our operations also pose a risk of releases of hazardous substances, such as lead or acids, into the environment, which can result in liabilities for the removal or remediation of such hazardous substances from the properties at which they have been released, liabilities which can be imposed regardless of fault, and our business could be held liable for the entire cost of cleanup even if we were only partially responsible. We are also subject to the possibility that we may receive notices of potential liability in connection with materials that were sent to third-party recycling, treatment, and/or disposal facilities under the Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended (“CERCLA”), and comparable state statutes, which impose liability for investigation and remediation of contamination without regard

17



to fault or the legality of the conduct that contributed to the contamination, and for damages to natural resources. Liability under CERCLA is retroactive, and, under certain circumstances, liability for the entire cost of a cleanup can be imposed on any responsible party. Any such liability could result in judgments or settlements that restrict our operations in a manner that materially adversely effects our operations and could result in fines, penalties or awards that could materially impair our financial condition and even threaten our continued operation as a going concern.
We will be subject to foreign government regulation and environmental, health and safety concerns that may adversely affect our business. As our business expands outside of the United States, our operations will be subject to the environmental, health and safety laws of the countries where we do business, including permitting and compliance requirements that address the similar risks as do the laws in the United States, as well as international legal requirements such as those applicable to the transportation of hazardous materials. Depending on the country or region, these laws could be as stringent as those in the US, or they could be less stringent or not as strictly enforced. In some countries in which we are interested in expanding our business, such as Mexico and China, the relevant environmental regulatory and enforcement frameworks are in flux and subject to change. Compliance with these requirements will cause our business to incur costs, and failure to comply with these requirements could adversely affect our business.
In the event we are unable to present and operate our AquaRefining process and operations as safe and environmentally responsible, we may face opposition from local governments, residents or public interest groups to the installation and operation of our facilities.
Risks Related to Owning Our Common Stock
A securities class action lawsuit and shareholder derivative lawsuit are pending against us and could have a material adverse effect on our business, results of operations and financial condition. A putative consolidated class action lawsuit and shareholder derivative lawsuit are pending against us and certain of our directors and officers. These lawsuits may divert financial and management resources that would otherwise be used to benefit our operations. Although we deny the material allegations in the lawsuits and intend to defend ourselves vigorously, defending the lawsuits could result in substantial costs. No assurances can be given that the results of these matters will be favorable to us. An adverse resolution of any of these lawsuits could have a material adverse effect on our results of operations and financial condition. In addition, we may be the target of securities-related litigation in the future, both related and unrelated to the existing class action and shareholder derivative lawsuits. Such litigation could divert our management’s attention and resources, result in substantial costs, and have an adverse effect on our business, results of operations and financial condition.
 
We maintain director and officer insurance that we regard as reasonably adequate to protect us from potential claims; however, we are responsible for meeting certain deductibles under the policies and, in any event, we cannot assure you that the insurance coverage will adequately protect us from claims made. Further, as a result of the pending litigation the costs of insurance may increase and the availability of coverage may decrease. As a result, we may not be able to maintain our current levels of insurance at a reasonable cost, or at all, which might make it more difficult to attract qualified candidates to serve as executive officers or directors.
Our common stock is thinly traded and our share price has been volatile. Our common stock has traded on the Nasdaq Capital Market, under the symbol “AQMS”, since July 31, 2015. Since that date, our common stock has at times been relatively thinly traded and subject to price volatility. There can be no assurance that we will be able to successfully maintain a liquid market for our common shares. The stock market in general, and early stage public companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of such companies. If we are unable to develop and maintain a liquid market for our common shares, you may not be able to sell your common shares at prices you consider to be fair or at times that are convenient for you, or at all. In addition, following periods of volatility in the market price of a company's securities, litigation has often been brought against that company and we may become the target of litigation as a result of price volatility. Litigation could result in substantial costs and divert our management's attention and resources from our business. This could have a material adverse effect on our business, results of operations and financial condition.
We are an “emerging growth company” under the JOBS Act of 2012 and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors. We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to:
not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act;
reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements;
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments; and
extended transition periods available for complying with new or revised accounting standards.

18



We have chosen to “opt out” of the extended transition periods available for complying with new or revised accounting standards, but we intend to take advantage of all of the other benefits available under the JOBS Act, including the exemptions discussed above. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.
We will remain an “emerging growth company until 2020, although we will lose that status sooner if our revenues exceed $1.07 billion, if we issue more than $1.07 billion in non-convertible debt in a three-year period, or if the market value of our common stock that is held by non-affiliates exceeds $700 million as of any June 30.
Our status as an “emerging growth company” under the JOBS Act may make it more difficult to raise capital as and when we need it. Because of the exemptions from various reporting requirements provided to us as an “emerging growth company,” we may be less attractive to investors and it may be difficult for us to raise additional capital as and when we need it. Investors may be unable to compare our business with other companies in our industry if they believe that our reporting is not as transparent as other companies in our industry. If we are unable to raise additional capital as and when we need it, our financial condition and results of operations may be materially and adversely affected.
We have not paid dividends in the past and have no plans to pay dividends. We plan to reinvest all of our earnings, to the extent we have earnings, in order to develop our recycling centers and cover operating costs and to otherwise become and remain competitive. We do not plan to pay any cash dividends with respect to our securities in the foreseeable future. We cannot assure you that we would, at any time, generate sufficient surplus cash that would be available for distribution to the holders of our common stock as a dividend. Therefore, you should not expect to receive cash dividends on our common stock.
Shares eligible for future sale may adversely affect the market for our common stock. Of the 44,354,852 shares of our common stock outstanding as of the date of this report, approximately 40,422,488 shares are held by “non-affiliates” and are freely tradable without restriction pursuant to Rule 144. In addition, in August 2016, we filed with the SEC a Registration Statement on Form S-3 for purposes of registering the resale of 3,711,872 shares of restricted common stock sold to Interstate Battery in May 2016, including 3,009,625 shares of common stock issuable to Interstate Battery upon exercise of its warrants and conversion of its convertible note, and in February 2017, we filed with the SEC a Registration Statement on Form S-3 for purposes of registering the resale of the 939,005 shares of restricted common stock we sold to Johnson Controls in February 2017. Both registration statements were declared effective by the SEC and the shares registered thereunder are eligible for sale without restriction. Any substantial sale of our common stock pursuant to Rule 144 or pursuant to any resale prospectus may have a material adverse effect on the market price of our common stock.
Our charter documents and Delaware law may inhibit a takeover that stockholders consider favorable. Provisions of our certificate of incorporation and bylaws and applicable provisions of Delaware law may delay or discourage transactions involving an actual or potential change in control or change in our management, including transactions in which stockholders might otherwise receive a premium for their shares, or transactions that our stockholders might otherwise deem to be in their best interests. The provisions in our certificate of incorporation and bylaws:
limit who may call stockholder meetings;
do not permit stockholders to act by written consent;
do not provide for cumulative voting rights;
establish an advance notice procedure for stockholders' proposals to be brought before an annual meeting, including proposed nominations of persons for election to our board of directors, and
provide that all vacancies may be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum.

In addition, Section 203 of the Delaware General Corporation Law may limit our ability to engage in any business combination with a person who beneficially owns 15% or more of our outstanding voting stock unless certain conditions are satisfied. This restriction lasts for a period of three years following the share acquisition. These provisions may have the effect of entrenching our management team and may deprive you of the opportunity to sell your shares to potential acquirers at a premium over prevailing prices. This potential inability to obtain a control premium could reduce the price of our common stock.
Our bylaws designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with the Company. Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders, (iii) any action asserting a claim against us or any our directors, officers or other employees arising pursuant to any provision of the Delaware General Corporation Law or our certificate of incorporation or bylaws, or (iv) any action asserting a claim

19



against us or any our directors, officers or other employees governed by the internal affairs doctrine. This forum selection provision in our bylaws may limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or any our directors, officers or other employees.
 

Item 1B.
Unresolved Staff Comments
 
Not applicable.

Item 2.
Properties

Our executive offices are presently located in 14,016 square feet of mixed office and warehouse space in McCarran, Nevada. We lease these facilities at a lease rate of approximately $10,000 per month. The lease term began in July 2018 and expires December 31, 2021.

Our executive offices were previously located in 21,697 square feet of office and industrial space in a multi-building commercial project known as “Marina Village” located in Alameda, California. The lease term is 76 months, commencing February 1, 2016 and expiring May 31, 2022. Subsequent to year end we sublet the property with the sublease commencing February 2019, and expiring May 31, 2022.
 
We have developed and own a 136,750 square foot LAB recycling facility on 11.73 acres of land located in TRIC, a 107,000-acre park located nine miles east of Reno, Nevada on I-80.

20



Item 3.
Legal Proceedings
 
Beginning on December 15, 2017, three purported class action lawsuits were filed in the United Stated District Court for the Northern District California against us, Stephen Clarke, Thomas Murphy and Mark Weinswig.  On March 23, 2018, the cases were consolidated under the caption In Re: Aqua Metals, Inc. Securities Litigation Case No 3:17-cv-07142. On May 23, 2018, the Court appointed lead plaintiffs and approved counsel for the lead plaintiffs.  On July 20, 2018, the lead plaintiffs filed a consolidated amended complaint (“Amended Complaint”), on behalf of a class of persons who purchased our securities between May 19, 2016 and November 9, 2017, against us, Stephen Clarke, Thomas Murphy and Selwyn Mould.  The Amended Complaint alleges the defendants made false and misleading statements concerning our lead recycling operations in violation of Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 promulgated thereunder and seeks to hold the individual defendants as control persons pursuant to Section 20(a) of the Exchange Act.  The Amended Complaint also alleges a violation of Section 11 of the Securities Act of 1933 (“Securities Act”) based on alleged false and misleading statements concerning our lead recycling operations contained in, or incorporated by reference in, our Registration Statement on Form S-3 filed in connection with our November 2016 public offering.   That claim is asserted on behalf of a class of persons who purchased shares pursuant to, or that are traceable to, that Registration Statement.  The Amended Complaint seeks to hold the individual defendants liable as control persons pursuant to Section 15 of the Securities Act.  The Amended Complaint seeks unspecified damages and plaintiffs’ attorneys’ fees and costs. On September 18, 2018, the defendants filed a motion to dismiss the Amended Complaint in its entirety and the plaintiff subsequently filed its opposition to the motion.  In January 2019, the court notified the parties that it will rule on the motion to dismiss without a hearing. We deny that the claims in the Amended Complaint have any merit and we intend to vigorously defend the action.

Beginning on February 2, 2018, five purported shareholder derivative actions were filed in the United States District Court for the District of Delaware against us and certain of our current and former executive officers and directors, Stephen R. Clarke, Selwyn Mould, Thomas Murphy, Mark Weinswig, Vincent DiVito, Mark Slade and Mark Stevenson.  On May 3, 2018, the cases were consolidated under the caption In re Aqua Metals, Inc. Stockholder Derivative Litigation, Case No. 1:18-cv-00201-LPS (D. Del.). The complaints were filed by persons claiming to be stockholders of Aqua Metals and generally allege that certain of our officers and directors breached their fiduciary duties to us by violating the federal securities laws and exposing us to possible financial liability.  The complaints seek unspecified damages and plaintiffs’ attorneys’ fees and costs.  The parties have entered into a stipulation staying the action until 30 days after a decision on our motion to dismiss the Amended Complaint in the class action described above.  The individual defendants deny that the claims in the shareholder derivative action have any merit and intend to vigorously defend the action.

We are not party to any other legal proceedings.  We may, from time to time, be party to litigation and subject to claims incident to the ordinary course of business.  As our growth continues, we may become party to an increasing number of litigation matters and claims.  The outcome of litigation and claims cannot be predicted with certainty, and the resolution of any future matters could materially affect our future financial position, results of operations or cash flows. 


Item 4.
Mine Safety Disclosures
 
Inapplicable.

21



PART II
 
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Repurchases of Equity Securities
 
Market Information
 
Our common stock has traded on the NASDAQ Capital Market under the symbol “AQMS,” since our initial public offering on July 31, 2015. Since then, our common stock has been relatively thinly traded at times and has experienced, and is expected to experience in the future, significant price and volume volatility. The following table shows the reported high and low closing prices per share for our common stock based on information provided by the NASDAQ Capital Market for the periods indicated.  

 
 
2018
 
2017
 
2016
 
 
High
 
Low
 
High
 
Low
 
High
 
Low
First Quarter
 
$
3.00

 
$
1.59

 
$
21.89

 
$
10.68

 
$
6.65

 
$
4.51

Second Quarter
 
$
4.14

 
$
2.26

 
$
18.56

 
$
10.44

 
$
12.92

 
$
7.15

Third Quarter
 
$
3.11

 
$
2.24

 
$
12.55

 
$
5.49

 
$
12.73

 
$
8.18

Fourth Quarter
 
$
2.92

 
$
1.55

 
$
6.91

 
$
1.88

 
$
13.66

 
$
8.62

 
Holders of Record
 
As of February 26, 2019, there were 10 holders of record of our common stock.
 
Dividend Policy
 
We have never declared or paid cash dividends on our common stock. We presently intend to retain earnings, if any, to finance the operation and expansion of our business.
 
Equity Compensation Plan Information
 
We have adopted the Aqua Metals, Inc. 2014 Stock Incentive Plan providing for the grant of non-qualified stock options and incentive stock options to purchase shares of our common stock and for the grant of restricted and unrestricted share grants.  We have reserved 2,113,637 shares of our common stock under the plan.  All of our officers, directors, employees and consultants are eligible to participate under the plan.  The purpose of the plan is to provide eligible participants with an opportunity to acquire an ownership interest in our company.
 
The following table sets forth the number and weighted-average exercise price of securities to be issued upon exercise of outstanding options and warrants, and the number of securities remaining available for future issuance, under our equity compensation plan at December 31, 2018.
Plan Category
 
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights
 
 
Weighted-Average Exercise Price of Outstanding Options and Warrants
 
Number of Securities Remaining Available for Future Issuance Under Equity compensation Plans
Equity compensation plans approved by stockholders
 
950,691

(1)
 
$
4.18

 
805,749

Equity compensation plans not approved by stockholders
 
3,180,828

(2)
 
$
6.57

 


(1) Includes 854,068 shares relating to outstanding options and 96,623 relating to restricted stock units under our Amended and Restated 2014 Stock Incentive Plan.
 
(2) Consists of warrants issued in connection with financing activities and 840,000 shares relating to outstanding options granted in reliance on Nasdaq Rule 5635(c)(4) .
 
Unregistered Sales of Equity Securities and Use of Proceeds

22



 
None.
 
Item 6.
Selected Financial Data

Set forth below is selected consolidated financial data of Aqua Metals, Inc. as of and for the years ended December 31, 2018, 2017, 2016, 2015 and the period from June 2014 (inception) to December 31, 2014. The financial data has been obtained or derived from our audited consolidated financial statements. The information below is not necessarily indicative of the results of future operations and should be read in conjunction with Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Item 1A, “Risk Factors,” of this Annual Report on Form 10-K, and the consolidated financial statements and related notes thereto included in Item 8, “Financial Statements and Supplementary Data”, of this Annual Report on Form 10-K, in order to fully understand factors that may affect the comparability of the information presented below.
 
 
 
 
 
 
 
 
 
 
Period from
Inception
 
 
Year Ended December 31,
 
(June 20, 2014) to
 
 
2018
 
2017
 
2016
 
2015
 
December 31, 2014
 
 
 
 
(in thousands, except share and per share data)
Consolidated Statements of Operations:
 
 
 
 
 
 
 
 
 
 
Product sales
 
$
4,449

 
$
2,088

 
$

 
$

 

Operating cost and expense
 
 
 
 
 
 
 
 
 
 
Cost of product sales
 
22,761

 
9,541

 

 

 

Research and development cost
 
4,502

 
8,103

 
6,348

 
2,280

 
231

General and administrative expense
 
14,214

 
6,891

 
6,610

 
3,171

 
1,176

Impairment charge
 

 
2,411

 

 

 

Total operating expense
 
41,477

 
26,946


12,958


5,451


1,407

Loss from operations
 
(37,028
)
 
(24,858
)

(12,958
)

(5,451
)

(1,407
)
Other income and expense
 
 
 
 
 
 
 
 
 
 
Increase in fair value of derivative liabilities
 

 

 

 
(5,776
)
 
(1,172
)
Interest expense
 
(3,447
)
 
(1,761
)
 
(639
)
 
(1,128
)
 
(217
)
Interest and other income
 
223

 
41

 
41

 
26

 
1

Total other income (expense), net
 
(3,224
)
 
(1,720
)

(598
)

(6,878
)

(1,388
)
Loss before income tax expense
 
(40,252
)
 
(26,578
)

(13,556
)

(12,329
)

(2,795
)
Income tax expense
 
(2
)
 
(2
)
 
(1
)
 
(3
)
 
421

Net loss
 
$
(40,254
)
 
$
(26,580
)

$
(13,557
)

$
(12,332
)

$
(2,374
)
Weighted average shares outstanding, basic and diluted
 
34,154,826

 
20,293,100

 
15,267,233

 
8,404,311

 
4,363,641

Basic and diluted net loss per share
 
$
(1.18
)
 
$
(1.31
)

$
(0.89
)

$
(1.47
)

$
(0.54
)
 

23



 
 
As of December 31,
 
 
2018
 
2017
Selected Consolidated Balance Sheet Data:
 
 
 
 
Cash, cash equivalents
 
$
20,892

 
$
22,793

Total assets
 
71,371

 
74,442

Working capital
 
10,953

 
21,850

Current liabilities
 
11,799

 
3,834

Long-term obligations, less current portion
 
9,482

 
11,643

Common stock and additional paid-in capital
 
145,186

 
113,807

Accumulated deficit
 
(95,096
)
 
(54,842
)
Total stockholders’ equity
 
$
50,090

 
$
58,965



24



Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
General
 
Aqua Metals (NASDAQ: AQMS) is engaged in the business of lead recycling through its novel, proprietary and patented AquaRefining technology. AquaRefining is a near room temperature, water and organic acid-based process that greatly reduces environmental emissions. We believe our suite of patented and patent pending AquaRefining technologies will allow the lead-acid battery industry to simultaneously improve the environmental impact of lead recycling and scale recycling production to meet demand. Furthermore, our AquaRefining technologies result in high purity lead. We were formed as a Delaware corporation on June 20, 2014 and since our formation, we have focused our efforts on the development and testing of our AquaRefining process, the construction of our initial lead acid battery, or LAB, recycling facility at the Tahoe-Reno Industrial Center, or TRIC, located in McCarran, Nevada and commercializing the AquaRefining process.

We completed the development of our first LAB recycling facility at TRIC and commenced production of battery breaking and limited operations during the first quarter of 2017. The TRIC facility now produces varying products for commercial sales primarily consisting of ingoted AquaRefined lead, lead compounds, ingoted hard lead and as well as plastic. In April 2017 we commenced the shipment of products for sale, consisting of lead compounds as well as plastics. In April 2018 we commenced the limited production of lead bullion, including AquaRefined lead. In July 2018 we commenced the sale of pure AquaRefined lead in the form of two tonne blocks and in October 2018 we commenced the sale of AquaRefined lead in the form of battery manufacturing ready ingots. In November 2018 we received official vendor certification from Johnson Controls for our AquaRefined lead and in December 2018 we commenced shipments directly to Johnson Controls owned and partner battery manufacturing facilities.
As of December 2017, we had installed 16 AquaRefining modules at TRIC.  To date, we have operated the first four of the 16 modules and have made continuous improvements which have led to individual modules running in a steady state producing 100Kg/hour for several days at a time. As we bring the modules into commercial operation, we expect to continue to adjust the modules to further enhance operation. Although we staffed the facility and ran one or two AquaRefining Modules on a 24x7 basis from October to December of 2018, we are currently running one or two modules 24-hours a day, four days a week to allow safe times for some of the key work to be completed for our contribution margin improvement projects. Subject to key work being completed in the first quarter of 2019, we intend to re-instate 24‑hour, seven days a week, continuous operations shortly thereafter and scale to running all four of the initial four modules before bringing the next four modules on line. In addition, we believe this operational strategy will allow us to maximize lead production, while enabling the remaining components of the plant to be synchronized in support of increased AquaRefining. Once we are satisfied with the operation of the first four modules, additional modules will be brought into production. This process will be repeated until full production is reached with all 16 modules. Our goal is to operate all 16 modules on a 24/7 continuous basis by the end of 2019. However, due to the delays and unforeseen issues in the completion of the AquaRefining production line we have experienced to date, there can be no assurance that we will not encounter additional delays and issues.
Upon completing and commissioning the infrastructure and operational improvements already underway in the facility which are intended to result in positive contribution margin for AquaRefined lead product, we will then scale the plant and bring additional modules on line.  These infrastructure and operational improvements are expected to allow us to recover and recycle our chemical feedstock much more efficiently thus improving our contribution margin. In December 2018, we announced that we were nearing completion of Phase One of our two-phase capital improvement program. Specifically, electrolyte recovery is critical to achieving positive contribution margin and, as of the date of this report, we are now conserving 67% of our target for electrolyte recovery. We expect to conserve 75% of our target for electrolyte recovery when we complete Phase One of the program during the first half of 2019 and conserve 100% when we complete Phase Two. We are already running a successful pilot program for the Phase Two solution of our capital improvement program, which, along with conserving additional electrolyte, should generate higher lead yields for our AquaRefining process, further improving contribution margin.

Ultimately, our goal is to operate all 16 modules running on a continuous basis, however we have decided that the initial operation of fewer modules continuously will allow us to reach full scale operations in a more cost-effective manner.  In addition, we believe this operational strategy will allow us to synchronize the remaining components of the plant in support of increased AquaRefining.  Once we have achieved positive contribution margin and are satisfied with the operation of the first four modules and the supporting infrastructure, additional modules will be brought into production.  This process will be repeated until full production is reached with all 16 modules. However, due to the delays and unforeseen operational issues we have experienced to date, there can be no assurance that we will be able to overcome the current production and performance issues in a timely manner or that we will not encounter additional delays and issues.
 

25



Since January 1, 2018, we have engaged in the following financing transactions:

Amendments of Interstate Battery agreements. On June 24, 2018, we entered into a series of agreements with Interstate Battery International, Inc. and its wholly-owned subsidiary (“Interstate Battery”), including an amendment to the Investor Rights Agreement dated May 18, 2016 with Interstate Battery pursuant to which, among other things, we agreed to compensate Interstate Battery should either Stephen Clarke, our former chief executive officer, or Selwyn Mould, our former chief operating officer, no longer hold such positions or no longer devote substantially all of their business time and attention to our company, whether as a result of resignation, death, disability or otherwise (such an event referred to as a “key-man event”). Pursuant to the Investor Rights Agreement, we agreed to pay Interstate Battery $2,000,000, per occurrence, if either officer was subject to a key-man event during the two years following May 18, 2016. We also agreed to pay Interstate Battery $2,000,000 if either or both officers are subject to a key-man event during the third year following May 18, 2016. Pursuant to the amendment to the Investor Rights Agreement, Interstate Battery agreed to waive all payments under the key-man provisions of the Investor Rights Agreement with respect to the resignation of our former chief executive officer, Stephen Clarke. In addition, the parties agreed that we, at our option, can elect to eliminate the key-man event and all related key-man payments associated with Mr. Mould by (i) paying Interstate Battery a one-time fee of $0.5 million, payable by us in cash and (ii) agreeing to pay Interstate Battery $2.0 million, payable at our election in cash or shares of our common stock, should our current president, Steve Cotton no longer serve as our president during the period ending May 18, 2019. Additionally:

With respect to a Credit Agreement dated May 18, 2016 between us and Interstate Battery, Interstate Battery waived the alleged breach of the Credit Agreement based on our acquisition of Ebonex IPR, Ltd.;
We adjusted the terms of a warrant to purchase 702,247 shares of its common stock issued to Interstate Battery in May 2016, pursuant to which the exercise price of the warrant was decreased from $7.12 per share to $3.33 per share and the expiration date of the warrant was extended to June 23, 2020; and
Interstate Battery agreed to provide us with more favorable pricing and payment terms under the Supply Agreement dated May 18, 2016 pursuant to which we buy used lead acid batteries from Interstate Battery.

Public Offering. On June 18, 2018, we completed a public offering of 10,085,500 shares of our common stock, at the price of $2.85 per share, for gross proceeds of $28.7 million. After the payment of underwriter discounts and offering expenses we received net proceeds of approximately $26.6 million.

In January 2019, we completed a public offering of 5,175,000 shares of our common stock, at the price of $1.90 per share, for gross proceeds of $9.8 million. After the payment of underwriter discounts and offering expenses, we received net proceeds of approximately $9.1 million.
 
Plan of Operations
 
Our plan of operations for the 12-month period following the date of this report, and upon the satisfactory operation of the first four modules, is to complete the commercial roll-out of all 16 AquaRefining modules installed at TRIC and to ramp up the production of AquaRefined lead. We may also install an additional 16 AquaRefining modules at TRIC, subject to the receipt of additional capital and any design improvements that are recommended based on the operation of the first 16 modules.
On February 28, 2019, after engaging in extensive diligence and engineering evaluations, we signed a long-term contract with Veolia North America Regeneration Services LLC (Veolia), to provide operations, maintenance and management services at Aqua Metals’ AquaRefining facility in McCarran, Nevada.

Veolia will contribute operational and technological expertise and organizational capabilities in aqueous based process chemistries and electrolysis along with taking on responsibility for operations, supply chain, offtake and management of the plant. Veolia employees will begin working onsite starting March 4, 2019 at the McCarran facility. In addition to receiving expertise and support from Veolia North America resources overall, this Agreement provides for Veolia to relocate up to six (6) full time employees with strong operations, process engineering, management expertise to join the Aqua Metals team at AquaRefinery in McCarran, NV. Veolia North America will take over the primary responsibility for scaling the facility through the remainder of 2019 to CP1-16 (Commercial Plant 1, 16 AquaRefining Modules) of capacity. The Agreement also provides for Veolia and Aqua Metals to work together to plan in 2019 and complete the expansion of the TRIC facility to 32 AquaRefining Modules.

We are now receiving the full previously negotiated premium value for ongoing shipments of AquaRefined lead from our partner Johnson Controls. As previously announced in October 2018, we have our ingot casting line in production, which enables us to ship our key product in final ingot form directly to battery manufacturing facilities and be compatible with the equipment in those facilities. We are also working with other prospective buyers in the lead industry who are seeking ultra-pure lead for both offtake diversity and an average higher premium than we’ve negotiated with Johnson Controls. In 2019, in addition to batteries being made from AquaRefined lead, we are also exploring non-battery products incorporating AquaRefining technologies.

Additionally, we plan to further improve the plant economics by processing a growing proportion of the metallic lead we recover from breaking batteries within the AquaRefinery and have begun to commission the third of our six kettles in the refining area. We anticipate the success of this planned program will unlock additional contribution margin in early 2019 by enabling us to

26



finish a growing proportion of these materials in-house, thus realizing a continually improving margin and positioning us for earning a premium later in 2019 by refining alloys in-house. We are in the process of commissioning the third of the already purchased kettles as a key part of our project to enable our capability to process this material. We are also developing what we believe to be industry leading know-how and other intellectual property that we are making every effort to secure and add to our suite of smelting-free lead recycling technologies that we believe we can in turn monetize by licensing.

In parallel with our efforts to commercialize our existing AquaRefining operations and test further the premiums we can receive for our ultra-pure AquaRefined lead, our 12-month plan of operations also includes our proposal to license our technology and to provide planning, engineering, technical assistance, equipment and other services in support of the addition of an AquaRefining facility to a battery recycling facility owned by Johnson Controls. Licensing could take the form of either a co-processing arrangement whereby we operate our technology in conjunction with an existing smelter or our licensee operates directly utilizing our technology. The proposed work with Johnson Controls is expected to produce a blueprint for further additions of AquaRefining facilities under a proposed definitive development agreement with Johnson Controls. Pursuant to this proposed definitive development agreement, we will collaborate with Johnson Controls for the deployment of AquaRefining technologies within Johnson Controls’ and certain strategic partners of Johnson Controls existing lead smelters to implement a lead recycling process utilizing our proprietary AquaRefining technology and equipment, know-how and services. However, there can be no assurance that we will be able to conclude a definitive development agreement with Johnson Controls on terms that benefit us, if at all.

Our 12-month plan of operations also includes the pursuit and evaluation of additional strategic relationships, including our recently announced relationship with Veolia and the licensing of our technology and the provision of equipment and services to other potential strategic partners. However, there can be no assurance that we will be able to effect any of these additional partnerships in the future on commercially reasonable terms, or at all.
 
Results of Operations for the Fiscal Year Ended December 31, 2018 Compared to the Fiscal Year Ended December 31, 2017
 
We were formed on June 20, 2014 and did not commence revenue producing operations until January 2017. During the second quarter of 2017, we began shipments of lead compounds and plastics to customers. During the second quarter of 2018, we began shipments of lead bullion in addition to lead compounds and plastics to customers. The following table summarizes results of operations with respect to the items set forth below for the year ended December 31, 2018 and 2017 together with the percentage change in those items (in thousands).
 
 
 
Year ended December 31,
 
 
2018
 
2017
 
Favorable
(Unfavorable)
 
%
Change
Product sales
 
$
4,449

 
$
2,088

 
$
2,361

 
113
 %
Cost of product sales
 
22,761

 
9,541

 
(13,220
)
 
(139
)%
Research and development cost
 
4,502

 
8,103

 
3,601

 
44
 %
General and administrative expense
 
14,214

 
6,891

 
(7,323
)
 
(106
)%
Impairment charge
 

 
2,411

 
2,411

 
100
 %
Total operating expense
 
$
41,477


$
26,946


$
(14,531
)
 
(54
)%
 
As mentioned above, product sales, consisting of lead compounds and plastics began in April 2017. Cost of product sales consists of all operating costs incurred at TRIC following the commencement of product sales. Costs incurred at TRIC prior to commencement of sales are included in research and development costs. Cost of product sales includes raw materials, supplies and related costs, salaries and benefits, consulting and outside services costs, depreciation and amortization costs and insurance, travel and overhead costs.

Revenue for the year ended December 31, 2018 doubled compared to the year ended December 31, 2017. This increase is due to increased sales of AquaRefined lead in our product mix as well as having a full year of operations in 2018 versus approximately eight months during 2017. AquaRefined lead sales comprised 16% and 9% of total revenue during the three and twelve months ended December 31, 2018, respectively. At full capacity, we expect AquaRefined lead sales to reach approximately 50% of total revenue. Prior to the increased sales of AquaRefined lead, including during the three months ended March 31, 2018, we ran the balance of the plant at a high level to pressure test the non-AquaRefining infrastructure and sold the constituent components of LABs, lead compounds and plastics, with little or no additional processing.


27



Cost of product sales remains high and can be attributed to a number of items, including but not limited to the cost of filling the AquaRefining system with electrolyte for our AquaRefining process, greater loss of electrolyte in the process than we expect to achieve following certain additional process improvements expected to be brought on-line over the next 12 months, increase in maintenance costs as we continue to adjust the modules as we increase operating time and hiring and training of personnel to run continuous operations of all 16 modules in advance of reaching continuous operations. At December 31, 2018, we had 61 employees in the TRIC facility versus 41 at December 31, 2017 due to increased level of operations and commissioning of our plant.

Research and development cost in 2017 included TRIC operating cost prior to the commencement of product sales, including the cost incurred to prepare our TRIC plant for operations. During the year ended December 31, 2018, research and development costs decreased by 44% over the comparable period in 2017. The decline in research and development expense is primarily associated with the cost of the TRIC facility being included in cost of product sales rather than research and development subsequent to the commencement of product sales during the second quarter of 2017 as well as an overall shift to production and commercial activities by the Company.
 
General and administrative expense has increased for the year ended December 31, 2018 versus December 31, 2017, primarily due to a $2.5 million accrual of key man penalties associated with our Interstate Battery Credit Agreement and Johnson Controls Investor Rights Agreement due to the resignations of Dr. Clarke and Mr. Mould; $0.6 million increased legal fees associated with shareholder lawsuits; $0.9 million in legal, proxy and solicitation fees associated with the efforts to address activist investors; $0.3 million in patent related legal fees; a $0.9 million severance accrual for our former chief executive officer; a $0.9 million severance accrual for our former chief operating officer; a net $0.4 million non-cash charge associated with modifying a warrant for 702,247 shares of common stock in connection with our settlement agreement with Interstate Battery (see Note 13 in the Consolidated Financial Statements for a more detailed description); a $0.8 million non-cash write-off of leasehold improvements at our former California location; as well as other increases in other professional fees. General and administrative expense during the year ended December 31, 2017 included a $0.6 million accrual for estimated costs to resolve a claim of breach of a negative covenant in our convertible loan agreement with Interstate Battery.
 
As described in Note 6 to the Consolidated Financial Statements, in April 2017, we acquired all of the capital shares of Ebonex IPR Limited for consideration of $2.5 million, consisting of cash, transaction costs and 123,776 shares of our common stock. The principal asset of Ebonex IPR Limited consisted of a patent portfolio with an independent fair value of $112,000. Included in the purchase were certain fixed assets that have been determined by management to have no immediate value and were not considered in the valuation of Ebonex IPR.
 
Due to the fair value of the patent portfolio being significantly less than total consideration, the early development stage of the technology acquired and the uncertainties inherent in research and development, we recorded a non-cash impairment charge of $2.4 million during the year ended December 31, 2017.

The following table summarizes our other income and interest expense for the year ended December 31, 2018 and 2017 together with the percentage change in those items (in thousands).
 
 
 
Year ended December 31,
 
 
2018
 
2017
 
Favorable
(Unfavorable)
 
%
Change
Other (expense) income
 
 

 
 

 
 

 
 

 
 
 
 
 
 
 
 
 
Interest expense
 
$
(3,447
)
 
$
(1,761
)
 
$
(1,686
)
 
96
%
Interest and other income
 
$
223

 
$
41

 
$
182

 
444
%
 
Interest during the year ended December 31, 2018 and 2017 relates primarily to the $5.0 million Interstate Battery convertible note and the $10.0 million notes payable, amortization of debt issuance costs incurred in connection with both of these notes, as well as an accrual for the USDA guarantee fee on the $10.0 million note to Green Bank.
 
The note discount associated with the Interstate Battery convertible note is amortized using the effective interest method over the three-year term of the note, maturing on May 24, 2019. Using the effective interest method results in higher expense in later periods. Thus, non-cash interest expense associated with the note discount amortization was $0.4 million in 2017, $2.0 million in 2018 and will be $2.6 million in 2019.
 
Results of Operations for the Fiscal Year Ended December 31, 2017 Compared to the Fiscal Year Ended December 31, 2016

28



 
As mentioned above, we did not commence revenue producing operations until January 2017. During the second quarter of 2017, we began shipments of lead compounds and plastics to customers. Prior to that, our operations consisted of the development and limited testing of our AquaRefining process, the development of our business plan, the raise of our working capital and the development of our initial lead acid battery, or LAB, recycling facility near Reno, Nevada. The following table summarizes our results of operations with respect to the items set forth below for the years ended December 31, 2017 and 2016 together with the percentage change in those items (in thousands).

 
 
Year Ended December 31,
 
 
2017
 
2016
 
Favorable
(Unfavorable)
 
%
Change
Product sales
 
$
2,088

 
$

 
$
2,088

 
 %
Cost of product sales
 
9,541

 

 
(9,541
)
 
 %
Research and development cost
 
8,103

 
6,348

 
(1,755
)
 
(28
)%
General and administrative expense
 
6,891

 
6,610

 
(281
)
 
(4
)%
Impairment charge
 
2,411

 

 
(2,411
)
 
 %
Total operating expense
 
$
26,946

 
$
12,958

 
$
(13,988
)
 
(108
)%
 
As mentioned above, product sales, consisting of lead compounds and plastics began in April 2017. Cost of product sales consists of all operating costs incurred at TRIC following the commencement of product sales. Costs incurred at TRIC prior to commencement of sales are included in research and development costs. Cost of product sales includes raw materials, supplies and related costs, salaries and benefits, consulting and outside services costs, depreciation and amortization costs and insurance, travel and overhead costs. There are no comparatives for the previous periods.
 
Research and development cost included TRIC operating cost prior to the commencement of product sales, including cost incurred to prepare our TRIC plant for operations. During the year ended December 31, 2017, research and development costs increased by 28% over the comparable period in 2016. At December 31, 2016, we had 30 employees in the TRIC facility and we focused on building the plant (cost included in research and development expense). At December 31, 2017, we had 41 employees at the TRIC facility and were focused on recycling lead operations as well as continuing to commission various processes within the plant (cost included in research and development expense until product sales began, at which point forward they were included in cost of product sales). The increase in research and development cost during the year ended December 31, 2017 versus the prior period is due to increased level of operations and commissioning of our plant in TRIC.
 
General and administrative expense was relatively consistent during the years ended December 31, 2017 and December 31, 2016. The small increase is primarily due to our $0.6 million accrual for estimated costs to resolve a claim of breach of a negative covenant in our convertible loan agreement with Interstate Battery.
 
As described above and in Note 6 to the Consolidated Financial Statements, in April 2017, we recorded a non-cash impairment charge of $2.4 million on our Ebonex IPR Limited acquisition during the year ended December 31, 2017.

The following table summarizes our other income and interest expense for the year ended December 31, 2017 and 2016 together with the percentage change in those items (in thousands).

 
 
Year Ended December 31,
 
 
2017
 
2016
 
Favorable
(Unfavorable)
 
%
Change
Other (expense) income
 
 

 
 

 
 

 
 

 
 
 
 
 
 
 
 
 
Interest expense
 
$
(1,761
)
 
$
(639
)
 
$
1,122

 
(175.59
)%
Interest income
 
$
41

 
$
41

 
$

 
 %
 
Interest during the year ended December 31, 2017 relates primarily to the $5.0 million Interstate Battery convertible note and the $10.0 million notes payable, amortization of debt issuance costs incurred in connection with both of these notes, as well as an

29



accrual for the USDA guarantee fee on the $10.0 million note to Green Bank. Interest relating to the $10.0 million notes payable during the year ended December 31, 2016 and 2015 was capitalized as part of the building cost of the TRIC facility in the amount of $0.5 million and $0.1 million, respectively. Interest capitalization ceased upon completion of the building in November 2016.
 
The note discount associated with the Interstate Battery convertible note is amortized using the effective interest method over the three-year term of the note, maturing on May 24, 2019. Using the effective interest method results in higher expense in later periods. Thus, non-cash interest expense associated with the note discount amortization was $0.4 million in 2017.

 
Liquidity and Capital Resources
 
As of December 31, 2018, we had total assets of $71.4 million and working capital of $11.0 million, which gives no effect to a January 2019 public offering of our common shares from which we received approximately $9.1 million of net proceeds.
 
The following table summarizes our cash used in operating, investing and provided by financing activities (in thousands):
 
 
 
Year ended December 31,
 
 
2018
 
2017
 
2016
Net cash used in operating activities
 
$
(26,318
)
 
$
(19,002
)
 
$
(11,121
)
Net cash used in investing activities
 
$
(3,929
)
 
$
(9,775
)
 
$
(29,606
)
Net cash provided by financing activities
 
$
28,346

 
$
24,988

 
$
35,501

 
Net cash used in operating activities
 
Net cash used in operating activities for the year ended December 31, 2018, 2017 and 2016 was $26.3 million, $19.0 million and $11.1 million, respectively. Net cash used in operating activities during each of these periods consisted primarily of our net loss adjusted for non-cash items such as depreciation, amortization, stock-based compensation charges, warrant modification charges (2018), loss on disposal of leasehold improvements (2018) and non-cash charges related the impairment charge (2017), as well as net changes in working capital.
 
Net cash used in investing activities
 
Net cash used in investing activities for the year ended December 31, 2018, 2017 and 2016 was $3.9 million, $9.8 million and $29.6 million, respectively. Net cash used in investing activities during each of these periods consists primarily of purchases of fixed assets related to the build out of our TRIC recycling facility in Nevada, and, to a lesser extent, our corporate headquarters during 2016.
 
Net cash provided by financing activities
 
Net cash provided by financing activities for the year ended December 31, 2018 consisted of $26.6 million net proceeds from our June 2018 public offering and $2.1 million net proceeds from underwriters’ exercise, in January 2018, of their overallotment option related to our December 2017 public offering partially offset by lease and debt payments. Net cash provided by financing activities for the year ended December 31, 2017 primarily consisted of $13.8 million net proceeds from the issuance of common stock in our December 2017 public offering, $10.5 million net proceeds from the issuance of common stock to Johnson Controls and $1.1 million proceeds from the exercise of stock options partially offset by lease and debt payments.

Net cash provided by financing activities for the year ended December 31, 2016 primarily consisted of $21.5 million net proceeds from the issuance of common stock in our November 2016 public offering; $9.1 million net proceeds from the issuance of common stock to Interstate Battery and other investors through our placement agent, National Securities Corporation; and $4.9 million net proceeds from the Interstate Battery convertible note.
 
As of the date of this report, and after giving effect to a January 2019 public offering of our common shares from which we received approximately $9.1 million of net proceeds, we believe that our working capital is sufficient to fund our current plan of operations at TRIC over the next twelve months. However, we will require additional capital in order to increase production of AquaRefined lead at TRIC beyond that planned for 16 modules, and to fund our continued losses from operations until such time as we are able to achieve positive cash flow from operations. We intend to seek additional funds through various financing sources, includin

30



g the sale of our equity and debt securities, licensing fees for our technology, joint ventures with capital partners and/or project financing of our recycling facilities. However, there can be no guarantees that such funds will be available on commercially reasonable terms, if at all. If such financing is not available on satisfactory terms, we may be unable to further pursue our business plan and we may be unable to continue operations. Additionally, Aqua Metals Reno, or AMR, was not in compliance with its the minimum debt service coverage ratio covenant on its loan from Green Bank as of the fiscal quarter ends between March 31, 2017 and December 31, 2018. AMR received a waiver for the minimum debt service coverage ratio covenant for those periods. While we expect to continue to receive waivers from Green Bank for non-compliance with such covenant, there is no guarantee that we will receive such waivers. If Green Bank determines not to grant us a waiver for non-compliance in the future, we would be in default of the loan and Green Bank would be able to accelerate the payment of all amounts under the loan.
 
Off-Balance Sheet Arrangements
 
We do not have any off-balance sheet financing arrangements.

Critical Accounting Policies and Significant Judgments and Estimates
 
Our management’s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP. The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of expenses during the period. Significant items subject to such estimates and assumptions include the carrying amount and valuation of long-lived assets, the valuation of conversion features of convertible debt, valuation allowances for deferred tax assets, the determination of estimated asset retirement obligations, the determination of stock option expense, and the determination of the fair value of stock warrants issued. Our actual results could differ from these estimates under different assumptions or conditions.
 
While our significant accounting policies are more fully described in Note 2 to the consolidated financial statements included in Item 8 of this Annual Report on Form 10-K, we believe that the following accounting policies are the most critical to assist stockholders and investors reading the consolidated financial statements in fully understanding and evaluating our financial condition and results of operations.
 
Accounts receivable
 
We sell our products to large well-established companies and extend credit without requiring collateral, based on an ongoing evaluation of the customer’s business prospects and financial condition. In the event that payment of a customer’s account receivable is doubtful, we would reserve the receivable under an allowance for doubtful accounts.
 
Inventory
 
Inventory is stated as the lower of cost or net realizable value. Inventory cost is recorded on a first-in, first-out basis using the weighted average method. Net realizable value is determined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.
 
Property and equipment
 
Property and equipment are stated at cost net of accumulated depreciation. Depreciation on property and equipment is calculated on the straight-line basis over the estimated useful lives of the assets. Leasehold improvements are depreciated over the shorter of the life of the asset or the remaining term of the lease.
 
Intangible and other long-lived assets
 
The intangible assets consist of a patent application contributed to us by five founding stockholders, patent applications for technology developed by us and trademark applications. The useful life of the intangible assets has been determined to be ten years and the assets are being amortized. We periodically evaluate our intangible and other long-lived assets for indications that the carrying amount of an asset may not be recoverable. In reviewing for impairment, we compare the carrying value of such assets to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition. When the estimated undiscounted future cash flows are less than their carrying amount, an impairment loss is recognized equal to the difference between the assets’ fair value and their carrying value. In addition to the recoverability assessment, we routinely review the remaining estimated lives of our long-lived assets. Any reduction in the useful life assumption will result in increased depreciation and amortization expense in the

31



period when such determination is made, as well as in subsequent periods. We evaluate the need to record impairment during each reporting period. No impairment has been recorded. We determined that the estimated life of the intellectual property properly reflected the current remaining economic life of the asset.
 
Asset retirement obligations
 
We record the fair value of estimated asset retirement obligations associated with tangible long-lived assets in the period incurred. Retirement obligations associated with long-lived assets are those for which there is an obligation for closures and/or site remediation at the end of the assets’ useful lives. These obligations are initially estimated based on discounted cash flow estimates and are accreted to full value over time through charges to operating expense. In addition, asset retirement costs are capitalized as part of the related asset’s carrying value and are depreciated on a straight-line basis over the assets’ respective useful lives.

Revenue Recognition
 
The Company records revenue recognition in accordance with ASC 606, Revenue from Contracts with Customers. ASC 606 provides a single comprehensive model for the recognition of revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. It requires an entity to recognize revenue when the entity transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which includes (1) identifying the contract(s) with the customer, (2) identifying the separate performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. ASC 606 requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including qualitative and quantitative information about contracts with customers, significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.
 
Research and development
 
Research and development expenditures are expensed as incurred.
 
Income taxes
 
We account for income taxes in accordance with the liability method of accounting for income taxes. Under the liability method, deferred assets and liabilities are recognized based upon anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases. The provision for income taxes is comprised of the current tax liability and the changes in deferred tax assets and liabilities. We established a valuation allowance to the extent that it is more likely than not that deferred tax assets will not be recoverable against future taxable income.
 
We recognize the effect of uncertain income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.
 
Stock-based compensation
 
We recognize compensation expense for stock-based compensation in accordance with ASC 718 “Compensation – Stock Compensation.” For employee stock-based awards, we calculate the fair value of the award on the date of grant using the Black-Scholes-Merton method for stock options; the expense is recognized over the service period for awards to vest.
 
The estimation of stock-based awards that will ultimately vest requires judgment and to the extent actual results or updated estimates differ from the original estimates, such amounts are recorded as a cumulative adjustment in the period estimates are revised. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class and historical experience.
 
Recent accounting pronouncements

See recent accounting pronouncements in Note 2 of the Consolidated Financial Statements located in Item 8 in this Annual Report.
 

32



Contractual Obligations and Commitments
 
The following table summarizes our contractual obligations as of December 31, 2018 and the effect such obligations are expected to have on our liquidity and cash flow in the future years (in thousands):

 
 
Total
 
Less than
1 year
 
1 to 3
years
 
3 to 5
years
 
More than
5 years
Operating lease obligations
 
$
2,156

 
$
624

 
$
1,305

 
$
227

 

Capital lease obligations
 
39

 
16

 
12

 
11

 

Convertible debt
 
6,651

 
6,651

 

 

 

Notes payable
 
9,506

 
295

 
648

 
737

 
7,826

 
 
$
18,352


$
7,586


$
1,965


$
975


$
7,826


Operating lease obligations
 
We lease our Alameda, California and McCarran, Nevada spaces under non-cancelable operating leases, expiring in 2022 and 2021, respectively. On February 4, 2019, we entered into a sublease agreement effective as of February 1, 2019 for the Alameda, California facility. The term of the sublease commenced in February 2019, and ends on May 1, 2022. The above obligations do not include partially offsetting sublease income of approximately $1.5 million.
 
Capital lease obligations
 
We financed certain of our lab equipment purchases through the use of capital leases. The lease terms are between 24 and 36 months with an option to purchase the asset at the end of the lease term for $1.
 
Convertible debt
 
Our convertible debt bears interest at 11% per annum and both interest and principal are due at maturity on May 25, 2019. Interest is not convertible. See Note 10 in the accompanying notes to the consolidated financial statements for further description. In January 2019, this note was paid in full.
 
Long-term debt
 
AMR entered into a $10,000,000 loan with Green Bank on November 3, 2015. The term of the loan is twenty-one years. For the first twelve months only interest was payable; thereafter monthly payments of interest and principal are due. The interest rate adjusts on the first day of each calendar quarter equal to the greater of six percent (6%) or two percent (2%) per annum above the minimum prime lending rate charged by large U.S. money center commercial banks as published in the Wall Street Journal. See Note 12 in the accompanying notes to the consolidated financial statements for further description.

33




Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
 
We do not enter into financial instruments for trading or speculative purposes. Our cash, cash equivalents and restricted cash balances as of December 31, 2018 consisted of cash and cash equivalents. Our primary exposure to market risk is interest expense related to our debt with Green Bank. The interest rate on this loan adjusts on the first day of each calendar quarter equal to the greater of six percent (6%) or two percent (2%) per annum above the minimum prime lending rate charged by large U.S. money center commercial banks as published by the Wall Street Journal. We experience market risk with respect to the volatility of lead commodity prices. The purchase price of our primary raw material used lead acid batteries (used LABs), and the sales price of our lead-based finished products are based on commodity pricing. Due to the relatively short turnaround between the purchase of used LABs and the sale of our finished goods, we believe the risk is minimized.

34



Item 8.
Financial Statements and Supplementary Data
 
Index To Consolidated Financial Statements
 
 
Page
 
 
 
 
 
 
 
 
 
 
 
 

35



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
To the Board of Directors and 
Stockholders of Aqua Metals, Inc. and Subsidiaries:
 
Opinion on the Financial Statements
 
We have audited the accompanying consolidated balance sheets of Aqua Metals, Inc. and Subsidiaries (collectively the “Company”) as of December 31, 2018 and 2017, the related consolidated statements of operations, stockholders’ equity, and cash flows, for each of the three years in the period ended December 31, 2018, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018 and 2017, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2018, in conformity with U.S. generally accepted accounting principles.
 
Basis for Opinion
 
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
 
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
 
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
 
We have served as the Company’s auditor since 2014.
 
/s/ Armanino LLP 
San Ramon, CA 
February 28, 2019

36

AQUA METALS, INC.
Consolidated Balance Sheets
(in thousands, except share and per share amounts)

ASSETS
 
 
 
 
 
 
December 31, 2018
 
December 31, 2017
Current assets
 
 

 
 

Cash and cash equivalents
 
$
20,892

 
$
22,793

Accounts receivable
 
725

 
882

Inventory
 
765

 
1,239

Prepaid expenses and other current assets
 
370

 
770

Total current assets
 
22,752

 
25,684

 
 
 
 
 
Non-current assets
 
 
 
 
Property and equipment, net
 
45,548

 
45,733

Intellectual property, net
 
1,271

 
1,461

Other assets
 
1,800

 
1,564

Total non-current assets
 
48,619

 
48,758

 
 
 
 
 
Total assets
 
$
71,371


$
74,442

 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
Accounts payable
 
$
2,088

 
$
1,436

Accrued expenses
 
5,196

 
1,801

Deferred rent, current portion
 
8

 
192

Lease liability, current portion
 
121

 

Notes payable, current portion
 
311

 
405

Convertible note payable, current portion
 
4,075

 

Total current liabilities
 
11,799

 
3,834

 
 
 
 
 
Deferred rent, non-current portion
 
27

 
771

Lease liability, non-current portion
 
110

 

Asset retirement obligation
 
745

 
701

Notes payable, non-current portion
 
8,600

 
8,839

Convertible note payable, non-current portion
 

 
1,332

Total liabilities
 
21,281


15,477

 
 
 
 
 
Commitments and contingencies
 


 


 
 
 
 
 
Stockholders’ equity
 
 
 
 
Common stock; $0.001 par value; 50,000,000 shares authorized; 38,932,437 and 27,554,076 shares issued and outstanding as of December 31, 2018 and December 31, 2017, respectively
 
39

 
27

Additional paid-in capital
 
145,147

 
113,780

Accumulated deficit
 
(95,096
)
 
(54,842
)
Total stockholders’ equity
 
50,090

 
58,965

 
 
 
 
 
Total liabilities and stockholders’ equity
 
$
71,371


$
74,442

 
The accompanying notes are an integral part of these consolidated financial statements.

37

AQUA METALS, INC.
Consolidated Statements of Operations
(in thousands, except share and per share amounts)

 
 
Year ended December 31,
 
 
2018
 
2017
 
2016
Product sales
 
$
4,449

 
$
2,088

 
$

 
 
 
 
 
 
 
Operating cost and expense
 
 
 
 
 
 
Cost of product sales
 
22,761

 
9,541

 

Research and development cost
 
4,502

 
8,103

 
6,348

General and administrative expense
 
14,214

 
6,891

 
6,610

Impairment charge
 

 
2,411

 

Total operating expense
 
41,477


26,946


12,958

 
 
 
 
 
 
 
Loss from operations
 
(37,028
)

(24,858
)

(12,958
)
 
 
 
 
 
 
 
Other income and expense
 
 
 
 
 
 
Interest expense
 
(3,447
)
 
(1,761
)
 
(639
)
Interest and other income
 
223

 
41

 
41

 
 
 
 
 
 
 
Total other expense, net
 
(3,224
)

(1,720
)

(598
)
 
 
 
 
 
 
 
Loss before income tax expense
 
(40,252
)

(26,578
)

(13,556
)
 
 
 
 
 
 
 
Income tax expense
 
(2
)
 
(2
)
 
(1
)
 
 
 
 
 
 
 
Net loss
 
$
(40,254
)

$
(26,580
)

$
(13,557
)
 
 
 
 
 
 
 
Weighted average shares outstanding, basic and diluted
 
34,154,826

 
20,293,100

 
15,267,233

 
 
 
 
 
 
 
Basic and diluted net loss per share
 
$
(1.18
)

$
(1.31
)

$
(0.89
)
 
The accompanying notes are an integral part of these consolidated financial statements.

38

AQUA METALS, INC.
Consolidated Statements of Stockholders’ Equity (Deficit)
(in thousands, except share amounts)

 
 
 
 
 
 
Additional Paid-in Capital
 
Accumulated Deficit
 
Total Stockholders' Equity (Deficit)
 
 
Common Stock
 
 
 
 
 
Shares
 
Amount
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2015
 
14,137,442

 
$
14

 
$
48,356

 
$
(14,705
)
 
$
33,665

 
 
 
 
 
 
 
 
 
 
 
Stock-based compensation - stock options
 

 

 
1,060

 

 
1,060

Warrants issued for consulting services
 

 

 
138

 

 
138

Cashless exercise of warrant
 
15,203

 

 

 

 

Exercise of options to purchase common stock
 
4,500

 

 
19

 

 
19

Common stock issued in May 2016 Private Placement, net of $345 offering costs
 
719,333

 
1

 
4,777

 

 
4,778

Common stock issued for cash in May 2016 from Interstate Battery, net of $629 allocated transaction cost
 
702,247

 
1

 
4,369

 

 
4,370

Common stock issued in November 2016 public offering, net of $1,688 offering costs
 
2,300,000

 
2

 
21,540

 

 
21,542

Proceeds allocated to warrants issued and beneficial conversion feature in connection with Interstate Batteries Agreement
 

 

 
4,975

 

 
4,975

Net loss
 

 

 

 
(13,557
)
 
(13,557
)
 
 
 
 
 
 
 
 
 
 
 
December 31, 2016
 
17,878,725

 
$
18

 
$
85,234

 
$
(28,262
)
 
$
56,990

 
 
 
 
 
 
 
 
 
 
 
Stock-based compensation
 

 

 
1,081

 

 
1,081

Cashless exercise of warrants
 
1,173,296

 
1

 
(1
)
 

 

Exercise of warrants to purchase common stock
 
2,500

 

 
15

 

 
15

Exercise of options to purchase common stock
 
284,370

 

 
1,071

 

 
1,071

Common stock issued under Officers and Directors Purchase Plan
 
2,404

 

 
8

 

 
8

Common stock issued for cash in February 2017 from Johnson Controls, net of $167 transaction cost
 
939,005

 
1

 
10,471

 

 
10,472

Common stock issued for purchase of Ebonex IPR Limited
 
123,776

 

 
2,149

 

 
2,149

Common stock issued in December 2017 public offering, net of $1,256 transaction cost
 
7,150,000

 
7

 
13,752

 

 
13,759

Net loss
 

 

 

 
(26,580
)
 
(26,580
)
 
 
 
 
 
 
 
 
 
 
 
December 31, 2017
 
27,554,076

 
$
27

 
$
113,780

 
$
(54,842
)
 
$
58,965

 
 
 
 
 
 
 
 
 
 
 
Stock-based compensation
 

 

 
1,201

 

 
1,201

Common stock issued under Officers and Directors Purchase Plan
 
2,034

 

 
4

 

 
4

Common stock issued upon RSU vesting
 
65,600

 

 

 

 

Common stock issued for consulting services
 
152,727

 

 
423

 

 
423

Common stock issued in overallotment related to December 2017 Public Offering, net of $10 transaction cost
 
1,072,500

 
2

 
2,101

 

 
2,103

Common stock issued for cash in June 2018 Public Offering, net of $2,096 transaction cost
 
10,085,500

 
10

 
26,636

 

 
26,646

Modification of Interstate Batteries warrant #1
 

 

 
1,002

 

 
1,002

Net loss
 

 

 

 
(40,254
)
 
(40,254
)
 
 
 
 
 
 
 
 
 
 
 
Balances, December 31, 2018
 
38,932,437

 
$
39

 
$
145,147

 
$
(95,096
)
 
$
50,090

 
The accompanying notes are an integral part of these consolidated financial statements.

39

AQUA METALS, INC.
Consolidated Statements of Cash Flows
(in thousands)

 
 
Year ended December 31,
 
 
2018

2017

2016
Cash flows from operating activities:
 
 
 
 
 
 
Net loss
 
$
(40,254
)
 
$
(26,580
)
 
$
(13,557
)
Reconciliation of net loss to net cash used in operating activities
 
 
 
 
 
 
Depreciation
 
3,213

 
2,908

 
687

Amortization of intellectual property
 
190

 
163

 
128

Accretion of asset retirement obligation
 

 

 

Fair value of warrant modification, net
 
402

 

 

Fair value of warrants issued for consulting services
 

 

 
138

Fair value of common stock issued for consulting services
 
423

 

 

Stock-based compensation
 
1,201

 
1,081

 
1,060

Amortization of debt discount
 
2,006

 
360

 
54

Amortization of deferred financing costs
 
83

 
83

 
62

Non-cash convertible note interest expense
 
690

 
618

 
343

Lease liability, net of deferred rent write-off
 
(493
)
 

 

Amortization of lease liability
 
(80
)
 

 

Impairment of acquired intellectual property
 

 
2,411

 

Loss on sale of equipment
 
869

 
76

 

Inventory write down
 
179

 
456

 

Changes in operating assets and liabilities
 
 
 
 
 
 
Accounts receivable
 
157

 
(882
)
 

Inventory
 
295

 
(1,636
)
 
(59
)
Prepaid expenses and other current assets
 
400

 
236

 
(394
)
Accounts payable
 
472

 
926

 
(176
)
Accrued expenses
 
4,009

 
924

 
564

Deferred rent
 
(124
)
 
(177
)
 

Net cash used in operating activities
 
(26,318
)

(19,002
)

(11,121
)
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
Purchases of property and equipment
 
(3,693
)
 
(8,819
)
 
(29,156
)
Proceeds from sale of equipment
 

 
4

 

Other assets
 
(236
)
 
(345
)
 
(250
)
Intellectual property related expenditures
 

 
(615
)
 
(200
)
Net cash used in investing activities
 
(3,929
)
 
(9,775
)
 
(29,606
)
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
Proceeds from issuance of common stock, net of transaction costs
 
28,753

 
25,325

 
30,709

Payments on notes payable
 
(277
)
 
(201
)
 
(14
)
Payments on capital leases
 
(130
)
 
(136
)
 
(52
)
Proceeds from issuance of convertible notes payable, net of issuance costs
 

 

 
4,858

Net cash provided by financing activities
 
28,346

 
24,988

 
35,501

 
 
 
 
 
 
 
Net decrease in cash, cash equivalents and restricted cash
 
(1,901
)
 
(3,789
)
 
(5,226
)
Cash, cash equivalents and restricted cash at beginning of period
 
22,793

 
26,582

 
31,808

 
 
 
 
 
 
 
Cash, cash equivalents and restricted cash at end of period
 
$
20,892


$
22,793


$
26,582


(Continued)

40

AQUA METALS, INC.
Consolidated Statements of Cash Flows
(in thousands)

 
 
Year ended December 31,
 
 
2018

2017

2016
Supplemental disclosure of cash flow information:
 
 
 
 
 
 
Cash paid for interest, net of amounts capitalized
 
$
668

 
$
699

 
$
330

Cash paid for income taxes
 
$
2

 
$
2

 
$
1

Non-cash investing activities
 
 
 
 
 
 
Tenant improvement allowances
 
$

 
$

 
$
78

 
 
 
 
 
 
 
Non-cash financing activities
 
 
 
 
 
 
Capital lease
 
$
38

 
$

 
$
310

Fair value of consulting warrants
 
$

 
$

 
$
138

Fair value of financing warrants
 
$

 
$

 
$
229

Fair value of common stock issued to consultants
 
$
423

 
$

 
$

Total non-cash financing activities
 
$
461


$


$
677

 
 
 
 
 
 
 
Supplemental disclosure of non-cash transactions
 
 
 
 
 
 
Change in property and equipment resulting from change in accounts payable
 
$
180

 
$
(1,062
)
 
$
1,200

Change in property and equipment resulting from change in accrued expenses
 
$
(14
)
 
$
(1,098
)
 
$
1,330

Recognition of convertible debt discount
 
$

 
$

 
$
4,975

Asset retirement obligation offset with asset retirement cost (property and equipment)
 
$

 
$
670

 
$

Fair value of common stock issued for intellectual property
 
$

 
$
2,149

 
$

Reduction in accrued liabilities upon modification of Interstate Battery warrant #1
 
$
600

 
$

 
$

 
The accompanying notes are an integral part of these consolidated financial statements.

41



AQUA METALS, INC.
Notes to Consolidated Financial Statements 
 
1.
Organization and Operations

Aqua Metals, Inc. (the “Company”) was incorporated in Delaware and commenced operations on June 20, 2014 (inception). On January 27, 2015, the Company formed two wholly-owned subsidiaries, Aqua Metals Reno, Inc. (“AMR”) and Aqua Metals Operations, Inc. (collectively, the “Subsidiaries”), both incorporated in Delaware. The Company is engaged in the business of lead recycling through its patented and patent-pending AquaRefiningTM technology. Unlike smelting, AquaRefining is a room temperature, water-based process that emits less pollution than smelting, the traditional method of lead recycling. The Company has built its first recycling facility in Nevada’s Tahoe Regional Industrial Complex (“TRIC”) in McCarran, Nevada and intends to pursue the development of additional lead acid battery recycling facilities based on the Company’s AquaRefining technology, likely through licensing or joint development arrangements. The Company commenced the shipment of products for sale, consisting of lead compounds and plastics, in April 2017, and through March 31, 2018, substantially all revenue was derived from the sale of lead compounds and plastics. In April 2018, the Company began shipping cast lead bullion (mixture of lead purchased to prime the kettles and AquaRefined lead from our AquaRefining process) blocks in addition to lead compounds and plastics and in June 2018, the Company began shipping high purity lead from its AquaRefining process.
 
Liquidity and Management Plans
 
The Company completed the development of its first LAB recycling facility at the Tahoe Reno Industrial Center (“TRIC”) and commenced production during the first quarter of 2017. The TRIC facility produces recycled lead, consisting of lead compounds, ingoted hard lead and ingoted AquaRefined lead as well as plastic.
 
The Company generated revenues of $4.4 million and $2.1 million during 2018 and 2017, had no revenue in 2016, and had net losses of $40.3 million, $26.6 million and $13.6 million for the years ended December 31, 2018, 2017 and 2016, respectively. As of December 31, 2018, the Company’s cash balance was $20.9 million. The Company believes that its working capital as of the date of this report is sufficient to fund the commissioning and commencement of commercial operations of 16 AquaRefining modules and its commercial operations at TRIC through, at least, April 2020, assuming the successful commercial rollouts of the 16 AquaRefining modules.

2.
Summary of Significant Accounting Policies

Basis of presentation and consolidation
 
The accompanying consolidated financial statements include those of Aqua Metals, Inc. and its subsidiaries, after elimination of all intercompany accounts and transactions. We have prepared the accompanying consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”).
 
Use of estimates
 
The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of expenses during the period. Significant items subject to such estimates and assumptions include the carrying amount and valuation of long-lived assets, the valuation of conversion features of convertible debt, valuation allowances for deferred tax assets, the determination of fair value of estimated asset retirement obligations, the determination of stock option expense and the determination of the fair value of stock warrants issued. Actual results could differ from those estimates.
 
Cash and cash equivalents
 
The Company considers all highly liquid instruments with original or remaining maturities of ninety days or less at the date of purchase to be cash equivalents. The Company maintains its cash balances in large financial institutions. Periodically, such balances may be in excess of federally insured limits.
 

42



Restricted cash
 
Restricted cash was comprised of funds held in escrow at Green Bank for the purpose of paying for the construction of the lead recycling plant building in McCarran, Nevada. As of December 31, 2017, the building was complete and the funds had been dispersed.

In November 2016, the Financial Accounting Standards Board, FASB issued Accounting Standards Update ("ASU") No. 2016-18. The amendments in ASU 2016-18 require an entity to reconcile and explain the period-over-period change in total cash, cash equivalents and restricted cash within its statements of cash flows rather than reconciling and explaining the period-over-period change in total cash and cash equivalents (excluding restricted cash). The Company adopted this new ASU beginning January 1, 2018 using the required full retrospective approach. The adoption of this standard resulted in an increase in net cash used in investing activities of $1.1 million and $10.5 million in the consolidated statements of cash flows for the year ended December 31, 2017 and December 31, 2016, respectively. As there is no restricted cash at December 31, 2018 or 2017, there is no effect on the year ended December 31, 2018.

 
 
December 31,
 
 
2016
 
2015
 
 
 
 
 
Cash and cash equivalents
 
$
25,458

 
$
20,141

Restricted cash
 
1,124

 
11,667

 
 
 
 
 
Total cash, cash equivalents and restricted
 
 
 
 
cash shown in the statement of cash flows
 
$
26,582

 
$
31,808



Accounts receivable
 
The Company sells its products to large well-established companies and extends credit without requiring collateral, based on an ongoing evaluation of the customer’s business prospects and financial condition. In the event that payment of a customer’s account receivable is doubtful, the Company would reserve the receivable under an allowance for doubtful accounts. As of December 31, 2018, and 2017, the Company believes that all receivables have been or will be collected and, therefore, has not created any reserve for doubtful accounts.
 
Inventory
 
Inventory is stated as the lower of cost or net realizable value. Cost is recorded on a first-in, first-out basis using the weighted average method. Net realizable value is determined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The Company records a write-down, if necessary, to reduce the carrying value of inventory to its net realizable value. The effect of these write-downs is to establish a new cost basis in the related inventory, which is not subsequently written up.
 
Property and equipment
 
Property and equipment are stated at cost net of accumulated depreciation. Depreciation on property and equipment is calculated on the straight-line basis over the estimated useful lives of the assets. Leasehold improvements are depreciated over the shorter of the life of the asset or the remaining term of the lease.
 
Intangible and other long-lived assets
 
Intangible assets consist of a patent application contributed to the Company by five founding stockholders, patent applications for technology developed by the Company, trademark applications and a patent portfolio acquired during 2017. The useful life of this intellectual property has been determined to be ten years and the assets are being amortized straight-line over this period. The Company periodically evaluates its intangible and other long-lived assets for indications that the carrying amount of an asset may not be recoverable. In reviewing for impairment, the Company compares the carrying value of such assets to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition. When the estimated undiscounted future cash flows are less than their carrying amount, an impairment loss is recognized equal to the difference between the assets’ fair value and their carrying value. In addition to the recoverability assessment, the Company routinely reviews the remaining estimated lives of its long-lived assets. Any reduction in the useful life assumption will result in increased depreciation and

43



amortization expense in the period when such determination is made, as well as in subsequent periods. The Company evaluates the need to record impairment during each reporting period. As further described in Note 6, the Company recorded an impairment of $2.4 million in the second quarter of 2017 on its patent portfolio. As of December 31, 2018, the Company determined that the estimated life of the Intellectual Property properly reflected the current remaining economic life of the asset.
 
Asset retirement obligations
 
The Company records the fair value of estimated asset retirement obligations associated with tangible long-lived assets in the period incurred. Retirement obligations associated with long-lived assets are those for which there is an obligation for closures and/or site remediation at the end of the assets’ useful lives. These obligations are initially estimated based on discounted cash flow estimates and are accreted to full value over time through charges to operating expense. In addition, asset retirement costs are capitalized as part of the related asset’s carrying value and are depreciated on a straight-line basis over the assets’ respective useful lives.
 
Revenue Recognition
 
The Company records revenue in accordance with Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers. ASC 606 provides a single comprehensive model for the recognition of revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. It requires an entity to recognize revenue when the entity transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which includes (1) identifying the contract(s) with the customer, (2) identifying the separate performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. ASC 606 requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including qualitative and quantitative information about contracts with customers, significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.
 
Revenue is generally recognized with the delivery of the Company’s products, primarily hard lead, lead compounds and plastics, to customers. Sales, value add, and other taxes, if any, that are collected concurrent with revenue-producing activities are excluded from revenue as they are subsequently remitted to governmental authorities. Incidental items that are immaterial in the context of the contract are recognized as expense. Freight and shipping costs related to the transfer of the Company’s products to customers are included in revenue and cost of product sales. Payment on invoices is generally due within 30 days of the invoice.

Arrangements with Multiple Performance Obligations
 
Contracts with customers may include multiple performance obligations. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The Company expects that many of our contracts will have a single performance obligation as the promise to transfer the individual goods or services will not be separately identifiable from other promises in the contracts and therefore, not distinct. For contracts with multiple performance obligations, revenue will be allocated to each performance obligation based on the Company’s best estimate of the standalone selling price of each distinct good or service in the contract. The primary method used to estimate standalone selling prices is based on prices charged separately to customers or expected cost-plus margin. At present, the Company does not have any arrangements with multiple performance obligations.

Significant Judgments
 
The Company estimates variable consideration for arrangements where the transaction price is not fully determinable until the completion of yield testing. The Company estimates variable consideration at the most likely amount to which it expects to be entitled and includes estimated amounts in revenue to the extent it is probable that a significant reversal of revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Adjustments to revenue is recognized in the period when the uncertainty is resolved. To date, any adjustments to estimates have not been material.
 
Practical Expedients and Exemptions
 
The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.


44



Research and development
 
Research and development expenditures are expensed as incurred.
 
Income taxes
 
The Company accounts for income taxes in accordance with the liability method of accounting for income taxes. Under the liability method, deferred assets and liabilities are recognized based upon anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases. The provision for income taxes is comprised of the current tax liability and the changes in deferred tax assets and liabilities. The Company establishes a valuation allowance to the extent that it is more likely than not that deferred tax assets will not be recoverable against future taxable income.
 
The Company recognizes the effect of uncertain income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.
 
Fair value measurements
 
The carrying amounts of cash and cash equivalents, accounts receivable, inventory, prepaid expenses and other current assets, accounts payable, accrued expenses, and deferred rent approximate fair value due to the short-term nature of these instruments. The carrying value of short and long-term debt, and lease liabilities also approximates fair value since these instruments bear market rates of interest or are calculated using market rates of interest. None of these instruments are held for trading purposes.
 
Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier far value hierarchy is used to prioritize the inputs in measuring fair value as follows:
 
Level 1. Quoted prices in active markets for identical assets or liabilities.
 
Level 2. Quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.
 
Level 3. Significant unobservable inputs that cannot be corroborated by market data.
 
The asset or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement.
 
There are no assets or liabilities that are measured at fair value on a recurring basis at December 31, 2018 or 2017.
 
Stock-based compensation
 
The Company recognizes compensation expense for stock-based compensation in accordance with ASC 718 “Compensation – Stock Compensation.” For employee stock-based awards, the Company calculates the fair value of the award on the date of grant using the Black-Scholes-Merton method for stock options; the expense is recognized over the service period for awards to vest.
 
The estimation of stock-based awards that will ultimately vest requires judgment and to the extent actual results or updated estimates differ from the original estimates, such amounts are recorded as a cumulative adjustment in the period estimates are revised.

Net loss per share
 
Basic net loss per share is computed by dividing net loss by the weighted average number of vested shares outstanding during the period. Diluted net loss per share is computed by giving effect to all potential dilutive common securities, including convertible notes, options and warrants. Potential dilutive common shares include the dilutive effect of the common stock underlying in-the-money stock options and is calculated based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of an option and the average amount of compensation cost, if any, for future services that the Company has not yet recognized when the option is exercised, are assumed to be used to repurchase shares in the current period.
 

45



For all periods presented in this report, convertible notes, stock options, and warrants were not included in the computation of diluted net loss per share because such inclusion would have had an antidilutive effect.

 
 
Year Ended December 31,
Excluded potentially dilutive securities (1):
 
2018
 
2017
 
2016
 
 
 
 
 
 
 
Convertible note - principal
 
702,247

 
702,247

 
702,247

Consulting warrants to purchase common stock
 

 

 
486,364

Options to purchase common stock
 
1,694,068

 
578,813

 
915,572

Unvested restricted stock
 
96,623

 
180,951

 

Financing warrants to purchase common stock
 
2,340,828

 
2,340,828

 
3,316,208

Total potential dilutive securities
 
4,833,766


3,802,839


5,420,391


(1)
The number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations as required if the securities were dilutive.

Segment and Geographic Information
 
Operating segments are defined as components of an enterprise engaging in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company views its operations and manages its business in one operating segment, and the Company operates in only one geographic segment.
 
Concentration of Credit Risk
 
Revenues from the following customers each represented at least 10% of total revenue for the periods listed below. Johnson Controls Battery Group, Inc. also represented a significant portion of our accounts receivable as of December 31, 2018 and 2017.
 
 
 
 
Accounts Receivable
 
 
Revenue
 
As of December 31,
 
 
2018
 
2017
 
2016
 
2018
 
2017
 
 
 
 
 
 
 
 
 
 
 
Johnson Controls Battery Group, Inc.
 
88
%
 
96
%
 
%
 
95
%
 
95
%

Substantially all of the chemicals used in our refining process are provided by one supplier and supply of used lead acid batteries has, during 2018 and 2017, been provided by two vendors as indicated below.

 
 
2018
 
2017
 
 
 
 
 
Supplier A
 
32
%
 
56
%
Supplier B
 
64
%
 
44
%

Recent accounting pronouncements
 
In February 2016, the FASB issued ASU 2016-2 - Leases (ASC 842), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors).  The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today.  ASC 842 supersedes

46



the previous leases standard, ASC 840 Leases. The standard is effective on January 1, 2019, with early adoption permitted. The new standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements, which amends ASC Topic 842 to provide another transition method, allowing a cumulative effect adjustment to the opening balance of retained earnings during the period of adoption. The Company has two longer term office leases and a few small equipment leases. At January 1, 2019, the Company will record a lease liability equal to the present value of future lease payments not yet paid on each of these leases and an asset for its right to use the underlying assets, net of any previously recorded impairment. The effect of the adoption of this standard is an increase in lease liabilities of $1.6 million offset by an increase in assets of the same amount.

There were no other recent accounting pronouncements or changes in accounting pronouncements during the year ended December 31, 2018 that are of significance or potential significance to the Company.

3.
Revenue recognition
 
The Company generates revenues by recycling lead acid batteries (“LABs”) and selling the recovered lead to its customers. Primary components of the recycling process include sales of recycled lead consisting of lead compounds, ingoted hard lead and ingoted AquaRefined lead as well as plastics. The Company commenced the shipment of products for sale, consisting of lead compounds and plastics, in April 2017, and through March 31, 2018, all revenue was derived from the sale of lead compounds and plastics. In April 2018, the Company began shipping lead bullion in addition to lead compounds and plastics. In June 2018, the Company began shipping high purity lead from its AquaRefining process.
 
Revenue from products transferred to customers at a single point in time with the delivery of the Company’s products to customers accounted for 100% of our revenue during the years ended December 31, 2018 and 2017.

4.
Inventory, net

Inventory consisted of the following (in thousands):
 
 
 
December 31,
 
 
2018
 
2017
 
 
 
 
 
Finished goods
 
$
43

 
$
512

Work in process
 
164

 
182

Raw materials
 
558

 
545

 
 
$
765

 
$
1,239



47



5.
Property and equipment, net
 
Property and equipment, net, consisted of the following (in thousands):

 
 
Useful Life (Years)
 
December 31,
Asset Class
 
 
2018
 
2017
 
 
 
 
 
 
 
Operational equipment
 
3-10
 
$
15,926

 
$
15,457

Lab equipment
 
5
 
698

 
685

Computer equipment
 
3
 
201

 
174

Office furniture and equipment
 
3
 
336

 
326

Leasehold improvements
 
5-7
 

 
1,408

Land
 
 
1,047

 
1,047

Building
 
39
 
24,820

 
24,847

Asset retirement cost
 
20
 
670

 
670

Equipment under construction
 
 
 
7,892

 
4,552

 
 
 
 
51,590

 
49,166

Less:  accumulated depreciation
 
 
 
(6,042
)
 
(3,433
)
 
 
 
 
 
 
 
 
 
 
 
$
45,548

 
$
45,733


Depreciation expense was $3.2 million, $2.9 million and $0.7 million for the years ended December 31, 2018, 2017 and 2016, respectively. The building is a 136,750 square foot lead acid battery recycling plant being built in McCarran, Nevada. Equipment under construction is primarily AquaRefining modules manufactured by the Company to be used in the McCarran, Nevada recycling plant.
 
Certain costs necessary to make the recycling facility ready for its intended use have been capitalized, including interest expense on notes payable. Capitalized interest totaled $0.5 million and $0.1 million for the years ended December 31, 2016 and 2015, respectively. Capitalization of interest ceased upon completion of the building in early November 2016.
 
The Company has financed certain of its lab equipment purchases through the use of capital leases. The lease terms are generally between 24 and 36 months with an option to purchase the asset at the end of the lease for $1. Total lab equipment included in the above table at December 31, 2018 subject to capital leases is $0.4 million less accumulated depreciation of $0.2 million resulting in net fixed assets under capital lease of $0.2 million. Total lab equipment included in the above table at December 31, 2017 subject to capital leases was $0.4 million less accumulated depreciation of $0.1 million resulted in net fixed assets under capital lease of $0.3 million. These assets are depreciated using the same useful lives as noted above and included in depreciation expense. See Note 12 – Notes Payable for minimum future payments related to these equipment leases.

6.
Intellectual Property
 
On April 13, 2017, the Company entered into an agreement to purchase all the capital shares of Ebonex IPR Limited, a company registered in England and Wales. Ebonex IPR Limited is a pre-revenue IP-based company that has developed patented technology in the field of advanced materials and manufacturing methods for advanced lead acid batteries. Total consideration was $2.5 million, consisting of cash, transaction costs and 123,776 shares of the Company’s common stock, which at the time had a closing market price of $17.36 per share. In accordance with ASC Topic 805-50, “Business Combinations – Related Issues”, the Company accounted for the transaction as an asset acquisition and allocated the consideration to the relative fair value of the assets acquired. The Company determined that the transaction was an asset acquisition rather than a business combination following the guidance in the above-mentioned standard. In order to be treated as a business combination, the acquired assets and assumed liabilities must constitute a business. A business requires a set of inputs and processes applied to those inputs that have the ability to contribute to the creation of outputs. Ebonex IPR Limited has no processes such as strategic management processes, operational processes, or employees. Further, Ebonex IPR Limited provides no goods or services to customers, nor has it any investment or other revenues. Therefore, the Company concluded that the acquired assets and assumed liabilities do not constitute a business and are instead treated as an asset acquisition. Assets acquired consisted of a patent portfolio. The fair value of the patent portfolio, of $112,000,

48



was determined by management with the assistance of an independent valuation specialist using an income approach. Included in the purchase were certain fixed assets that have been determined by management to have no immediate value and were not considered in the valuation of Ebonex IPR.
 
The Company initially recorded the transaction as an increase of $2.5 million to intellectual property, net on the balance sheet. Subsequently, due to the fair value of the patent portfolio being significantly less than total consideration, the early development stage of the technology acquired and the uncertainties inherent in research and development, the Company recorded a non-cash impairment charge of $2.4 million during the three-month period ended June 30, 2017.
 
The remaining $0.1 million is being amortized straight-line over a 10-year period.
 
The increase of $0.6 million (including the Ebonex transaction detailed above) and $0.2 million in 2017 and 2016, respectively, was due to fees associated with additional patent and trademark filings. There were no increases to intellectual property in 2018. The intellectual property balance is being amortized straight-line over a 10-year period.
 
Intellectual property, net, is comprised of the following (in thousands):
 
 
2018
 
2017
Intellectual property
 
$
1,906

 
$
1,906

Accumulated amortization
 
(635
)
 
(445
)
Intellectual property, net
 
$
1,271

 
$
1,461

 
Aggregate amortization expense for the year ended December 31, 2018, 2017 and 2016 was $0.2 million, $0.2 million and $0.1 million, respectively.
 
Estimated future amortization is as follows as of December 31, 2018 (in thousands):

2019
$
191

2020
191

2021
191

2022
191

2023
191

Thereafter
316

Total estimated future amortization
$
1,271


7.
Other Assets
 
Other assets consist of the following (in thousands).
 
 
 
December 31,
 
 
2018
 
2017
 
 
 
 
 
Alameda security deposit (1)
 
$
55

 
$
321

CD for Green Bank collateral security (2)
 
1,026

 
1,019

Nevada sales and use tax deposit
 
49

 
49

Facility Closure Trust deposit (3)
 
670

 
450

 
 
1,800

 
1,839

Less:  current portion (1)
 

 
(275
)
 
 
 
 
 
Other assets, non-current
 
$
1,800

 
$
1,564



49



(1)
The lease deposit related to the Alameda headquarters was released over time: $275,000 was released in June 2018; the remainder will be released at the end of the lease term. The current portion in 2017 was included in prepaid expenses and other current assets in the consolidated balance sheet.

(2)
The $1.0 million certificate of deposit is held by Green Bank as collateral for the Green Bank note payable balance. The deposit with Green Bank will be released after TRIC has three consecutive months of positive cash flow from operations.

(3)
The Company has entered into a Facility Closure Trust Agreement for the benefit of the Nevada Division of Conservation and Natural Resources (NDEP). Funds deposited in the Trust are to be available when and if needed, for closure and/or post-closure care of the facility related to potential decontamination and hazardous material cleanup. The Trustee will reimburse the Company or other persons as specified by the NDEP from the fund for closure and post-closure expenditures in such amounts as the NDEP shall direct in writing. In addition, the Trustee shall refund to the Company such amounts as the NDEP specifies in writing. $100,000 was deposited upon establishment of the Trust Fund, on October 31, 2016; $350,000 was deposited on October 31, 2017; and $220,000 was deposited on October 31, 2018.

8.
Accrued liabilities
 
Accrued liabilities consist of the following (in thousands).

 
 
December 31,
 
 
2018
 
2017
 
 
 
 
 
Fixed asset related
 
$
218

 
$
232

Payroll related
 
2,115

 
470

Use tax accrual
 
2

 
75

Professional services
 
159

 
88

Key man penalty accrual
 
2,500

 

Estimated Interstate Battery settlement
 

 
600

Other
 
202

 
336

 
 
$
5,196

 
$
1,801


9.
Asset Retirement Obligation
 
ASC Topic 410-20, “Asset Retirement and Environmental Obligations, Asset Retirement Obligations” requires the recording of a liability in the period in which an asset retirement obligation (ARO) is incurred, in an amount equal to the discounted estimated fair value of the obligation that is capitalized. In each subsequent fiscal quarter, this liability is accreted up to the final retirement cost. The determination of the ARO is based on an estimate of the future cost to remove and decontaminate the Company’s facility at TRIC upon closure. The estimated fair value of the closure costs is based on vendor quotes to remove and decontaminate the McCarran facility in accordance with the Company’s closure plan as filed with the State of Nevada in its “Application for the Recycling of Hazardous Waste, by Written Determination” in 2016. The actual costs could be higher or lower than current estimates. The discounted estimated fair value of the closure costs was $0.7 million and the obligation was recorded as of March 31, 2017, when the obligation was deemed to have occurred. Offsetting this ARO is, as noted in Note 5 above, an asset retirement cost of the same amount that was capitalized. Accretion of the ARO for the year ended December 31, 2018 and 2017 was $44,000 and $31,000 respectively.

The Company entered into a facility closure trust agreement in October 2017 for the benefit of the Nevada Division of Environmental Protection (NDEP), an agency of the Nevada Division of Conservation and Natural Resources. Funds deposited in the trust are to be available, when and if needed, for potential decontamination and hazardous material cleanup in connection with the closure and/or post-closure care of the facility. The trustee will reimburse the Company or other persons as specified by the NDEP from the fund for closure and post-closure expenditures in such amounts as the NDEP shall direct in writing. Through December 31, 2018, $670,000 has been contributed to the trust fund.


50



10.
Convertible Notes
 
As described more completely under the caption “Interstate Battery Agreements” below in Note 13, the Company issued to Interstate Battery System International, Inc. and its wholly-owned subsidiary (collectively “Interstate Battery”) a convertible note with a face amount of $5.0 million and interest of 11% per annum due May 25, 2019. The note is convertible at $7.12 per share of common stock. The Company allocated the proceeds from the Interstate Battery agreements to the convertible note, common stock and warrants comprising the financing agreements based on the relative fair value of the individual securities on the May 24, 2016 closing date of the agreements. Additionally, the convertible notes contained an embedded conversion feature having intrinsic value at the issuance date, which value the Company treated as an additional discount attributed to the convertible note, subject to limitations on the absolute amount of discount attributable to the convertible notes and its allocated value. The Company recorded a corresponding credit to additional paid-in capital attributable to the beneficial conversion feature (“BCF”). The discounts attributable to the convertible note, an aggregate of $4,975,000, are being amortized using the effective interest method over the three-year term of the note, maturing on May 24, 2019. Because the discount on the convertible note exceeds 99% of its initial face value, and because the discount is amortized over the period from issuance to maturity, the calculated effective interest rate is 184.75% per annum.
 
Interest cost on the note for the years ended December 31, 2018, 2017 and 2016 totaled $0.7 million, $0.6 million and $0.3 million, respectively. Amortization of the note discount for the years ended December 31, 2018, 2017 and 2016 totaled $2.0 million, $0.4 million and $0.1 million, respectively. Amortization of the deferred financing costs, more fully described in Note 13, totaled $47,000, $48,000 and $27,000 for the years ended December 31, 2018, 2017 and 2016, respectively.
 
The convertible note payable is comprised of the following (in thousands):
 
 
December 31,
 
 
2018
 
2017
 
 
 
 
 
Convertible note payable
 
$
5,000

 
$
5,000

Accrued interest
 
1,651

 
961

Deferred financing costs, net
 
(20
)
 
(67
)
Note discount
 
(2,556
)
 
(4,562
)
 
 
 
 
 
Less current portion
 
$
4,075

 
$

 
 
 
 
 
Convertible note payable, non-current portion
 
$

 
$
1,332

 
As of December 31, 2018, the Interstate Battery convertible note’s “if-converted value” did not exceed its principal amount. As further described in Note 19 - Subsequent Events. This note was fully paid off in January 2019.

11.
Deferred Rent

On August 7, 2015, the Company signed a lease for 21,697 square feet of mixed office and manufacturing space in Alameda, CA. The term of the lease is 76 months plus 6 months pre-commencement date for tenant improvement construction. The total cost of the lease is $3.0 million which was being amortized over 82 months at approximately $37,000 per month. As of December 31, 2016, the landlord had paid for $0.9 million in tenant improvements. The tenant improvements cost has been included in owned assets and deferred rent and was being amortized over the life of the lease.

In July 2018, the Company signed a lease for 14,016 square feet of mixed office and warehouse space in McCarran, Nevada. The lease term is 42 months. The total cost of the lease is $0.4 million, which is being amortized over 42 months at approximately $9,000 per month.

Amortization of deferred rent expense for the years ended December 31, 2018 and 2017 was $0.1 million and $0.2 million, respectively. Net deferred rent expense for the year ended December 31, 2016 was $29,000.

In October 2018, the Company moved its corporate headquarters to its McCarran, Nevada facility and ceased to use its Alameda, California facility. In February 2019, the Company sublet the California facility. Upon vacating the property, the Company wrote

51



off the remaining amount of deferred rent in the amount of $0.8 million, and recorded a liability for the present value of remaining lease payments less estimated sublease income in the amount of $0.3 million recorded in the balance sheet as lease liability. Additionally, the Company wrote off the net book value of its leasehold improvements of approximately $0.8 million during the fourth quarter of 2018.

12.
Notes Payable

AMR entered into a $10,000,000 loan with Green Bank on November 3, 2015. The term of the loan is twenty-one years. For the first twelve months only interest was payable; thereafter monthly payments of interest and principal are due. The interest rate adjusts on the first day of each calendar quarter equal to the greater of six percent (6%) or two percent (2%) per annum above the minimum prime lending rate charged by large U.S. money center commercial banks as published in the Wall Street Journal. The terms of the Loan Agreement contain various affirmative and negative covenants. Among them, AMR must maintain a minimum debt service coverage ratio of 1.25 to 1.0 (beginning with the twelve-month period ending March 31, 2017), a maximum debt-to-net worth ratio of 1.0 to 1.0 and a minimum current ratio of 1.5 to 1.0. AMR was in compliance with all covenants as of and for the years ending December 31, 2016 and 2015. AMR was in compliance with all but the minimum debt service coverage ratio covenant as of and for each of the calendar quarters in the period March 31, 2017 through December 31, 2018. AMR has received a waiver for the minimum debt service coverage ratio covenant for each period of non-compliance.
 
Collateral for this loan is AMR’s accounts receivable, goods, equipment, fixtures, inventory, accessions and a certificate of deposit in the amount of $1.0 million.
 
The loan is guaranteed by the United States Department of Agriculture Rural Development (“USDA”), in the amount of 90% of the principal amount of the loan. The Company paid a guarantee fee to the USDA in the amount of $270,000 at the time of closing and will be required to pay to the USDA an annual fee in the amount of 0.50% of the guaranteed portion of the outstanding principal balance of the loan as of December 31 of each year.
 
Notes payable is comprised of the following (in thousands): 
 
 
December 31,
 
 
2018
 
2017
 
 
 
 
 
Notes payable, current portion
 
 
 
 
Capital equipment leases, current portion
 
$
16

 
$
128

Green Bank, net of issuance costs
 
295

 
277

 
 
$
311

 
$
405

 
 
 
 
 
Notes payable, non-current portion
 
 
 
 
Capital equipment leases, non-current portion
 
$
31

 
$
11

Green Bank, net of issuance costs
 
8,569

 
8,828

 
 
$
8,600

 
$
8,839

 
The capital equipment lease obligations relate to capital leases further discussed in Note 5 – Property and Equipment, net. The costs associated with obtaining the Green Bank loan of $0.8 million were recorded as a reduction to the carrying amount of the note and are being amortized as interest expense over the twenty-one year life of the loan. Amortization of the deferred financing costs was $35,000, $35,000 and $35,000 for the years ended December 31, 2018, 2017 and 2016, respectively. The principal payments detailed below are excluding the effect of the reduction in the carrying amount related to the deferred financing costs.
 

52



The future principal payments related to the Green Bank note and capital equipment lease obligations are as follows as of December 31, 2018 (in thousands):

2019
311

2020
319

2021
341

2022
363

2023
385

Thereafter
7,826

Total loan payments
9,545


13.
Stockholders’ Equity

Authorized capital
 
The authorized capital stock of the Company consists of 50,000,000 shares of common stock, par value $0.001 per share. In the event of liquidation of the Company, dissolution or winding up, the holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities. The common stock has no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the common stock. The outstanding shares of common stock are fully paid and non-assessable.
 
The holders of the Company’s common stock are entitled to one vote per share. Holders of common stock are entitled to receive a ratable share of dividends, if any, as may be declared by the board of directors.  
 
Interstate Battery Agreements
 
Investment Agreement
 
The Company entered into a Credit Agreement dated May 18, 2016 with Interstate Battery pursuant to which Interstate Battery loaned the Company $5.0 million in consideration of the Company’s issuance of a secured convertible promissory note in the original principal amount of $5.0 million. The note bears interest at the rate of eleven percent (11%) per annum, compounding monthly, and all interest is payable upon the earlier of maturity or conversion of the principal amount. The loan matures on May 24, 2019. The outstanding principal is convertible into shares of the Company’s common stock at a conversion price of $7.12 per share. The Company’s obligations under the note and Credit Agreement are secured by a second priority lien on the real estate, fixtures and equipment at the Company’s recycling facility at McCarran, Nevada. The Credit Agreement includes representations, warranties, and affirmative and negative covenants that are customary of institutional credit agreements. Interstate Battery had previously raised a claim that the Company was in technical breach of a negative covenant under loan. The claimed breach related to the Company’s failure to obtain Interstate Battery’s prior written consent to the Company’s acquisition of Ebonex IPR, Ltd. The Company estimated in 2017 that resolving the claim would result in a charge of $0.6 million. The Company recorded the $0.6 million in general and administrative expenses as of December 31, 2017 with the offset in accrued liabilities. The Company resolved this alleged breach in connection with a series of agreements with Interstate Battery in June 2018 as further described below and in Note 14.
 
Pursuant to the Credit Agreement, the Company also issued to Interstate Battery two common stock purchase warrants, including:

a warrant to purchase 702,247 shares of the Company’s common stock, at an exercise price of $7.12 per share, that is exercisable upon grant and expires on May 24, 2018; and
a warrant to purchase 1,605,131 shares of the Company’s common stock, at an exercise price of $9.00 per share, that is exercisable commencing November 24, 2016 and expires on May 24, 2019.

The warrants contain cashless exercise and standard anti-dilution adjustment provisions. The first warrant issued above was modified in June 2018 to extend the expiration date to June 30, 2020 and reduce the exercise price to $3.33 peer share. See Note 14 for further details of this modification. If Interstate converts its convertible note and exercises both warrants in their entirety, it will own approximately 8.3% of the Company’s common stock at an average price per share of approximately $7.22.
 

53



The Company also entered into a Stock Purchase Agreement dated May 18, 2016 with Interstate Battery pursuant to which the Company issued and sold to Interstate Battery 702,247 shares of the Company’s common stock at $7.12 per share for gross proceeds of approximately $5.0 million. The Stock Purchase Agreement includes customary representations, warranties, and covenants by Interstate Battery and us, and an indemnity from us in favor of Interstate Battery.
 
In connection with the investment transactions, the Company also entered into an Investors Rights Agreement dated May 18, 2016 with Interstate Battery pursuant to which the Company granted Interstate Battery customary demand and piggyback registration rights, limited board observation rights over the next three years and limited preemptive rights allowing Interstate Battery the right to purchase its proportional share of certain future equity issuances by the Company over the next three years. The Company included all of the Interstate Battery shares in its S-3 Registration Statement filed with the Securities and Exchange Commission on August 1, 2016.
 
The investment transactions with Interstate Battery closed on May 24, 2016. There were no sales commissions paid by the Company in connection with its sale of securities to Interstate Battery.
 
The Company allocated the $10.0 million proceeds from the Credit Agreement and Stock Purchase Agreement, to the various securities based on their relative fair values on the closing date of May 24, 2016.

The fair value of the note was calculated using an average of the Merrill Lynch US High Yield CCC rate of 16.21% on May 24, 2016 and the Merrill Lynch US High Yield B effective yield of 7.44% on May 24, 2016.
The fair value of the common stock was based on the closing market price of the Company’s common stock on the NASDAQ stock market on May 24, 2016.
 
The fair value of the warrants using the Black-Scholes-Merton option pricing model and the assumptions are listed in the table below (FV of warrant in thousands).
 
 
 
Warrant #1
 
Warrant #2
Warrant shares issued
 
702,247

 
1,605,131

Market price
 
11.39

 
11.39

Exercise price
 
7.12

 
$
9.00

Term (years)
 
2 years

 
3 years

Risk-free interest rate
 
0.91
%
 
1.05
%
Volatility
 
65.70
%
 
67.80
%
Dividend rate
 
%
 
%
Per share FV of warrant
 
5.89

 
5.89

FV of warrant
 
$
4,136

 
$
9,450


Both warrants were issued on May 24, 2016, when the closing market price of the Company’s stock was $11.39.
The table below presents the allocation of the proceeds based on the relative fair values of the stock, warrants and note (in thousands).

 
 
Fair value
 
Allocated value
 
 
 
 
 
Allocation of Proceeds
 
 

 
 

Convertible note
 
$
4,879

 
$
1,844

Warrants
 
13,586

 
5,134

Common stock
 
7,998

 
3,022

 
 
 
 
 
 
 
$
26,463

 
$
10,000

 
The difference between the face value of the convertible note and the allocated amount (which considers both the allocated fair value of the issued stock and allocated fair value of the warrants) was recorded as an initial discount to the convertible note; common stock was recorded at its allocated fair value as a credit to par value and additional paid-in capital as appropriate, based

54



on the number of shares issued, and the allocated fair value of the warrant was credited to additional paid-in capital. After taking into consideration the amortization of the note discount, the effective interest rate on the convertible note is 184.75% per annum.
 
The convertible note includes an embedded BCF. The intrinsic value of the BCF was treated as an additional component of the discount attributable to the convertible note. The initial discount (attributable to the stock and warrants as noted above) and the discount attributable to the BCF exceeds the face amount of the convertible note. To avoid reducing the initial net carrying value of the convertible note to or below zero, the discount attributable to the BCF was limited such that the aggregate of all discounts does not exceed 99.5% of the face amount of the convertible note. The discount is being accreted to interest expense using the effective interest method over the three-year life of the loan. If the loan is converted prior to its maturity, any remaining discount will be expensed immediately.
 
Costs incurred in connection with the deal of $771,000 were allocated between additional paid-in capital and prepaid financing/ debt discount (“debt issuance costs”) in the same manner as the above allocation of proceeds. The allocated debt issuance costs of $142,000 were recorded as a reduction to the carrying amount of the convertible note and are being amortized as interest expense over the three-year life of the loan. The remaining $629,000 was recorded as a reduction to additional paid-in capital.
 
National Securities Placement
 
On May 18, 2016, the Company entered into a Stock Purchase Agreement and a Registration Rights Agreement with certain accredited investors pursuant to which the Company issued and sold to the investors 719,333 shares of its common stock at a price of $7.12 per share for the gross proceeds of approximately $5.1 million. The Stock Purchase Agreement includes customary representations, warranties, and covenants by the investors and the Company, and an indemnity from the Company in favor of the investors. The private placement closed on May 24, 2016. The Company included all of these shares in its S-3 Registration Statement filed with the Securities and Exchange Commission on August 1, 2016.
 
National Securities Corporation acted as placement agent for the private placement and received sales commission in the amount of six percent (6%) of the gross proceeds, or a total of $307,000 in commissions from us. In addition, we reimbursed National Securities for its out-of-pocket expenses and legal fees in the aggregate amount of $38,000. The total costs of $345,000 have been recorded as a reduction to additional paid-in capital.
 
2016 Public Offering
 
On November 21, 2016, the Company completed a public offering of 2.3 million shares of its common stock at a public offering price of $10.00 per share. Net proceeds to the Company from the public offering were approximately $21.5 million after deducting underwriting discounts, commissions and offering expenses. In connection with the public offering, the underwriter received a fee of $1.4 million and a warrant to purchase 33,450 shares of the Company’s common stock at $10.00 per share that is exercisable commencing May 20, 2017 and expires on November 21, 2019. The fair value of the warrant, $229,000, was recorded as an increase to offering expenses and an increase to additional paid-in capital. The Company calculated the fair value of the warrant using a BlackScholes Merton model with the assumptions as follows: $12.66 closing market value on the date of grant; 3-year term; 72% volatility; 1.36% discount rate and 0% annual dividend rate.

Johnson Controls Agreement
 
On February 7, 2017, the Company entered into a Stock Purchase Agreement with Johnson Controls pursuant to which the Company issued and sold to a wholly-owned subsidiary of Johnson Controls International plc, (“Johnson Controls”), 939,005 shares of its common stock at $11.33 per share for the gross proceeds of approximately $10.6 million. Costs incurred in connection with the transaction, primarily legal fees, totaled approximately $167,000. The Stock Purchase Agreement includes customary representations, warranties, and covenants by Johnson Controls and the Company, and an indemnity from the Company in favor of Johnson Controls.
 
In connection with the investment transactions, the Company also entered into an Investors Rights Agreement dated February 7, 2017 with Johnson Controls pursuant to which the Company granted Johnson Controls customary demand and piggyback registration rights, limited board observation rights and limited preemptive rights allowing Johnson Controls the right to purchase its proportional share of certain future equity issuances by the Company. The board observation and preemptive rights shall expire on the earlier of (i) such time as Johnson Controls no longer owns 50% of the acquired shares or (ii) the termination of both the Tolling/Lead Purchase Agreement and Equipment Supply Agreement.  
 
There were no sales commissions paid by the Company in connection with the sale of its common shares to Johnson Controls.
 
2017 Public Offering

55




On December 12, 2017, the Company completed a public offering of 7,150,000 shares of its common stock at a public offering price of $2.10 per share. Net proceeds to the Company from the public offering were approximately $13.8 million after deducting underwriting discounts, commissions and offering expenses. In January 2018, the underwriter exercised their overallotment option resulting in an additional 1,072,500 shares being issued and net proceeds of approximately $2.1 million.

2018 Public Offering

On June 18, 2018, the Company completed a public offering of 10,085,500 shares of its common stock, at the price of $2.85 per share, for gross proceeds of $28.7 million. After the payment of underwriter discounts and offering expenses, the Company received net proceeds of approximately $26.6 million.

Other shares issued

The Company issued 65,600 shares of common stock upon vesting of Restricted Stock Units during the year ended December 31, 2018. Additionally, the Company issued 2,034 shares of common stock pursuant to the Officers and Directors Purchase Plan during the year ended December 31, 2018 for proceeds of $4,000.

The Company issued 152,727 shares of common stock in conjunction with consulting agreements during the fourth quarter of 2018 with a fair value of $0.4 million. Fair value was determined using the intrinsic value method: total number of shares issued under the consulting contract multiplied by the closing market price of the date of issuance.
 
Warrants issued

Warrants to purchase 12,500 of the Company’s common stock were issued on January 31, 2016, April 30, 2016 and July 31, 2016, all with an exercise price of $6.00 per share. The warrants were fully vested upon issuance and expire, if not exercised, on July 31, 2018. All of these warrants were exercised during 2017.  
 
The following assumptions were used in the Black-Scholes-Merton pricing model to estimate the fair value of the warrants (FV of warrants in thousands).
 
 
1/31/2016
 
4/30/2016
 
7/31/2016
Warrant shares issued
 
12,500

 
12,500

 
12,500

Market price
 
4.63

 
8.37

 
9.31

Exercise price
 
$
6.00

 
$
6.00

 
$
6.00

Term (years)
 
1.25

 
2.25

 
2

Risk-free interest rate
 
0.97
%
 
0.77
%
 
0.72
%
Volatility
 
80.00
%
 
80.00
%
 
80.00
%
Dividend rate
 
%
 
%
 
%
Per share FV of warrant
 
1.24

 
4.58

 
5.19

FV of warrant
 
$
16

 
$
57

 
$
65

 
The fair value of each of the warrants was recorded as increase to business development and management costs and increase in additional paid in-capital.
 
As noted in the preceding section, warrants to purchase 2,307,378 and 33,450 shares of the Company’s common stock were also issued for the Interstate Battery deal and the November 2016 Public Offering, respectively, during 2016. Please refer to the above section for specific valuation assumptions for these warrants.
 
Warrants exercised
 
On June 7, 2016, when the five-day average of closing prices for the Company’s common stock was $12.16 per share, 15,203 shares of the Company’s common stock were issued pursuant to a cashless exercise of a warrant for 30,000 shares of the Company’s common stock with an exercise price of $6.00 per share.
 

56



During the year ended December 31, 2017, 1,175,796 shares were issued pursuant to cash and cashless warrant exercises as detailed below. Generally, the warrants specify using the preceding five-day average of closing prices for the Company’s common stock in the calculation of common stock to be issued pursuant to a cashless exercise.
Date of
Warrant
Exercise
 
Average Closing
Market Price
Per Share
 
Exercise Price
Per Share
 
Warrant
Shares
Exercised
 
Common
Shares
Issued
 
 
 
 
 
 
 
 
 
2/10/2017
 
$
11.016

 
0.0034375

 
392,728

 
392,605

2/13/2017
 
$
13.062

 
$
3.00

 
25,119

 
19,349

2/13/2017
 
$
13.062

 
$
6.00

 
72,420

 
39,154

2/15/2017
 
$
16.768

 
$
6.00

 
65,177

 
41,856

2/16/2017
 
$
16.768

 
$
6.00

 
35,000

 
22,470

3/17/2017
 
$
20.262

 
$
6.00

 
2,500

 
2,500

3/20/2017
 
$
20.304

 
$
3.00

 
226,068

 
192,666

3/20/2017
 
$
20.304

 
$
6.00

 
586,596

 
413,253

4/3/2017
 
$
19.148

 
0.0034375

 
43,636

 
43,628

4/11/2017
 
$
17.920

 
$
6.00

 
12,500

 
8,315

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,461,744

 
1,175,796


Warrant modification

On June 24, 2018, the Company entered into a series of agreements (see Note 14 for details) with Interstate Battery, which modified the terms of a warrant to purchase 702,247 shares of our common stock by reducing the exercise price of the warrant from $7.12 per share to $3.33 per share and extended the expiration date of the warrant from June 24, 2018 to June 23, 2020. The expiration date had previously been extended from May 2018 to June 2018 as part of the overall negotiations. The incremental fair value resulting from this modification was calculated to be $1.0 million using the Black-Scholes-Merton Option Pricing Model with the assumptions as follows: $3.26 per share fair value on the date of modification; 2-year term; 80.2% volatility; 2.56% discount rate and 0% annual dividend rate.

The Company previously recorded $0.6 million in general and administrative expense during the year ended December 31, 2017 with the offset in accrued liabilities as an estimate of this liability. Upon modification, the Company recorded an additional $0.4 million in general and administrative expense for the three months ended June 30, 2018, relieved $0.6 million in accrued liabilities with the $1.0 million offset to additional paid-in capital.

Warrants outstanding
 
Warrants outstanding to purchase shares of the Company’s common stock at a weighted average exercise price of $7.31 per share are as follows.
Exercise Price
per Share
 
Expiration
Date
 
Shares Subject to purchase
at December 31, 2018
 
 
 
 
 
$
3.33

 
6/23/2020
 
702,247

$
9.00

 
5/18/2019
 
1,605,131

$
10.00

 
11/21/2019
 
33,450

 
 
 
 
 
 
 
 
 
2,340,828

 
Stock-based compensation
 
In 2014, the Board of Directors adopted the Company’s stock incentive plan (the “2014 Plan”). The 2014 Plan was most recently amended and restated effective as of the Company’s 2017 Annual Stockholders’ Meeting. A total of 2,113,637 shares of common stock was authorized for issuance pursuant to the 2014 Plan at the time of its most recent amendment and restatement in 2017.

57



The 2014 Plan provides for the following types of stock-based awards: incentive stock options; non-statutory stock options; restricted stock; and performance stock. The 2014 Plan, under which equity incentives may be granted to employees and directors under incentive and non-statutory agreements, requires that the option price may not be less than the fair value of the stock at the date the option is granted. Option awards are exercisable until their expiration, which may not exceed 10 years from the grant date.

Stock-based compensation expense recorded was allocated as follows (in thousands):
 
 
Year ended December 31,
 
 
2018
 
2017
 
2016
Cost of product sales
 
$
154

 
$
143

 

Research and development cost
 
215

 
456

 
256

General and administrative expense
 
832

 
482

 
804

Total
 
$
1,201

 
$
1,081

 
$
1,060

 
The following assumptions were used in the Black-Scholes-Merton option pricing model to estimate the fair value of the awards granted during the year ended December 31, 2018, 2017 and 2016.
 
 
Year ended December 31,
 
 
2018
 
2017
 
2016
 
 
 
 
 
 
 
Expected stock volatility
 
76.9% - 86.3

 
70.5% - 73.2

 
71%-80

Risk free interest rate
 
2.1% - 3.0

 
1.4% - 2.0

 
0.9%-1.8

Expected years until exercise
 
2.5-3.5

 
2.5-3.5

 
2.5-4.0

Dividend yield
 
%
 
%
 
%
 
The risk-free interest rate assumption was based on the United States Treasury’s zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The weighted-average expected life of the options was calculated using the simplified method as prescribed by the Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin No. 107 and No. 110 (“SAB No. 107 and 110”). This decision was based on the lack of relevant historical data due to the Company’s limited historical experience. In addition, due to the Company’s limited historical data, the estimated volatility also reflects the application of SAB No. 107 and 110, using the weighted average of the Company’s historical volatility and the historical volatility of several unrelated public companies within the recycling industry. Forfeitures are recognized as they occur.
 
The following table summarizes the 2014 Plan activity and related information through December 31, 2018.
 
 
 
 
Options Outstanding
 
RSU’s outstanding
 
 
Number of
Shares
Available for
Grant
 
Number of Shares
 
Weighted-
Average
Exercise
Price Per
Share
 
Number of
RSU’s
 
Weighted-
Average
Grant Date
Fair Value
Per Share
Balance at December 31, 2016
 
443,565

 
915,572

 
$
4.96

 

 
$

Authorized
 
750,000

 
 
 
 
 
 
 
 
Granted
 
(330,884
)
 
134,933

 
11.19

 
195,951

 
7.28

Exercised
 

 
(284,370
)
 
3.77

 

 

Forfeited
 
202,322


(187,322
)

6.44


(15,000
)

5.78

Balance at December 31, 2017
 
1,065,003

 
578,813

 
6.51

 
180,951

 
7.40

Granted
 
(640,275
)
 
1,269,925

 
3.99

 
207,623

 
2.42

Exercised
 

 

 

 
(65,600
)
 
5.78

Forfeited
 
381,021

 
(154,670
)
 
7

 
(226,351
)
 
4.74

Balance at December 31, 2018
 
805,749

 
1,694,068

 
$
4.57

 
96,623

 
$
4.01



58



The number of options granted during 2018 include 840,000 options subject to the terms and conditions of the Company’s Amended and Restated 2014 Stock Incentive Plan (“2014 Plan) but were not issued under the 2014 Plan in reliance on Nasdaq Rule 5635(c)(4) and therefore do not reduce the number of shares available under the 2014 Plan.

The weighted-average grant-date fair value of options granted during the year ended December 31, 2018, 2017 and 2016 was $1.71, $5.55 and $4.47 per share, respectively. The intrinsic value of options exercised during the year ended December 31, 2017 and 2016 was $1.5 million and $22,000, respectively. There were no stock option exercises during the year ended December 31, 2018. The amount of cash received from exercise of stock options during the year ended December 31, 2017 was $1.1 million.
 
Additional information related to the status of options at December 31, 2018 is as follows:
 
 
Shares
 
Weighted-
Average
Exercise
Price Per
Share
 
Weighted-
Average
Remaining
Contractural
Life (Years)
 
Aggregate
Intrinsic
Value (in
thousands)
Outstanding
 
1,694,068

 
4.57
 
3.77
 
6

Vested and exercisable
 
678,264

 
5.21
 
2.86
 


The intrinsic value of options is the fair value of the Company’s stock at December 31, 2018 less the per share exercise price of the option multiplied by the number of shares.
 
As of December 31, 2018, there is approximately $1.7 million of total unrecognized compensation cost related to the unvested share-based (option and RSU) compensation arrangements granted under the 2014 Plan. The remaining unrecognized compensation cost will be recognized over a weighted-average period of 2.1 years.
 
The following table summarizes information about stock options outstanding as of December 31, 2018:
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Quantity
 
Weighted-
Average
Remaining
Contractural
Life
(Years)
 
Quantity
 
Weighted-
Average
Remaining
Contractural
Life
(Years)
 
 
 
 
 
 
 
 
 
$1.60 -$2.93
 
212,750

 
4.77
 

 
0.00
$2.94 - $3.00
 
422,500

 
4.33
 
82,500

 
4.33
$3.01 - $3.95
 
395,220

 
2.98
 
305,458

 
2.58
$3.96 - $6.92
 
310,267

 
3.44
 
134,494

 
2.30
$6.93 - $19.20
 
353,331

 
3.70
 
155,812

 
3.13
 
 
 
 
 
 
 
 
 
 
 
1,694,068

 
3.78
 
678,264

 
2.86

Stock option issuances

In connection with his appointment as President of the Company in May 2018, Stephen Cotton was awarded options to purchase up to 840,000 shares of the Company’s common stock. Options to purchase 420,000 common shares are exercisable over a five-year period at an exercise price of $3.00 per share. Options to purchase 210,000 common shares are exercisable over a five-year period at an exercise price of $5.00 per share and options to purchase 210,000 common shares are exercisable over a five-year period at an exercise price of $7.00 per share. The options vest in 1/36th increments during each of the first twelve months following the date of grant and thereafter the options vest in one-third increments on the second and third anniversary of the date of grant. The options issued are subject to the terms and conditions of the 2014 Plan but were not issued under the 2014 Plan in reliance on with Nasdaq Rule 5635(c)(4) and therefore do not reduce the number of shares available under the 2014 Plan.

Option modification 


59



In connection with his termination, the stock options of the Company’s former CEO were modified to extend the exercise period upon termination from 90 days to 2 years. The expense related to the modification of these stock option awards was approximately $15,000 and was recorded during the second quarter of 2018.

During the three months ended June 30, 2016, the Compensation Committee of the Board of Directors approved the modification of the terms of a stock option previously granted to a member of its Board of Directors to accelerate vesting and the waiver of the early termination of the option based upon the director’s end of service to the Company. The modification resulted in additional compensation expense of $175,000.
 
Restricted Stock Units
 
In April 2018, the Company granted 150,000 restricted stock units (RSUs), all of which were subject to vesting, with a grant fair value of $339,000 to its then-Chief Financial Officer, Francis Knuettel II, as part of his employment agreement. Mr. Knuettel resigned in August 2018 and all of the RSUs expired by their terms prior to vesting.

In July 2017, the Company granted 49,751 restricted stock units (RSUs) with a grant date fair value per share of $11.68 to its then Chief Financial Officer, Mr. Weinswig, as part of his employment agreement. Mr. Weinswig resigned in March 2018 and all of the RSUs expired by their terms prior to vesting.

Total intrinsic value of RSUs vested and released during 2018 was $0.1 million. Intrinsic value of RSUs outstanding at December 31, 2018 was $0.2 million.

As of December 31, 2018, there is approximately $11,000 of total unrecognized compensation cost related to the unvested share-based (RSU) compensation arrangements granted under the 2014 Plan. The remaining unrecognized compensation cost will be recognized over a weighted-average period of 11 days.

Reserved shares
 
At December 31, 2018, the Company has reserved shares of common stock for future issuance as follows:
 
Number of
Shares
Equity Plan
 

Subject to outstanding options and restricted shares
1,790,691

Available for future grants
805,749

Convertible note-principal
702,247

Officer and Director Purchase Plan
245,562

Warrants
2,340,828

 
5,885,077


14.
Commitments and Contingencies

Executive resignations

On April 19, 2018, Stephen Clarke resigned as president and chief executive officer and as a member of the Board. Dr. Clarke’s resignation as an officer the Company was treated as a termination without cause under his employment agreement with the Company. Pursuant to his employment agreement, Dr. Clarke was entitled to one-time severance benefits that includes severance and benefits continuation expense of approximately $0.9 million paid out over a 2-year period in consideration of his execution of a customary release and separation agreement. Additionally, as noted above, Dr. Clarke was granted an extension of the exercise period of his stock options upon termination from 90 days to 2 years. The expense related to the modification of these stock option awards was approximately $15,000.

On December 3, 2018, Sewlyn Mould resigned as chief operating officer. Mr. Mould’s resignation as an officer the Company was treated as a termination without cause under his employment agreement with the Company. Pursuant to his employment agreement, Mr. Mould was entitled to one-time severance benefits that includes severance and benefits continuation expense of approximately $0.9 million paid out over a 2-year period in consideration of his execution of a customary release and separation agreement. Pursuant to a Separation Agreement and Release between the Company and Mr. Mould, Mr. Mould has agreed to receive, in lieu

60



of two years of salary, a cash severance payment of $100,000 payable in six equal installments in accordance with the Company's regular payroll practices, plus an award of restricted stock units that will entitle him to receive, for each of the 21 consecutive months commencing on March 1, 2019, $33,333 of the Company's common shares based on volume-weighted average price over the 20 trading days preceding the first business day of the respective month. The Company has reserved the right, at its option, to pay Mr. Mould $33,333 of cash in lieu of any of the 21 monthly share issuances. The Separation Agreement and Release includes customary indemnification, confidentiality, non-disparagement and non-solicitation covenants and agreements of the parties.

Lease commitments
 
As discussed in Note 11, On August 7, 2015, the Company signed a lease for 21,697 square feet of mixed office and manufacturing space in Alameda, CA. On October 10, 2014, the Company entered into an operating lease for its current Oakland facility which expired in April 2018. The Company entered into a sublease agreement dated as of February 4, 2019 for the Alameda facility. The term of the sublease commences in February 2019, and ends on May 1, 2022. Total base rent payable by the sublessee through the end of the term of the sublease is approximately $1.5 million.

In July 2018, the Company signed a lease for 14,016 square feet of mixed office and warehouse space in McCarran, Nevada.

The future minimum payments related to these leases are as follows as of December 31, 2018 (in thousands):

2019
624

2020
643

2021
662

2022
227

Total minimum lease payments
$
2,156


During the years ended December 31, 2018, 2017 and 2016, the Company has incurred total rent expense of $0.5 million, $0.5 million and $0.3 million, respectively.
 
See Note 12 for lease commitments associated with capital leases for fixed assets.
 
Interstate Battery Agreement commitment
 
Pursuant to the 2016 Interstate Battery Investor Rights Agreement, the Company had agreed to compensate Interstate Battery should either Stephen Clarke, the Company’s former chief executive officer, or Selwyn Mould, the Company’s current chief operating officer, no longer hold such positions or no longer devote substantially all of their business time and attention to the Company, whether as a result of resignation, death, disability or otherwise (such an event referred to as a “key-man event”). The Company had agreed to pay Interstate Battery $2.0 million, per occurrence, if either officer was subject to a key-man event during the two years following May 18, 2016. The Company also agreed to pay Interstate Battery $2.0 million if either or both officers were subject to a key-man event during the third year following May 18, 2016. Pursuant to the Interstate Battery Investor Rights Agreement, the key-man payments are payable, at the option of the Company, in cash or shares of the Company’s common stock. Pursuant to the agreement, if Interstate Battery, in its sole and absolute discretion, agrees with the Company on mutually acceptable replacements. for Messrs. Clarke and/or Mould, as the case may be, the key man penalties shall be deemed waived by Interstate Battery.

Interstate Battery had previously raised a claim that the Company was in technical breach of a negative covenant under the Credit Agreement dated May 18, 2016 between the Company and Interstate Battery. The claimed breach related to the Company’s failure to obtain Interstate Battery’s prior written consent to its acquisition of Ebonex IPR, Ltd.

On June 24, 2018, the Company entered into a series of agreements with Interstate Battery, including an amendment to the Investor Rights Agreement. Pursuant to the amendment to the Investor Rights Agreement, Interstate Battery agreed to waive all payments under the key-man provisions of the Investor Rights Agreement with respect to the resignation of the Company’s former chief executive officer, Stephen Clarke. In addition, the parties agreed that the Company, at its option, can elect to eliminate the key-man event and all related key-man payments associated with Mr. Mould by (i) paying Interstate Battery a one-time fee of $0.5 million, payable in cash and (ii) agreeing to pay Interstate Battery $2.0 million, payable at the Company’s election in cash or shares of its common stock, should the Company’s current president, Stephen Cotton no longer serve as president of the Company during the period ending May 18, 2019. On December 3, 2018, Mr. Mould resigned as chief operating officer. The Company agreed to to pay the one time fee of $0.5 million. Additionally:


61



With respect to a Credit Agreement dated May 18, 2016 between the Company and Interstate Battery, Interstate Battery waived the alleged breach of the Credit Agreement based on the Company’s acquisition of Ebonex IPR, Ltd.;
The Company adjusted the terms of a warrant to purchase 702,247 shares of its common stock issued to Interstate Battery in May 2016, pursuant to which the exercise price of the warrant was decreased from $7.12 per share to $3.33 per share and the expiration date of the warrant was extended to June 23, 2020; and
Interstate Battery agreed to provide the Company with more favorable pricing and payment terms under the Supply Agreement dated May 18, 2016 pursuant to which the Company buys used lead acid batteries from Interstate Battery.

Johnson Controls Agreement Commitment
 
Pursuant to the Johnson Controls Investor Rights Agreement, the Company has agreed to compensate Johnson Controls should either Stephen Clarke, the Company’s current chief executive officer, or Selwyn Mould, the Company’s current chief operating officer, no longer hold such positions or no longer devote substantially all of their business time and attention to the Company, whether as a result of resignation, death, disability or otherwise (such an event referred to as a “key-man event”). The Company has agreed to pay Johnson Controls $1.0 million per occurrence, if either officer is subject to a key-man event during the 18 months following February 7, 2017. The Company also agreed to pay Johnson Controls $1.0 million if either or both key-man events occur after 18 months and prior to 30 months following February 7, 2017. Pursuant to the agreement, if Johnson Controls, in its sole and absolute discretion, agrees with the Company on mutually acceptable replacements. for Dr. Clarke and/or Mr. Mould, as the case may be, the key man penalties shall be deemed waived by Johnson Controls. In connection with the resignations by Dr. Clarke and Mr. Mould described above, Johnson Controls has submitted to the Company its claim for payment of the key-man penalties in the total amount of $2.0 million. The Company has accrued the $2.0 million at December 31, 2018 but believes, however, that Johnson Controls’ demand was premature as it had not considered the adequacy of the replacements for Dr. Clarke or Mr. Mould and that any such claim can be asserted after their replacements have been appointed and considered in good faith.
 
Legal proceedings
 
Beginning on December 15, 2017, three purported class action lawsuits were filed in the United Stated District Court for the Northern District California against the Company, Stephen Clarke, Thomas Murphy and Mark Weinswig.  On March 23, 2018, the cases were consolidated under the caption In Re: Aqua Metals, Inc. Securities Litigation Case No 3:17-cv-7142.  On May 23, 2018, the Court appointed lead plaintiffs and approved counsel for the lead plaintiffs.  On July 20, 2018, the lead plaintiffs filed a consolidated amended complaint (“Amended Complaint”), on behalf of a class of persons who purchased the Company’s securities between May 19, 2016 and November 9, 2017, against the Company, Stephen Clarke, Thomas Murphy and Selwyn Mould.  The Amended Complaint alleges the defendants made false and misleading statements concerning the Company’s lead recycling operations in violation of Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 promulgated thereunder.  The Amended Complaint seeks to hold the individual defendants as control persons pursuant to Section 20(a) of the Exchange Act.  The Amended Complaint also alleges a violation of Section 11 of the Securities Act of 1933 (“Securities Act”) based on alleged false and misleading statements concerning the Company’s lead recycling operations contained in, or incorporated by reference in, the Company’s Registration Statement on Form S-3 filed in connection with its November 2016 public offering.   That claim is asserted on behalf of a class of persons who purchased shares pursuant to, or that are traceable to, that Registration Statement.  The Amended Complaint seeks to hold the individual defendants liable as control persons pursuant to Section 15 of the Securities Act.  The Amended Complaint seeks unspecified damages and plaintiffs’ attorneys’ fees and costs. On September 18, 2018, the defendants filed a motion to dismiss the Amended Complaint in its entirety and the plaintiff subsequently filed its opposition to the motion.  In January 2019, the court notified the parties that it will rule on the motion to dismiss without a hearing. The Company denies that the claims in the Amended Complaint have any merit and it intends to vigorously defend the action.

Beginning on February 2, 2018, five purported shareholder derivative actions were filed in the United States District Court for the District of Delaware against the Company and certain of its current and former executive officers and directors, Stephen R. Clarke, Selwyn Mould, Thomas Murphy, Mark Weinswig, Vincent DiVito, Mark Slade and Mark Stevenson.  On May 3, 2018, the cases were consolidated under the caption In re Aqua Metals, Inc. Stockholder Derivative Litigation, Case No. 1:18-cv-201-LPS (D. Del.). The complaints were filed by persons claiming to be stockholders of Aqua Metals and generally allege that certain of the Company’s officers and directors breached their fiduciary duties to the Company by violating the federal securities laws and exposing the Company to possible financial liability.  The complaints seek unspecified damages and plaintiffs’ attorneys’ fees and costs.  The parties have entered into a stipulation staying the action until 30 days after a decision on the Company’s motion to dismiss the Amended Complaint in the class action described above.  The individual defendants deny that the claims in the shareholder derivative action have any merit and it intends to vigorously defend the action.

The Company is not party to any other legal proceedings.  The Company may, from time to time, be party to litigation and subject to claims incident to the ordinary course of business.  As its growth continues, the Company may become party to an increasing number of litigation matters and claims.  The outcome of litigation and claims cannot be predicted with certainty, and the resolution of any future matters could materially affect its future financial position, results of operations or cash flows. 

62




 
15.
Related Party Transactions

Related party transactions comprised the following for the years ended December 31, 2018, 2017 and 2016:

a series of transactions with Interstate Battery and its affiliate, a greater than five percent owner of our common shares described at “Management’s Discussion and Analysis of Financial Condition and Results of Operations – General - Interstate Battery Partnership” in this Form 10-K; and
the payment of $116,000 of salary during the year ended December 31, 2017; $156,000 of salary, bonus and consulting fees during the year ended December 31, 2016 to a former employee who is the brother of the Company’s former chief executive officer.
 
The Company has adopted a policy that any transactions with directors, officers, beneficial owners of five percent or more of our common shares, any immediate family members of the foregoing or entities of which any of the foregoing are also officers or directors or in which they have a financial interest, will only be on terms consistent with industry standards and approved by a majority of the disinterested directors of our board.

63



16.
Income Taxes
 
Net loss before income tax expense consists of the following (in thousands):
 
 
Year ended December 31,
 
 
2018
 
2017
 
2016
US
 
(40,252
)
 
(26,578
)
 
(13,556
)
Foreign
 

 

 

Total
 
$
(40,252
)

$
(26,578
)

$
(13,556
)

The components of the provision for income tax expense consist of the following (in thousands):
 
 
Year ended December 31,
 
 
2018
 
2017
 
2016
Current
 
 
 
 
 
 
Federal
 

 

 

State
 
2

 
2

 
1

 
 
 
 
 
 
 
Deferred
 
 
 
 
 
 
Federal
 

 

 

State
 

 

 

 
 
 
 
 
 
 
Total provision for income taxes
 
2


2


1


 
Reconciliation of the statutory federal income tax rates consist of the following :
 
 
Year ended December 31,
 
 
2018
 
2017
 
2016
Tax at federal statutory rate
 
21.00
 %
 
34.00
 %
 
34.00
 %
State tax, net of federal benefit
 
0.22
 %
 
 %
 
(0.01
)%
Change in rate
 
(0.04
)%
 
(22.13
)%
 
(1.30
)%
Valuation allowance
 
(20.24
)%
 
(15.78
)%
 
(30.70
)%
Impairment charge of acquired IP
 
 %
 
6.86
 %
 
 %
Excess benefits from equity compensation
 
 %
 
(3.08
)%
 
 %
Other
 
(0.93
)%
 
0.14
 %
 
(2.00
)%
Provision for taxes
 
0.01
 %
 
0.01
 %
 
(0.01
)%


64



The components of deferred tax assets (liabilities) included on the consolidated balance sheet are as follows (in thousands):
 
 
As of December 31,
 
 
2018
 
2017
Deferred tax assets
 
 
 
 
Capitalized start-up costs
 
$
4,103

 
$
4,312

Credits
 
465

 
484

Net operating losses
 
13,134

 
5,350

Others
 
1,153

 
818

Total gross deferred tax assets
 
18,855

 
10,964

Valuation allowance
 
(18,299
)
 
(10,370
)
Total gross deferred tax assets (net of valuation allowance)
 
556

 
594

 
 
 
 
 
Deferred tax liabilities
 
 
 
 
Patents
 
(250
)
 
(239
)
Fixed assets
 
(108
)
 

Beneficial conversion feature - debt discount
 
(198
)
 
(355
)
Total gross deferred tax liabilities
 
(556
)
 
(594
)
Net deferred tax assets
 

 

 
The Company’s effective tax rate for the period ended December 31, 2018 was lower than the statutory tax rate primarily because of the valuation allowance on its US deferred tax assets taxed at lower rates, partially offset by state taxes and tax credits. The income tax expense for the year ended December 31, 2018, 2017 and 2016 relate to state minimum income tax.
 
On December 22, 2017, President Trump signed the Tax Cuts and Jobs Act (the “Act”) into law. The new legislation decreases the U.S. corporate federal income tax rate from 35% to 21% effective January 1, 2018. There was no impact on recorded deferred tax balances as the remeasurement of net deferred tax assets was offset by a change in valuation allowance. The Act also includes a number of other provisions including the elimination of loss carrybacks and limitations on the use of future losses, repeal of the Alternative Minimum Tax regime, and the introduction of a base erosion and anti-abuse tax. These provisions are not expected to have immediate effects on the Company.
 
Based on the available objective evidence at this time, management believes that it is more likely than not that the net deferred tax assets of the Company will not be fully realized. Accordingly, management has applied a full valuation allowance against net deferred tax assets at both December 31, 2018 and December 31, 2017. The net valuation allowance increased by approximately $7.9 million during the year ended December 31, 2018. The increase in net valuation allowance primarily relates to net operating losses generated during 2018 partially offset by a decrease related to the lower U.S. corporate federal income tax rate effective January 1, 2018.
 
The Company has Federal and California net operating loss carry-forwards of approximately $61.3 million and $3.8 million, respectively, available to reduce future taxable income which will begin to expire in December 31, 2034 for Federal and California purposes.
 
At December 31, 2018, the Company had research and development credits carryforward of approximately $0.3 million and $0.5 million for Federal and California income tax purposes, respectively. If not utilized, the Federal research and development credits carryforward will begin to expire in December 31, 2034. The California credits can be carried forward indefinitely.
 
Utilization of the Company’s net operating loss may be subject to substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code and similar state provisions. Such an annual limitation could result in the expiration of net operating loss carryforwards prior to utilization.
 
The Company’s policy is to account for interest and penalties as income tax expense. As of December 31, 2018, the Company had no interest related to unrecognized tax benefits. No amounts of penalties related to unrecognized tax benefits were recognized in the provision for income taxes.

The Company maintains liabilities for uncertain tax positions. These liabilities involve considerable judgement and estimation and are continuously monitored by management based on the best information available, including changes in tax regulations, the

65



outcome of relevant court cases, and other information. The Company recognizes potential accrued interest and penalties related to unrecognized tax benefits as income tax expense. At December 31, 2018, the Company’s total amount of unrecognized tax benefit was approximately $0.2 million, none of which will affect the effective tax rate, if recognized. The Company does not expect its unrecognized benefits to change materially over the next twelve months.
 
The Company files income tax returns with the United States federal government and the State of California. The Company’s tax returns for all prior years from the Company's inception in 2014 remain open to audit for Federal and California purposes.
 
Prior to January 1, 2017, the Company recognized the excess tax benefits of stock-based compensation expense as additional paid-in capital (“APIC”), and tax deficiencies of stock-based compensation expense in the income tax provision or as APIC to the extent that there were sufficient recognized excess tax benefits previously recognized. As a result of the prior requirement that excess tax benefits reduce taxes payable prior to be recognized as an increase in paid in capital, the Company had not recognized certain deferred tax assets (all tax attributes such as loss or credit carryforwards) that could be attributed to tax deductions related to equity compensation in excess of compensation recognized for financial reporting.
 
Effective as of January 1, 2017, the Company adopted a change in accounting policy in accordance with ASU 2016-9 to account for excess tax benefits and tax deficiencies as income tax expense or benefit, and to recognize previously unrecognized deferred tax assets that arose directly from (or the use of which was postponed by) tax deductions related to equity compensation in excess of compensation recognized for financial reporting. The change was applied on a modified retrospective basis; no prior periods were restated as a result of this change in accounting policy.
 
ASU 2016-9 also eliminates the requirement that excess tax benefits be realized as a reduction in current taxes payable before the associated tax benefit can be recognized as an increase in paid in capital. Approximately $0.2 million of capitalized start-up costs (none of which were included in the deferred tax assets recognized in the statement of financial position as of December 31, 2016) have been attributed to tax deduction for stock-based compensation in excess of the related book expense. Under ASU 2016-9, these previously unrecognized deferred tax assets were recognized on a modified retrospective basis as of January 1, 2017, the start of the year in which the Company adopted ASU 2016-9. The capitalized start-up costs recognized as of January 1, 2017, as described above, have been offset by a valuation allowance. As a result, there was no tax-related cumulative-effect to retained earnings for US tax purpose.
 
The Company made the election to early adopt ASU 2015-17 at December 31, 2016 to classify all deferred tax assets and liabilities, along with any related valuation allowance, as noncurrent on the balance sheet.
 
17.
401(k) Savings Plan
The Company maintains a defined-contribution savings plan under Section 401(k) of the Internal Revenue Code (the “401(k) Plan”). The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pretax basis. The Plan does not currently provide for matching contributions.
 
18.
Supplemental Financial Information

Quarterly Results of Operations (Unaudited)
 
The following table presents the unaudited statements of operations data for each of the eight quarters in the period ended December 31, 2018. The information has been presented on the same basis as the audited financial statements and all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts below to present fairly the unaudited quarterly results when read in conjunction with the audited financial statements and related notes. The operating results for any quarter should not be relied upon as necessarily indicative of results for any future period.


66



Unaudited Quarterly Results of Operations 
(in thousands, except share and per share amounts) 
 
 
Three months ended
 
 
 
 
March 31,
2018
 
June 30,
2018
 
September 30,
2018
 
December 31,
2018
 
Total for year
2018
 
 
 
 
 
 
 
 
 
 
 
Revenue - sales
 
$
1,726

 
$
483

 
$
1,169

 
$
1,071

 
$
4,449

 
 
 
 
 
 
 
 
 
 
 
Operating expenses
 
 
 
 
 
 
 
 
 
 
Cost of product sales
 
5,436

 
4,600

 
6,453

 
6,272

 
22,761

Research and development cost
 
1,475

 
1,203

 
967

 
857

 
4,502

General and administrative expense
 
1,775

 
3,913

 
2,174

 
6,352

 
14,214

Total operating expenses
 
8,686


9,716


9,594


13,481


41,477

Loss from operations
 
(6,960
)

(9,233
)

(8,425
)

(12,410
)

(37,028
)
Other income and expense
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(587
)
 
(719
)
 
(919
)
 
(1,222
)
 
(3,447
)
Interest and other income
 
17

 
25

 
81

 
100

 
223

Total other expense, net
 
(570
)

(694
)

(838
)

(1,122
)

(3,224
)
 
 
 
 
 
 
 
 
 
 
 
Loss before income tax expense
 
(7,530
)
 
(9,927
)
 
(9,263
)
 
(13,532
)
 
(40,252
)
Income tax expense
 
(2
)
 

 

 

 
(2
)
Net loss
 
(7,532
)

(9,927
)

(9,263
)

(13,532
)

(40,254
)
Weighted average shares outstanding, basic and diluted
 
27,768,008

 
30,134,995

 
38,779,710

 
38,905,282

 
34,154,826

Basic and diluted net loss per share
 
$
(0.27
)

$
(0.33
)

$
(0.24
)

$
(0.35
)

$
(1.18
)
 
 
 
Three months ended
 
 
 
 
March 31,
2017
 
June 30,
2017
 
September 30,
2017
 
December 31,
2017
 
Total for year
2017
 
 
 
 
 
 
 
 
 
 
 
Revenue - sales
 

 
603

 
589

 
896

 
2,088

 
 
 
 
 
 
 
 
 
 
 
Operating expenses
 
 
 
 
 
 
 
 
 
 
Cost of product sales
 

 
2,531

 
3,140

 
3,870

 
9,541

Research and development cost
 
2,987

 
2,184

 
1,367

 
1,565

 
8,103

General and administrative expense
 
1,528

 
1,444

 
1,925

 
1,994

 
6,891

Impairment charge
 
 
 
2,411

 

 

 
2,411

Total operating expenses
 
4,515


8,570


6,432


7,429


26,946

Loss from operations
 
(4,515
)
 
(7,967
)
 
(5,843
)
 
(6,533
)
 
(24,858
)
Other income and expense
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(388
)
 
(408
)
 
(454
)
 
(511
)
 
(1,761
)
Interest and other income
 
11

 
10

 
7

 
13

 
41

Total other expense, net
 
(377
)

(398
)

(447
)

(498
)

(1,720
)
 
 
 
 
 
 
 
 
 
 
 
Loss before income tax expense
 
(4,892
)
 
(8,365
)
 
(6,290
)
 
(7,031
)
 
(26,578
)
Income tax expense
 
(2
)
 

 

 

 
(2
)
Net loss
 
(4,894
)

(8,365
)

(6,290
)

(7,031
)

(26,580
)
Weighted average shares outstanding, basic and diluted
 
18,792,850

 
20,123,041

 
20,265,020

 
21,956,993

 
20,293,100

Basic and diluted net loss per share
 
(0.26
)

(0.42
)

(0.31
)

(0.32
)

(1.31
)
 


19.
Subsequent Events

The Company has evaluated subsequent events through the date which the consolidated financial statements were available to be issued.

2019 Public Offering

67



On January 21, 2019, the Company completed a public offering of 5,175,000 shares of its common stock, at the price of $1.90 per share, for gross proceeds of $9.8 million. After the payment of underwriter discounts and offering expenses, the Company received net proceeds of approximately $9.1 million.

Payment of outstanding convertible debt
On January 24, 2018, the Company repaid Interstate Batteries the outstanding principal and interest on the convertible debt in the amount of $6.7 million. In connection with the payoff, the Company amortized the remaining discount on the note of $2.6 million and remaining deferred financing expenses of $20,000 to interest expense.

Alameda, California sublease agreement
The Company entered into a sublease agreement dated as of February 4, 2019 for the Alameda facility. The term of the sublease commences on February 1, 2019 and ends on May 1, 2022. Total base rent payable by the sublessee through the end of the term of the sublease is approximately $1.5 million.

Equity awards
In January 2019, the Company granted 748,531 options and RSUs to employees and directors primarily in connection the Company's 2018 short-term and long-term incentive programs.

Operations, Management and Maintenance contract
On February 27, 2019, the Company entered into an Operations, Maintenance and Management Agreement ("Agreement") with Veolia North America Regeneration Services, LLC ("Veolia") pursuant to which Veolia will provide operational, maintenance and managerial services in regard to the Company’s AquaRefining facility located at the Trans-Reno Industrial Complex outside of McCarran, Nevada ("TRIC").

The Agreement has a minimum term of two (2) years and upon the expiration of the initial term the Agreement automatically extends for an additional one-year period unless either party delivers its written notice of termination no later than 180 days’ prior the end of the then current term. Either party may terminate the Agreement on ten days’ prior written notice in the event of breach by the other party that goes uncorrected during the notice period. Veolia may terminate the Agreement for any reason during the first six months of the Agreement and may also terminate the Agreement in the event of the Company’s failure to provide certain funding and support to the AquaRefining facility at TRIC. The Agreement contains representations, warranties and indemnities that are customary to commercial agreements of this nature.

Pursuant to the Agreement, the Company and Veolia have agreed to enter into good faith negotiations for a longer-term version of the Agreement that will provide for Veolia’s management and operation of the TRIC facility for a ten-year term. The parties have agreed to commence negotiations no later than April 1, 2020 and to use their good faith commercial best-efforts to conclude negotiations by September 30, 2020.

In consideration of the services to be provided by Veolia under the Agreement, the Company has agreed to issue to Veolia a total of 2,350,000 shares of its common stock in eight quarterly installments of 293,750 shares. Each installment is subject to weighted average antidilution adjustments in the event of the Company’s sale of common shares for cash consideration during the preceding quarterly period at a price less than $2.41 per share. In addition, the number of shares to be issued in each installment shall be capped at the current market value of $1.25 million based on the volume weighted average price of the Company’s shares over the 20 trading days preceding the date for issuance of such installment. The Company has also agreed to issue to Veolia, on the one-year anniversary of the Agreement, warrants to purchase an additional 2,000,000 shares of its common stock at an exercise price of $5.00 per share and, on the second anniversary of the Agreement, warrants to purchase an additional 2,000,000 shares of its common stock at an exercise price $7.00 per share. The warrants will have a term of ten years from the date of issuance.



68



Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
 
Not applicable.
 
Item 9A.
Controls and Procedures
 
(a)
Evaluation of Disclosure Controls and Procedures.
 
Our management, with the participation of our chief executive officer and chief financial officer evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based upon that evaluation, our management, including our chief executive officer and chief financial officer, concluded that for the reasons described below our disclosure controls and procedures were effective as of December 31, 2018 in ensuring all material information required to be filed has been made known in a timely manner.
 
(b)
Changes in internal control over financial reporting.
 
There were no changes to our internal control over financial reporting, as defined in Rules 13a-15(f) under the Exchange Act that occurred during the fiscal quarter ended December 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
(c)
Management’s report on internal controls over financial reporting.
 
Our management is responsible for establishing and maintaining adequate internal controls over financial reporting, as defined under Rule 15a-15(f) under the Exchange Act. Our management has assessed the effectiveness of our internal controls over financial reporting as of December 31, 2018 based on the framework established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Our internal control system was designed to provide reasonable assurance to our management and board of directors regarding the preparation and fair presentation of published financial statements. An internal control material weakness is a significant deficiency, or aggregation of deficiencies, that does not reduce to a relatively low level the risk that material misstatements in financial statements will be prevented or detected on a timely basis by employees in the normal course of their work. Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2018, and based on that evaluation, management concluded that our internal control over financial reporting was effective as of December 31, 2018.
 
This report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the Securities and Exchange Commission that permit us to provide only management’s report in this annual report.
 
Item 9B.
Other Information

Veolia Agreement
 
On February 28, 2019, the Company entered into an Operations, Maintenance and Management Agreement ("Agreement") with Veolia North America Regeneration Services, LLC ("Veolia") pursuant to which Veolia will provide operational, maintenance and managerial services in regard to the Company’s AquaRefining facility located at the Trans-Reno Industrial Complex outside of McCarran, Nevada ("TRIC").

Pursuant to the Agreement, we have agreed with Veolia on annual capital and operational budgets and commercialization plans, and that the Veolia general manager will manage the operations of our AquaRefining facility at TRIC in accordance with those budgets and plans.

Pursuant to the Agreement, we have granted Veolia the right of first refusal to manage any future AquaRefining facilities directly owned by us on terms substantially similarly to those in the Agreement. We have also agreed to include Veolia in the marketing of any potential licensing of our AquaRefining technology to third parties with the goal of assisting Veolia in obtaining an engagement by the licensee to serve as operations and management service provider for such facility.

Pursuant to the Agreement, we and Veolia have agreed to enter into good faith negotiations for a longer-term version of the Agreement that will provide for Veolia’s management and operation of the TRIC facility for a ten-year term. The parties have agreed to

69



commence negotiations no later than April 1, 2020 and to use their good faith commercial best-efforts to conclude negotiations by September 30, 2020. We have also agreed to enter into good faith negotiations with Veolia for a long-term agreement concerning Veolia’s participation in the commercial licensing and management of future AquaRefining facilities developed by licensees of Aqua Metals. We have agreed to commence negotiations on the long-term licensing agreement no later than December 31, 2019 and to use our good faith commercial best-efforts to conclude negotiations by June 30, 2020.

The Agreement has a minimum term of two years and upon the expiration of the initial term the Agreement automatically extends for an additional one-year period unless either party delivers its written notice of termination no later than 180 days’ prior the end of the then current term. Either party may terminate the Agreement on ten days’ prior written notice in the event of breach by the other party that goes uncorrected during the notice period. Veolia may terminate the Agreement for any reason during the first six months of the Agreement and may also terminate the Agreement in the event of our failure to provide certain funding and support to the AquaRefining facility at TRIC. The Agreement contains representations, warranties and indemnities that are customary to commercial agreements of this nature.

In consideration of the services to be provided by Veolia under the Agreement, we have agreed to issue to Veolia a total of 2,350,000 shares of our common stock in eight quarterly installments of 293,750 shares. Each installment is subject to weighted average antidilution adjustments in the event of our sale of common shares for cash consideration during the preceding quarterly period at a price less than $2.41 per share. In addition, the number of shares to be issued in each installment shall be capped at the current market value of $1.25 million based on the volume weighted average price of our shares over the 20 trading days preceding the date for issuance of such installment. We have also agreed to issue to Veolia, on the one-year anniversary of the Agreement, warrants to purchase an additional 2,000,000 shares of our common stock at an exercise price of $5.00 per share and, on the second anniversary of the Agreement, warrants to purchase an additional 2,000,000 shares of our common stock at an exercise price $7.00 per share. The warrants will have a term of ten years from the date of issuance. The securities will be issued pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b) thereunder.


Executive Compensation

Effective as of February 25, 2019, we amended the Employment Agreement of our Chief Executive Officer, Stephen Cotton, to increase Mr. Cotton’s salary to $450,000 per year, effective as of January 7, 2019. We also agreed to provide Mr. Cotton with a change-in-control payment equal to twice his then annual salary and target annual bonus amount in the event of his termination without cause or his resignation for good reason following a change-in-control of Aqua Metals. At the same time, we granted Mr. Cotton a non-incentive stock option to purchase up to 1,260,000 shares of our common stock, with 420,000 options vesting on a one-year anniversary and exercisable at $3.08 per share, 420,000 options vesting on a two-year anniversary and exercisable at $3.68 per share and 420,000 options vesting on a three-year anniversary and exercisable at $4.18 per share.

Effective as of February 25, 2019, we also agreed to amend the Employment Agreement of our Chief Financial Officer, Judd Merrill, to provide Mr. Merrill with a change-in-control payment equal to 150% of his then annual salary and target annual bonus amount in the event of his termination without cause or his resignation for good reason following a change-in-control of Aqua Metals.



70



PART III
 
The information required by Part III is omitted from this report because we will file a definitive proxy statement within 120 days after the end of our 2018 fiscal year pursuant to Regulation 14A for our 2019 Annual Meeting of Stockholders, or the 2019 Proxy Statement, and the information to be included in the 2019 Proxy Statement is incorporated herein by reference.
 
Item 10.
Directors, Executive Officers and Corporate Governance
 
The information required by this item will be contained in the 2019 Proxy Statement and is hereby incorporated by reference.
 
Item 11.
Executive Compensation
 
The information required by this item will be contained in the 2019 Proxy Statement and is hereby incorporated by reference.
 
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
 
The information required by this item will be contained in the 2019 Proxy Statement and is hereby incorporated by reference.
 
Item 13.
Certain Relationships and Related Transactions, and Director Independence
 
The information required by this item will be contained in the 2019 Proxy Statement and is hereby incorporated by reference.
 
Item 14.
Principal Accountant Fees and Services
 
The information required by this item will be contained in the 2019 Proxy Statement and is hereby incorporated by reference.

71



PART IV
 
Item 15.
Exhibits and Financial Statement Schedules
 
(a)
Financial statements

Reference is made to the Index and Financial Statements under Item 8 in Part II hereof where these documents are listed.
 
(b)
Financial statement schedules

Financial statement schedules are either not required or the required information is included in the consolidated financial statements or notes thereto filed under Item 8 in Part II hereof.
 
(c)
Exhibits

The exhibits to this Annual Report on Form 10-K are set forth below. The exhibit index indicates each management contract or compensatory plan or arrangement required to be filed as an exhibit.
 
Number
 
Exhibit Description
 
Method of Filing
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Current Report on Form 8-K filed on December 11, 2017.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Current Report on Form 8-K filed January 17, 2019
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Current Report on Form 8-K filed on September 27, 2018.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 25, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on July 20, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on July 20, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on August 10, 2016
 
 
 
 
 

72



 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on August 10, 2016
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on August 10, 2016
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Annual Report on Form 10-K filed on March 2, 2017
 
 
 
 
 
 
 
Filed electronically herewith
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Proxy Statement on Form DEF 14A filed on April 24, 2017.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Current Report on Form 8-K filed on August 27, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed November 10, 2015.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed November 10, 2015.
 
 
 
 
 
 
 
Filed as an exhibit to the Registrant’s Registration Statement on Form S-3 filed on August 1, 2016.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on August 10, 2016.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on August 10, 2016.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on August 10, 2016.
 
 
 
 
 

73



 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on August 10, 2016.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on May 10, 2017.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on May 10, 2017.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on Form S-3 filed on February 27, 2017
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on August 9, 2017.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on August 9, 2017.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed on November 9, 2017.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant's Current Report on Form 8-K filed on April 19, 2018.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant's Quarterly Report on Form 10-Q filed on May 9, 2018.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant's Current Report on Form 8-K filed on April 25, 2018.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant's Current Report on Form 8-K filed on May 2, 2018.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant's Current Report on Form 8-K filed on May 2, 2018.
 
 
 
 
 
 
 
Incorporated by reference from the Registrant's Quarterly Report on Form 10-Q filed on August 8, 2018.
 
 
 
 
 
 
 
Filed electronically herewith
 
 
 
 
 
 
 
Filed electronically herewith
 
 
 
 
 
 
 
Incorporated by reference from the Registrant’s Registration Statement on S-1 filed on June 9, 2015.
 
 
 
 
 
 
 
Filed electronically herewith.
 
 
 
 
 

74



 
 
Filed electronically herewith.
 
 
 
 
 
 
 
Filed electronically herewith.
 
 
 
 
 
 
 
Filed electronically herewith.
 
 
 
 
 
101.INS
 
XBRL Instance Document
 
Filed electronically herewith
 
 
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
Filed electronically herewith
 
 
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
Filed electronically herewith
 
 
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
Filed electronically herewith
 
 
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
Filed electronically herewith
 
 
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
 
Filed electronically herewith
 
 
 
 
 
* Indicates management compensatory plan, contract or arrangement.
 
 
 
 
 
+ Certain portions of the exhibit have been omitted pursuant to Registrant’s confidential treatment request filed with the Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934. The omitted text has been filed separately with the Commission.


75



SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this annual report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
AQUA METALS, INC.
 
 
Date: February 28, 2019
By:
/s/ Stephen Cotton
 
 
Stephen Cotton,
 
 
President and Chief Executive Officer
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
Signature
 
Title
 
Date
 
 
 
 
 
/s/ Stephen Cotton
 
President, Chief Executive Officer and Director
 
February 28, 2019
Stephen Cotton
 
(Principal Executive Officer)
 
 
 
 
 
 
 
/s/ Judd Merrill
 
Chief Financial Officer
 
February 28, 2019
Judd Merrill
 
(Principal Financial and
Accounting Officer
 
 
 
 
 
 
 
/s/ S. Shariq Yosufzai
 
Director, Chairman of the Board
 
February 28, 2019
S. Shariq Yosufzai
 
 
 
 
 
 
 
 
 
/s/Vincent L. DiVito
 
Director
 
February 28, 2019
Vincent L. DiVito
 
 
 
 
 
 
 
 
 
/s/ Sushil Kapoor
 
Director
 
February 28, 2019
Sushil Kapoor
 
 
 
 
 
 
 
 
 
/s/ Gayle Gibson
 
Director
 
February 28, 2019
Gayle Gibson
 
 
 
 
 
 
 
 
 
/s/Mark Stevenson
 
Director
 
February 28, 2019
Mark Stevenson
 
 
 
 

76